Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3011985	p-reninm	mU/l (mu/l)	4638	7242	0.36%
3011985	fp-reninm	mU/l (mu/l)	1084	1612	0.00%
3011985	p-reninm	— (—)	710	841	100.00%	Distribution not available
3011985	fp-reniini,konsentraatio	mU/l (mu/l)	179	275	0.00%
3011985	fp-renin	mU/l (mu/l)	157	184	0.00%
3011985	fp-renin	— (—)	153	183	100.00%	Distribution not available
3011985	fp-reninm	— (—)	120	145	100.00%	Distribution not available
3011985	p-reninm	mU/l______ (mu/l)	93	123	0.00%
3011985	p-reniini,konsentraatio	mU/l______ (mu/l)	56	66	0.00%
3011985	p-reniinm	mU/l (mu/l)	30	35	0.00%
3011985	p-areninm	— (—)	21	21	100.00%	Distribution not available
3011985	p-oreninm	— (—)	21	21	100.00%	Distribution not available
3011985	p-vreninm	— (—)	19	19	100.00%	Distribution not available
3011985	reniini,konsentraatio	mU/l______ (mu/l)	18	19	0.00%
3011985	reniini,konsentraatio,plasmasta	mU/l (mu/l)	9	9	0.00%	Distribution not available	Distribution not available
3011985	p-reniini,konsentraatio	mU/l (mu/l)	8	9	0.00%	Distribution not available
3011985	reniini,konsentraatio	— (—)	8	8	100.00%	Distribution not available
3011985	fp-reniini,konsentraatio	— (—)	7	9	100.00%	Distribution not available
3011985	p-vreninm	mU/l (mu/l)	7	7	0.00%	Distribution not available
3011985	p-areninm	mU/l (mu/l)	6	6	0.00%	Distribution not available
3011985	p-oreninm	mU/l (mu/l)	5	5	0.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Disorders of other endocrine glands

1487

2666

5.78

307.65

2.8

1.3

66.09

61.82

mu/l

0.21

1371

2391

Hypertension

2028

1648

7.19

307.65

1.6

1.7

73.25

51.86

mu/l

1.82

1856

1508

Endocrine, nutritional and metabolic diseases

1239

1544

4.12

307.65

1.9

1.3

73.42

58.10

mu/l

0.77

1134

1405

Other disorders of fluid, electrolyte and acid-base balance

1312

1446

9.18

307.65

1.9

1.4

71.49

58.52

mu/l

0.61

1160

1278

Other disorders of adrenal gland

479

203

31.24

307.65

4.7

1.3

85.54

84.56

mu/l

0.01

453

185

Hyperaldosteronism

426

119

58.19

307.65

2.7

1.2

56.12

66.88

mu/l

0.13

389

109

Hypertension, essential

2001

1617

7.25

307.65

1.6

1.7

74.24

46.14

mu/l

4.18

1833

1480

Hypertensive diseases

2028

1649

7.19

307.65

1.6

1.7

73.25

51.83

mu/l

1.82

1856

1509

Secondary hypertension

514

171

34.10

307.65

2.3

1.5

80.38

36.00

mu/l

3.46

464

150

Hypokalaemia

856

550

18.08

307.65

1.8

1.4

58.65

56.21

mu/l

0.07

752

492

Benign neoplasm: Adrenal gland

1233

375

52.95

307.65

1.4

59.69

79.72

mu/l

0.45

1175

334

Exclusions for E4_PCOS_BROAD

775

986

8.55

307.65

3.5

1.3

75.48

68.40

mu/l

0.28

730

881

Cardiovascular diseases

1139

1006

6.15

307.65

1.8

2.2

66.05

58.22

mu/l

0.28

1052

923

Cardiovascular diseases (excluding rheumatic etc)

1347

1192

6.64

307.65

1.7

2.1

68.29

56.59

mu/l

0.54

1246

1096

Benign neoplasm of other and unspecified endocrine glands

1365

665

26.42

307.65

1.5

59.17

70.22

mu/l

0.38

1297

590

Adrenocortical insufficiency

415

165

34.59

307.65

5.2

1.2

81.87

83.54

mu/l

0.02

393

152

Hypertensive diseases (excluding secondary)

1578

943

10.19

307.65

1.7

1.9

72.24

57.43

mu/l

0.64

1455

862

Metabolic disorders

1983

3342

3.64

307.65

1.9

1.5

73.66

60.30

mu/l

1.07

1798

3013

Antihypertensive medication - note that there are other indications

1122

833

7.20

307.65

1.7

2.3

72.83

51.66

mu/l

0.94

1030

774

Other heart diseases

742

952

5.17

298.70

1.5

1.9

79.92

57.71

mu/l

0.87

679

870

Anaemias

392

228

11.30

287.42

1.9

1.6

87.22

83.86

mu/l

0.03

353

211

Hypertensive heart and/or renal disease

463

540

6.44

242.20

1.4

1.6

90.00

40.20

mu/l

2.84

411

486

Hypothyroidism (congenital or acquired)

375

232

9.23

224.78

2.4

1.7

76.17

51.09

mu/l

0.79

346

215

Diseases of arteries, arterioles and capillaries (FINNGEN)

417

446

6.63

218.05

1.4

1.6

113.60

42.75

mu/l

3.13

361

400

Heart failure and antihypertensive medication

381

332

7.64

217.53

1.4

1.8

99.72

64.14

mu/l

0.60

337

304

Hypothyroidism, levothyroxine purchases

365

231

9.03

215.95

2.4

1.7

78.86

43.65

mu/l

1.45

336

214

Hypothyroidism and >3 levothyroxin purchases

365

231

9.03

215.95

2.4

1.7

78.86

43.65

mu/l

1.45

336

214

Cerebrovascular diseases (FINNGEN)

484

636

5.45

212.66

1.5

1.7

71.34

46.91

mu/l

2.15

437

579

Disorders of lipoprotein metabolism and other lipidaemias

1270

2919

2.69

199.96

1.5

1.4

77.54

60.79

mu/l

1.47

1167

2622

Hypo-osmolality and hyponatraemia

407

787

5.33

197.05

2.3

1.3

80.73

55.67

mu/l

0.49

362

700

Hypertensive Heart Disease

381

505

5.87

186.05

1.4

1.6

82.23

40.99

mu/l

1.72

342

454

Type 2 diabetes, wide definition

1302

3304

2.53

183.41

1.6

1.5

87.30

53.22

mu/l

4.34

1179

2977

All chronic kidney diseases

973

2780

2.85

183.21

1.5

100.67

57.60

mu/l

3.88

874

2500

Benign neoplasms

1441

3296

2.41

177.11

1.7

66.04

70.87

mu/l

0.26

1327

2952

Hypothyroidism, drug reimbursement

230

148

11.13

176.35

3.0

1.4

51.33

30.98

mu/l

2.21

209

136

Diabetes mellitus

1585

4062

2.28

175.82

1.7

1.6

78.45

53.56

mu/l

3.35

1431

3684

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

1486

3829

2.33

174.48

1.6

81.13

54.00

mu/l

3.81

1349

3465

Diabetes, varying definitions

1572

4071

2.27

171.99

1.7

1.6

78.64

53.56

mu/l

3.35

1419

3693

Type 2 diabetes

1509

3907

2.26

164.57

1.6

79.25

52.94

mu/l

3.44

1354

3538

Sleep apnoea

1516

4340

2.23

163.31

1.5

1.6

72.89

62.34

mu/l

0.87

1362

3921

Pure hypercholesterolaemia

1092

2744

2.56

159.33

1.5

1.4

77.26

60.08

mu/l

1.35

1001

2459

Sleep apnoea, including avohilmo

1558

4371

2.18

157.58

1.5

1.6

66.12

61.58

mu/l

0.32

1404

3949

Diabetes medication

1588

4348

2.16

155.05

1.6

76.66

56.08

mu/l

2.48

1436

3935

All kidney diseases

1526

4789

2.16

154.54

1.6

80.64

60.33

mu/l

2.26

1365

4347

Diabetes, insulin treatment (Kela reimbursement)

1544

4335

2.15

149.17

1.6

80.05

57.08

mu/l

2.97

1404

3909

Malaise and fatigue

851

2537

2.68

143.76

1.8

1.5

57.95

65.93

mu/l

0.55

742

2303

Other nutritional deficiencies

1127

4519

2.31

143.42

1.6

79.51

63.43

mu/l

1.29

1015

4084

Atrial fibrillation and flutter

400

580

4.53

139.43

1.4

1.6

89.83

46.32

mu/l

1.76

361

528

Type 2 diabetes, definitions combined

1395

3771

2.18

139.21

1.5

1.6

79.68

52.79

mu/l

3.15

1258

3409

Hypopituitarism

220

335

6.98

138.87

2.2

1.3

73.02

91.66

mu/l

0.31

204

301

Type 2 diabetes, strict (exclude DM1)

1399

3795

2.17

138.44

1.5

1.6

81.34

52.78

mu/l

3.37

1262

3430

Other CVD (FINNGEN)

210

200

8.27

138.15

1.5

1.6

68.55

36.61

mu/l

1.19

185

180

Headache

1032

3389

2.38

136.23

1.6

63.23

66.88

mu/l

0.15

919

3093

Depression medications

310

246

6.42

135.27

1.8

1.7

82.10

42.81

mu/l

1.04

284

229

General symptoms and signs

1513

3621

2.12

134.99

1.6

61.33

66.62

mu/l

0.35

1345

3312

Other (not insulin) diabetes medications

1452

4084

2.11

134.39

1.5

1.6

81.47

55.56

mu/l

3.06

1313

3685

Heart failure, not strict

1171

3510

2.28

134.19

1.4

1.5

98.33

57.21

mu/l

4.14

1037

3168

Drug-induced adrenocortical insufficiency

122

15.80

132.94

2.9

1.2

58.43

65.00

mu/l

0.07

107

Type 2 diabetes, definitions combined, including avohilmo

1373

3767

2.13

129.80

1.5

1.6

79.44

52.85

mu/l

3.08

1233

3410

Obesity and other hyperalimentation

1051

4418

2.27

128.86

1.6

81.36

62.03

mu/l

1.65

948

3985

Obesity

1048

4410

2.27

128.66

1.6

81.37

61.91

mu/l

1.66

945

3978

Renal tubulo-interstitial diseases

1314

4618

2.11

128.06

1.5

1.6

79.12

59.24

mu/l

1.95

1175

4181

Pain in throat and chest

1211

3260

2.22

127.86

1.6

1.7

73.52

66.35

mu/l

0.35

1093

2945

Atrial fibrillation and flutter with reimbursement

335

437

4.92

126.91

1.4

1.6

94.99

38.88

mu/l

2.21

301

391

Cardiac arrhythmias

841

2103

2.60

126.75

1.5

1.8

77.60

52.02

mu/l

1.61

767

1911

Episodal and paroxysmal disorders

1482

3697

2.05

123.15

1.6

1.7

61.80

62.75

mu/l

0.05

1354

3343

Chronic kidney disease

539

1718

3.09

122.82

1.4

103.23

50.50

mu/l

2.99

472

1532

Renal failure

763

2553

2.59

122.38

1.4

97.43

55.76

mu/l

3.28

674

2285

Obesity due to excess calories

810

3355

2.46

120.26

1.5

1.6

85.49

60.66

mu/l

1.85

719

3032

First line medication for Crohn's disease

1551

4253

1.98

118.89

2.2

1.4

61.65

66.04

mu/l

0.32

1413

3845

Abnormalities of breathing

1228

3315

2.14

117.35

1.6

1.7

63.80

65.98

mu/l

0.11

1121

2995

Other heart diseases, wide

1331

3979

2.05

114.74

1.5

1.7

73.47

62.34

mu/l

0.75

1201

3623

Abnormal blood-pressure reading, without diagnosis

153

197

8.30

112.47

1.7

1.4

37.76

38.10

mu/l

0.02

138

172

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

1416

4935

1.95

110.19

1.6

77.36

61.76

mu/l

1.38

1261

4477

Tramadol

1155

3315

2.12

108.84

1.5

1.7

74.18

61.06

mu/l

0.89

1043

3004

Hyperkalaemia

153

209

7.71

106.56

2.4

1.3

138.67

86.13

mu/l

0.58

139

186

Nausea and vomiting

481

1584

3.02

106.40

2.0

1.5

54.15

67.32

mu/l

0.69

418

1430

Biguanides

1356

4188

1.98

106.14

1.5

1.6

80.98

57.22

mu/l

2.45

1230

3770

Paroxysmal tachycardia

278

525

4.47

105.19

1.4

1.7

57.68

43.33

mu/l

0.84

251

475

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

552

2032

2.78

104.90

1.4

1.5

107.07

58.23

mu/l

3.11

497

1812

Glucagon-like peptide-1 (GLP-1) analogues

552

2032

2.78

104.90

1.4

1.5

107.07

58.23

mu/l

3.11

497

1812

Symptoms and signs involving the circulatory and respiratory systems

1319

3323

2.01

103.10

1.6

1.7

62.53

65.88

mu/l

0.17

1204

3003

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

600

2337

2.62

101.87

2.0

1.5

60.97

59.89

mu/l

0.05

544

2098

Used for control exclusion in common control thyroid runs

1388

3628

1.95

99.80

1.9

1.4

68.41

61.90

mu/l

0.46

1260

3277

Insulin medication

851

3204

2.23

98.23

1.7

1.6

96.34

58.31

mu/l

3.21

770

2878

Neoplasms

966

2317

2.21

97.45

1.7

63.31

70.26

mu/l

0.32

896

2069

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

441

870

3.23

97.42

1.6

1.8

82.02

46.72

mu/l

1.47

395

792

Abnormalities of heart beat

558

2070

2.66

97.28

1.5

60.53

58.04

mu/l

0.09

484

1839

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

1275

4513

1.93

95.34

1.6

75.80

63.27

mu/l

0.98

1156

4073

Any reimbursement code in KELA

690

1380

2.53

92.28

1.8

1.4

75.05

54.71

mu/l

0.83

631

1262

Implicit Sepsis

1086

4061

1.99

91.10

1.6

1.5

74.00

62.67

mu/l

0.77

985

3634

Postprocedural endocrine and metabolic disorders, not elsewhere classified

237

562

4.35

90.79

2.9

1.4

56.07

51.98

mu/l

0.16

215

503

Sleep disorders (combined)

1449

4132

1.85

90.16

1.5

1.6

70.10

60.13

mu/l

0.77

1308

3737

Statin medication

885

2291

2.20

90.03

1.7

78.72

53.49

mu/l

1.81

815

2088

Other metabolic disorders

246

607

4.17

89.34

2.8

1.4

55.41

51.05

mu/l

0.18

222

543

Dyspnoea

1253

4846

1.88

89.09

1.5

1.6

69.88

64.02

mu/l

0.36

1132

4362

Disorders of mineral metabolism

188

381

5.14

87.68

2.2

1.4

49.19

61.84

mu/l

0.29

168

339

Hard cardiovascular diseases

1168

3583

1.95

87.44

1.4

1.6

80.56

61.82

mu/l

1.27

1060

3228

STROKE

776

2350

2.25

87.36

1.4

1.5

69.85

47.88

mu/l

2.36

714

2119

Any gastric operation

962

2307

2.11

85.93

1.6

1.7

69.93

62.62

mu/l

0.31

878

2083

GASTRO-related operations

962

2307

2.11

85.93

1.6

1.7

69.93

62.62

mu/l

0.31

878

2083

Implicit Sepsis, including avohilmo

1153

4351

1.91

85.52

1.5

1.6

74.40

63.31

mu/l

0.79

1048

3910

Insulin, intermediate and long-acting

794

3627

2.14

85.03

1.7

1.5

93.87

60.02

mu/l

2.67

721

3256

Non-invasive ventilation

340

906

3.29

84.77

1.5

1.7

50.67

63.25

mu/l

0.46

312

827

Hyperlipidaemia, other/unspecified

509

1780

2.61

84.37

1.4

99.70

57.80

mu/l

2.08

454

1580

Asthma, unspecified (mode), excluding more controls

751

2447

2.22

83.29

1.6

58.26

61.99

mu/l

0.22

675

2232

Other bacterial diseases, including avohilmo

1375

4823

1.80

81.42

1.7

1.6

75.42

62.93

mu/l

0.96

1228

4378

Condition for Implicit Sepsis (Organ dysfunction codes)

1178

4421

1.86

80.35

1.6

78.17

62.60

mu/l

1.27

1068

3981

Insulin, combination of fast acting with intermediate-acting or long-acting

852

3861

2.02

77.99

1.7

1.5

96.34

60.90

mu/l

2.88

770

3463

Oedema, not elsewhere classified

486

1894

2.55

77.98

1.6

1.4

77.38

63.79

mu/l

0.58

424

1707

Ischemic heart diseases

1138

3630

1.89

77.79

1.5

78.67

62.61

mu/l

1.00

1029

3270

Autoimmune diseases excluding thyroid diseases

1340

4073

1.80

77.28

1.9

1.4

65.87

61.14

mu/l

0.36

1224

3675

Asthma, unspecified (mode)

768

2629

2.13

77.14

1.6

57.33

62.24

mu/l

0.32

692

2393

Asthma, excluding more controls

991

2579

1.99

76.52

1.6

66.72

61.81

mu/l

0.27

899

2357

Medical observation and evaluation for suspected diseases and conditions

845

2060

2.12

76.52

1.6

1.5

74.16

68.15

mu/l

0.19

747

1852

Hypertensive Renal Disease

11.32

74.29

1.4

120.94

47.89

mu/l

1.18

Autoimmune diseases

1408

4096

1.76

74.29

2.0

1.4

71.67

61.04

mu/l

0.86

1277

3697

Neurological diseases

1034

2703

1.94

73.56

1.6

1.7

75.97

64.08

mu/l

0.59

948

2455

Other bacterial diseases

1268

4769

1.78

73.49

1.6

71.40

64.75

mu/l

0.45

1127

4325

Disorders of the thyroid gland

1226

4474

1.79

72.99

2.0

1.5

67.14

59.63

mu/l

0.55

1100

4044

Disorders of parathyroid gland

332

1125

2.98

72.03

2.0

1.2

51.79

59.87

mu/l

0.33

296

1001

Exclusions for E4_PCOS_CONSORTIUM

998

3295

1.91

71.78

2.1

1.6

55.28

63.04

mu/l

0.65

908

2978

Asthma (only as main-diagnosis), excluding more controls

917

2579

1.98

71.59

1.5

1.6

62.99

61.81

mu/l

0.05

834

2357

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

173

389

4.63

71.33

1.7

1.8

86.00

56.62

mu/l

0.75

157

361

Codeine

1175

3533

1.81

69.61

1.5

1.7

65.82

60.21

mu/l

0.33

1063

3208

Asthma

1016

2775

1.91

69.37

1.6

65.91

62.37

mu/l

0.19

922

2532

Symptoms and signs involving cognition, perception, emotional state and behaviour

1273

4933

1.74

68.75

1.5

1.6

66.40

63.89

mu/l

0.13

1145

4465

Other headache syndromes

576

2614

2.22

68.64

1.6

48.79

55.93

mu/l

0.57

532

2328

Percutaneous Coronary Intervention

1054

3504

1.85

68.14

1.4

1.5

80.43

61.69

mu/l

1.17

960

3155

Asthma (mode)

1007

2815

1.90

68.12

1.5

1.6

61.04

64.66

mu/l

0.19

912

2569

Insulin, fast-acting

528

2335

2.30

67.66

1.9

1.5

87.34

59.28

mu/l

1.89

475

2098

Obesity related asthma

544

2442

2.27

67.45

1.5

79.47

61.46

mu/l

0.84

497

2185

Dipeptidyl peptidase 4 (DPP-4) inhibitors

727

2811

2.05

67.28

1.4

79.50

55.42

mu/l

2.22

643

2499

Malignant neoplasm of endocrine gland, including Hilmo

188

472

4.15

67.15

2.5

1.4

59.00

63.88

mu/l

0.11

166

428

Oral corticosteroids

1371

4753

1.70

67.14

1.6

62.37

66.49

mu/l

0.28

1231

4307

Other arrhythmias

861

3357

1.93

66.92

1.4

1.7

59.39

59.35

mu/l

0.00

777

3034

Disorders of thyroid, IBD co-morbidities

233

429

3.77

66.49

2.1

1.8

77.45

56.42

mu/l

0.85

204

392

Coronary revascularization (ANGIO or CABG)

1047

3505

1.83

65.95

1.4

1.5

80.49

61.67

mu/l

1.17

957

3156

Opioids

1210

3567

1.76

65.12

1.6

1.7

69.40

60.02

mu/l

0.61

1094

3239

Other soft tissue disorders, not elsewhere classified

1194

3889

1.76

65.10

1.6

1.7

74.24

61.96

mu/l

0.81

1081

3539

Type 1 diabetes

364

1382

2.68

64.97

2.3

1.6

83.20

55.43

mu/l

1.29

327

1251

Autoimmune diseases excluding thyroid diseases, strict definition

1236

3879

1.75

64.93

1.9

1.4

66.48

61.52

mu/l

0.36

1128

3509

Major coronary heart disease event

1104

3715

1.79

64.81

1.4

1.5

82.16

62.61

mu/l

1.28

1006

3334

Pain in limb

1072

3814

1.80

64.68

1.5

1.7

76.63

62.06

mu/l

0.87

961

3468

Hypothyroidism, other/unspecified

1124

4208

1.77

64.52

2.1

1.5

67.05

59.49

mu/l

0.51

1005

3805

Persons encountering health services in other circumstances, wide

1434

4429

1.68

64.22

1.5

1.6

68.49

65.12

mu/l

0.18

1281

4015

Asthma (only as main-diagnosis)

933

2775

1.90

64.21

1.5

1.6

62.73

62.37

mu/l

0.02

849

2532

Disorders of calcium metabolism

136

274

5.16

63.99

2.4

1.3

47.93

64.58

mu/l

0.29

122

241

Neurological diseases, wide definition

346

581

3.02

63.84

1.6

1.8

76.35

72.56

mu/l

0.06

321

538

Disorders of gallbladder, biliary tract and pancreas

1271

4669

1.71

63.53

1.6

68.51

61.45

mu/l

0.52

1169

4190

Persons encountering health services for other counselling and medical advice, not elsewhere classified

1390

4425

1.68

63.42

1.6

68.80

65.15

mu/l

0.21

1249

4013

ILD medications: prednisolone, methylprednisolone, prednisone

1378

4594

1.68

63.30

1.7

1.6

62.30

64.93

mu/l

0.17

1238

4163

Emergency coronary revascularization (for ACS)

1108

3798

1.78

63.18

1.4

1.5

79.78

62.42

mu/l

1.11

1006

3402

Diarrhoea and gastroenteritis of presumed infectious origin

931

4582

1.83

63.17

2.2

1.5

72.17

65.49

mu/l

0.40

839

4145

Symptoms and signs involving the nervous and musculoskeletal systems

788

4156

1.92

62.79

1.5

63.73

64.15

mu/l

0.02

722

3721

Migraine

665

2531

2.07

62.76

1.8

1.7

51.80

57.04

mu/l

0.35

615

2287

Malignant neoplasm of endocrine gland

169

413

4.27

62.68

2.6

1.4

58.60

62.65

mu/l

0.08

153

373

Obesity, other/unspecified

501

2246

2.26

62.29

1.6

88.09

56.09

mu/l

1.63

456

2044

Insulin, fast-acting or short human

530

2433

2.21

62.06

1.9

1.5

87.01

65.58

mu/l

1.21

477

2189

Complications of surgical and medical care, not elsewhere classified

1286

5138

1.68

61.82

1.5

1.6

65.93

64.25

mu/l

0.10

1156

4644

Codeine or tramadol medication

1410

4645

1.66

61.78

1.5

1.6

68.10

61.37

mu/l

0.41

1266

4194

Hypothyreosis and Thyroxine purchase for inclusion criteria

1166

4460

1.73

61.28

2.1

1.5

66.35

58.81

mu/l

0.53

1041

4030

Intestinal infectious diseases

1220

5420

1.69

60.38

2.0

1.5

70.43

63.43

mu/l

0.47

1100

4909

Asthma (diagnoses ohter than nonallergic)

1133

5391

1.71

60.04

1.5

1.6

56.73

63.78

mu/l

0.71

1019

4873

Syncope and collapse

581

2312

2.12

59.61

1.5

64.31

61.58

mu/l

0.11

525

2095

Other antidepressants

1257

3801

1.70

59.31

1.5

1.6

77.21

56.17

mu/l

1.55

1115

3456

Other diseases of intestines

1310

4402

1.67

58.97

1.6

1.7

63.74

67.18

mu/l

0.19

1179

4002

ILD medications

1405

4645

1.64

58.83

1.7

1.6

67.91

64.64

mu/l

0.18

1266

4212

Low back pain

988

3773

1.78

58.41

1.6

1.7

63.53

63.28

mu/l

0.01

873

3431

Type 1 diabetes, wide definition, subgroup 1

305

1126

2.76

57.70

2.2

1.6

82.91

56.70

mu/l

1.08

276

1013

Volume depletion

151

360

4.30

57.52

1.9

1.4

103.07

69.78

mu/l

0.56

128

316

Ischaemic heart disease, wide definition

996

3483

1.78

57.05

1.4

1.5

84.64

59.30

mu/l

1.82

893

3124

Benzodiazepine use

1279

5284

1.65

56.69

1.6

64.15

64.27

mu/l

0.01

1129

4798

Dizziness and giddiness

973

4345

1.76

56.25

1.4

1.6

65.77

61.43

mu/l

0.20

862

3918

Diseases of oesophagus, stomach and duodenum

1330

4832

1.64

56.18

1.7

1.6

68.60

64.96

mu/l

0.22

1198

4375

Inflammatory bowel disease treatment related agents

1405

4859

1.61

55.52

1.6

61.18

66.28

mu/l

0.37

1264

4406

Type 1 diabetes, wide definition

313

1194

2.66

55.50

2.2

1.6

82.03

56.45

mu/l

1.08

281

1078

Pain, not elsewhere classified

395

1684

2.38

55.30

1.6

1.5

55.48

68.74

mu/l

0.68

352

1530

Persons encountering health services for specific procedures and health care

1345

4923

1.62

55.06

1.7

1.6

67.06

65.40

mu/l

0.09

1214

4459

Mood disorders, excluding more controls

1190

4210

1.67

54.74

1.6

68.00

57.88

mu/l

0.69

1060

3823

Implicit bacterial Sepsis, including avohilmo

603

2506

2.02

54.59

1.5

1.4

79.96

60.40

mu/l

1.05

545

2214

Implicit viral Sepsis, including avohilmo

429

1904

2.28

54.41

1.7

1.4

73.82

60.11

mu/l

0.57

391

1681

Lower back pain or/and sciatica

1352

5248

1.61

54.40

1.6

63.24

62.78

mu/l

0.02

1195

4763

Acute renal failure

322

1264

2.59

54.08

1.5

1.4

110.21

53.67

mu/l

2.44

291

1134

Spondylopathies

976

3303

1.76

53.98

1.4

1.6

63.96

64.85

mu/l

0.05

869

2994

Parasetamol

828

2249

1.87

53.95

1.6

1.7

74.63

69.22

mu/l

0.19

738

2063

Infections, IBD-co-morbidities

194

378

3.66

53.69

1.8

1.6

74.76

83.36

mu/l

0.12

171

346

Fever of other and unknown origin

676

3071

1.92

53.47

1.8

1.6

70.71

66.02

mu/l

0.22

606

2796

Hyperparathyroidism

266

945

2.84

53.12

1.6

1.2

52.94

62.96

mu/l

0.34

236

840

Other symptoms and signs involving the nervous and musculoskeletal systems

576

2924

1.99

51.65

1.5

52.49

64.97

mu/l

1.01

528

2613

Implicit bacterial Sepsis

541

2283

2.06

51.39

1.5

1.4

80.33

61.22

mu/l

0.90

487

2016

Complications of procedures, not elsewhere classified

1030

4980

1.68

51.02

1.5

1.6

61.46

63.28

mu/l

0.11

926

4498

Intestinal infectious diseases, including avohilmo, including avohilmo

1410

5004

1.58

50.97

1.7

1.5

74.49

61.58

mu/l

0.88

1267

4532

Viral Sepsis

303

1193

2.58

50.59

1.8

1.5

81.09

63.12

mu/l

0.52

277

1061

Implicit viral Sepsis

302

1192

2.58

50.17

1.8

1.5

81.16

63.17

mu/l

0.52

276

1060

Dorsalgia

1185

3844

1.64

49.94

1.6

1.7

68.87

63.33

mu/l

0.28

1051

3500

Hypothyroidism, strict autoimmune

852

3169

1.78

49.86

2.1

1.4

71.39

58.45

mu/l

0.77

764

2850

Heart failure,strict

650

2378

1.93

49.52

1.3

1.4

89.22

56.84

mu/l

2.62

563

2130

Bacterial Sepsis

605

2591

1.95

49.38

1.5

1.4

79.80

60.63

mu/l

1.02

545

2293

Benign neoplasm: Pituitary gland, craniopharyngeal duct

119

268

4.64

49.18

2.2

1.4

51.38

67.66

mu/l

0.34

111

243

Asthma, hospital admission 2, infections

755

4135

1.80

49.03

1.6

67.00

64.25

mu/l

0.11

681

3714

Asthma-related infections

755

4135

1.80

49.03

1.6

67.00

64.25

mu/l

0.11

681

3714

Abnormal findings on examination of blood, without diagnosis

607

2875

1.93

48.90

1.6

1.5

70.11

64.56

mu/l

0.30

551

2565

Mood disorders

1276

5167

1.59

48.81

1.6

66.36

62.47

mu/l

0.21

1143

4684

Persons encountering health services in other circumstances

546

2745

1.99

48.72

1.7

1.6

51.83

62.31

mu/l

0.92

477

2479

Chronic lower respiratory diseases

1457

4969

1.55

48.54

1.5

1.7

62.66

66.15

mu/l

0.24

1319

4497

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

849

4287

1.74

48.36

1.6

1.5

68.81

59.16

mu/l

0.54

772

3830

Mood [affective] disorders

1272

5170

1.59

48.27

1.6

66.25

62.52

mu/l

0.20

1139

4687

Symptoms and signs involving the digestive system and abdomen

1159

3555

1.64

48.27

1.6

61.65

68.38

mu/l

0.46

1038

3228

Diverticular disease of intestine

883

3171

1.75

48.19

1.5

63.11

63.52

mu/l

0.02

794

2853

Other functional intestinal disorders

589

2792

1.94

47.88

1.6

1.5

56.40

64.39

mu/l

0.49

518

2512

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

1246

5058

1.59

47.79

1.8

1.5

73.11

61.85

mu/l

0.70

1124

4581

Intracranial trauma

643

2290

1.91

47.67

1.6

1.8

64.62

65.67

mu/l

0.04

578

2086

Complications of medical and surgical care

932

5036

1.68

46.77

1.5

1.6

57.93

63.55

mu/l

0.45

844

4531

Depression

1200

5075

1.59

46.59

1.7

1.6

68.18

63.08

mu/l

0.28

1076

4599

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

387

819

2.39

46.56

1.7

1.6

65.29

71.76

mu/l

0.13

351

756

Care involving use of rehabilitation procedures

824

4319

1.73

46.47

1.6

1.5

56.61

66.53

mu/l

0.77

750

3901

Spondylosis

694

2995

1.83

46.02

1.4

1.5

51.75

63.42

mu/l

1.21

630

2705

587

3096

1.90

45.82

1.7

1.6

63.98

63.90

mu/l

0.00

531

2796

Examination and observation for other reasons

678

2059

1.87

45.36

1.7

1.5

70.69

68.18

mu/l

0.08

632

1851

Abdominal and pelvic pain

1142

3555

1.62

45.29

1.6

64.82

68.38

mu/l

0.21

1025

3228

Other and unspecified iron deficiency

455

2227

2.07

45.05

1.5

101.98

60.32

mu/l

1.57

391

2007

Nutritional anaemias

626

3255

1.85

44.78

1.6

1.5

95.52

57.87

mu/l

2.03

538

2920

Concussion

561

2262

1.94

44.65

1.6

1.7

58.01

66.11

mu/l

0.44

505

2060

Coronary atherosclerosis

784

2831

1.76

44.16

1.4

1.5

93.15

57.02

mu/l

2.57

699

2528

General examination and investigation of persons without complaint and reported diagnosis

719

2059

1.83

43.68

1.6

1.5

65.61

68.18

mu/l

0.10

653

1851

Hypotension

242

919

2.68

43.58

1.5

1.4

64.35

60.60

mu/l

0.08

212

821

Cholelithiasis, broad definition with cholecystitis

1046

4337

1.62

43.30

1.6

73.02

57.54

mu/l

1.34

961

3881

Depression or dysthymia

790

2467

1.76

43.19

1.6

80.80

56.76

mu/l

1.42

701

2246

Acute tubulo-interstitial nephritis

751

3666

1.74

43.13

1.6

1.5

63.84

55.15

mu/l

0.49

659

3305

Cholelithiasis

1011

4275

1.63

43.03

1.6

1.5

72.21

57.45

mu/l

1.21

927

3824

Spinal stenosis

625

2514

1.85

42.63

1.4

61.76

63.65

mu/l

0.09

549

2259

Anxiety disorders, excluding more controls

1016

4031

1.62

42.30

1.7

1.6

70.66

58.35

mu/l

0.86

905

3661

Fibromyalgia

172

553

3.20

42.25

1.6

63.75

46.95

mu/l

0.64

158

508

Sciatica+with lumbago

657

3269

1.80

42.09

1.5

1.6

61.77

64.64

mu/l

0.16

589

2963

Other CVD

269

1096

2.49

41.86

1.5

1.4

61.88

58.78

mu/l

0.08

236

976

Combinations of oral blood glucose lowering drugs

359

1659

2.20

41.67

1.4

126.12

56.92

mu/l

2.83

317

1470

1077

3965

1.60

41.52

1.6

67.90

62.82

mu/l

0.30

961

3594

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

1077

3965

1.60

41.52

1.6

67.90

62.82

mu/l

0.30

961

3594

Diseases of arteries, arterioles and capillaries

791

3428

1.71

41.05

1.4

1.5

87.04

57.52

mu/l

1.97

698

3060

Genitourinary diseases

646

1758

1.86

41.00

1.5

1.6

83.02

78.32

mu/l

0.12

586

1616

Erysipelas, including avohilmo

888

4016

1.65

40.78

1.4

1.5

82.35

60.82

mu/l

1.33

780

3627

Certain infectious and parasitic diseases

1133

3614

1.58

40.31

1.6

1.5

63.80

62.95

mu/l

0.04

1025

3280

Continuous positive airway pressure

213

643

2.80

40.22

1.3

1.6

115.07

64.85

mu/l

0.93

186

583

Autoimmune diseases related-to ILD

1032

5503

1.58

40.10

1.9

1.5

81.77

59.71

mu/l

1.69

937

4968

Other dorsopathies, not elsewhere classified

1155

3853

1.57

39.94

1.6

1.7

59.17

63.26

mu/l

0.25

1028

3509

Sub-endpoint used in defining T1D endpoints

372

1745

2.12

39.68

2.3

1.5

77.28

66.03

mu/l

0.39

335

1572

Nerve, nerve root and plexus disorders

1265

5027

1.52

39.45

1.6

73.98

60.71

mu/l

0.90

1133

4546

Iron deficiency anaemia

538

2863

1.86

39.45

1.5

98.08

58.27

mu/l

1.84

462

2568

Asthma, hospital admissions , main diagnosis only

987

5463

1.58

39.20

1.6

61.08

65.15

mu/l

0.23

896

4937

Bacterial infection, other or unspecified, including avohilmo

705

3370

1.73

39.15

1.7

1.5

67.48

63.22

mu/l

0.24

633

3020

Other intervertebral disc disorders

964

3585

1.61

38.92

1.6

69.79

64.20

mu/l

0.26

867

3254

Migraine without aura

254

1043

2.47

38.84

2.0

1.8

52.01

54.42

mu/l

0.09

237

940

Other diseases of liver

276

1179

2.38

38.83

1.6

1.4

87.70

63.64

mu/l

0.85

252

1064

Finngen Rheumatological endpoints

1114

4079

1.56

38.56

1.6

1.7

72.68

60.39

mu/l

0.68

1005

3700

Hypoparathyroidism

171

5.09

38.33

3.8

1.2

67.27

90.28

mu/l

0.25

151

Hypocalcemia

114

6.27

38.25

3.1

1.3

36.45

100.29

mu/l

0.74

105

Other septicaemia, including avohilmo

474

2339

1.92

38.06

1.7

1.4

84.97

63.00

mu/l

0.86

431

2095

Other septicaemia

464

2285

1.93

38.05

1.7

1.4

86.47

62.66

mu/l

0.93

421

2045

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

748

4417

1.67

37.99

1.6

1.5

60.39

62.60

mu/l

0.12

674

3964

Convulsions, not elsewhere classified

298

1311

2.27

37.76

1.8

1.5

57.95

72.31

mu/l

0.66

269

1192

Asthma, including avohilmo

1382

5157

1.48

37.75

1.5

1.6

64.83

65.16

mu/l

0.02

1247

4669

Bleeding

987

4411

1.58

37.60

1.5

64.46

65.55

mu/l

0.05

879

3974

Explicit Sepsis

530

2636

1.85

37.59

1.7

1.5

81.24

61.56

mu/l

0.85

478

2342

Other pulmonary diagnosis

910

2802

1.64

37.52

1.5

1.6

67.11

62.08

mu/l

0.22

812

2556

Vocal cord dysfunction

158

448

3.15

37.26

1.7

69.97

67.17

mu/l

0.03

144

410

Other special examinations and investigations of persons without complaint or reported diagnosis

707

2060

1.75

37.25

1.6

1.5

65.25

68.15

mu/l

0.10

644

1852

Pain in joint

673

2379

1.75

37.09

1.7

1.6

83.25

60.56

mu/l

1.00

600

2172

Osteopathies and chondropathies

710

3870

1.69

37.08

1.7

1.5

59.41

60.86

mu/l

0.08

627

3480

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

1163

4852

1.52

37.05

1.5

1.7

66.76

64.94

mu/l

0.09

1043

4412

Explicit Sepsis, including avohilmo

539

2697

1.83

36.90

1.7

1.5

80.10

61.71

mu/l

0.79

487

2396

Migraine with aura

305

1386

2.23

36.87

1.7

56.21

54.64

mu/l

0.05

281

1245

Glomerular diseases

257

1089

2.40

36.85

1.4

1.5

91.74

63.76

mu/l

1.03

220

978

Polyarthropathies

797

3102

1.66

36.71

1.5

1.6

75.53

60.99

mu/l

0.86

709

2831

Pregnancy hypertension

517

2522

1.85

36.70

1.7

65.09

52.82

mu/l

0.79

474

2283

Glomerular disorders in diseases classified elsewhere

183

660

2.84

36.67

1.4

1.5

88.74

75.15

mu/l

0.30

162

599

Aplastic and other anaemias

547

2789

1.81

36.38

1.4

86.05

60.86

mu/l

1.58

487

2486

Recurrent or chronic depression

501

1855

1.89

36.30

1.7

1.6

76.24

58.04

mu/l

0.84

440

1689

Influenza and pneumonia

1257

5223

1.49

36.27

1.6

67.28

64.25

mu/l

0.18

1127

4738

Thyroiditis, ILD-related definition

182

659

2.82

36.18

3.7

1.5

118.71

58.12

mu/l

1.60

166

593

Exposure to unspecified factor

1208

5516

1.50

36.03

1.6

71.90

62.87

mu/l

0.43

1073

5007

Anxiety (asthma-related co-morbidities)

741

3403

1.67

35.69

1.8

1.7

61.59

60.91

mu/l

0.03

661

3093

Disorder of lipoprotein metabolism, unspecified

165

570

2.95

35.69

1.8

1.4

69.93

60.11

mu/l

0.21

156

503

Anxiety disorders

1094

4955

1.52

35.46

1.7

1.6

69.91

62.61

mu/l

0.44

978

4490

Excluding asthma or asthma-COPD overlap

899

2802

1.62

35.36

1.5

1.6

67.61

62.08

mu/l

0.24

801

2556

Angina pectoris

658

2545

1.73

35.31

1.4

1.5

91.88

55.84

mu/l

2.11

598

2267

Septicaemia

505

2530

1.84

35.17

1.7

1.4

82.55

63.43

mu/l

0.76

457

2269

Valvular heart disease excluding rheumatic fever

536

2117

1.82

34.93

1.3

1.5

87.16

60.71

mu/l

1.06

480

1905

Neurotic, stress-related and somatoform disorders

1083

4936

1.52

34.80

1.7

1.6

70.33

62.37

mu/l

0.49

967

4474

Non-rheumatic valve diseases

532

2099

1.82

34.70

1.3

1.5

87.44

59.65

mu/l

1.13

477

1888

Hernia of abdominal wall, postoperative

229

939

2.45

34.62

1.4

108.32

51.76

mu/l

1.66

207

837

Bacterial infection, other or unspecified

633

3138

1.72

34.52

1.7

1.4

69.85

63.22

mu/l

0.38

565

2807

Symptoms and signs involving the urinary system

898

4327

1.58

34.38

1.6

1.5

58.92

67.38

mu/l

0.64

800

3894

Cholecystectomy

845

4542

1.59

34.37

1.6

1.5

66.08

57.81

mu/l

0.57

785

4056

Erysipelas

663

3413

1.69

34.17

1.4

70.74

64.29

mu/l

0.36

576

3075

Other disorders of kidney and ureter

199

778

2.61

34.05

1.4

86.92

67.58

mu/l

0.50

174

694

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

691

4193

1.66

33.95

1.6

1.5

57.00

63.71

mu/l

0.50

621

3770

ILD differential diagnosis

894

2815

1.60

33.76

1.5

1.6

65.52

64.66

mu/l

0.03

797

2569

Covid-19 confirmed case

455

2463

1.86

33.70

1.6

1.5

59.48

67.67

mu/l

0.46

400

2207

COPD differential diagnosis

893

2817

1.60

33.49

1.5

1.6

65.59

64.62

mu/l

0.03

796

2571

Cerebrovascular diseases

859

3780

1.59

33.41

1.4

1.5

73.64

58.83

mu/l

1.27

772

3379

Other anaemias

501

2619

1.81

33.25

1.4

86.15

61.41

mu/l

1.41

446

2339

Other and unspecified anaemias

497

2600

1.81

33.24

1.4

86.29

61.55

mu/l

1.40

442

2321

All pneumoniae

1198

5298

1.48

33.15

1.6

66.76

64.49

mu/l

0.13

1070

4806

Pneumonia, organism unspecified

1085

4983

1.50

32.88

1.6

65.58

64.97

mu/l

0.03

969

4516

Asthma/COPD (KELA code 203)

1106

4968

1.50

32.77

1.5

1.7

63.26

66.16

mu/l

0.16

1012

4496

Lumbar disc prolapse

754

3464

1.62

32.64

1.6

70.18

64.71

mu/l

0.21

684

3142

Nonalcoholic fatty liver disease

168

620

2.78

32.32

1.4

81.60

63.95

mu/l

0.40

157

558

Heart failure, strict

672

2814

1.67

32.29

1.3

1.4

86.69

62.38

mu/l

1.71

583

2514

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

560

2818

1.74

32.21

1.7

63.96

53.23

mu/l

0.71

512

2548

Any mental disorder

1240

4240

1.47

32.11

1.5

1.6

71.14

60.33

mu/l

0.67

1106

3853

Diseases of liver

445

2437

1.85

31.99

1.7

1.5

89.93

64.73

mu/l

1.19

401

2177

Pneumonias (Asthma/COPD co-morbidities)

1186

5304

1.47

31.90

1.6

66.91

64.44

mu/l

0.14

1058

4812

Epilepsy

345

1732

2.01

31.87

1.6

1.5

76.58

69.46

mu/l

0.14

310

1550

Dorsopathies

1136

3868

1.49

31.81

1.6

1.7

61.28

63.57

mu/l

0.13

1019

3524

Haemorrhage from respiratory passages

377

1724

1.95

31.66

1.5

1.4

65.31

65.65

mu/l

0.01

333

1531

Major coronary heart disease event excluding revascularizations

675

2696

1.66

31.55

1.4

1.5

92.78

60.43

mu/l

1.79

612

2398

Gastrointestinal diseases

620

1808

1.73

31.43

1.6

1.7

73.24

71.53

mu/l

0.04

564

1656

Constipation

1040

4725

1.50

31.32

1.5

1.6

52.91

66.67

mu/l

1.84

928

4266

All anxiety disorders

750

3650

1.61

31.31

1.8

1.7

62.00

63.42

mu/l

0.06

669

3323

All-cause Heart Failure

659

2771

1.67

31.30

1.3

1.4

83.37

60.76

mu/l

1.56

572

2478

COPD/asthma/ILD related infections

1165

3965

1.48

30.95

1.6

62.13

62.82

mu/l

0.03

1041

3594

COPD/asthma related infections

1165

3965

1.48

30.95

1.6

62.13

62.82

mu/l

0.03

1041

3594

Cough

457

2369

1.81

30.89

1.6

1.5

59.68

65.53

mu/l

0.18

413

2120

Diseases of the skin and subcutaneous tissue

1108

3745

1.49

30.72

1.5

1.6

75.08

62.97

mu/l

0.69

996

3403

Gastro-oesophageal reflux disease

802

4346

1.57

30.62

1.6

1.5

65.57

64.95

mu/l

0.03

715

3925

Use of hypnotics and sedatives

1216

4799

1.46

30.58

1.6

74.68

63.17

mu/l

0.70

1064

4368

Functional dyspepsia

353

1822

1.96

30.51

1.6

1.5

35.46

59.61

mu/l

3.41

315

1627

Selective serotonin reuptake inhibitors

1089

3816

1.49

30.34

1.6

69.42

56.65

mu/l

0.89

973

3471

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

1156

5314

1.46

29.96

1.6

66.81

64.87

mu/l

0.10

1029

4822

Dermatitis and eczema

1288

5350

1.43

29.94

1.6

72.90

62.37

mu/l

0.71

1156

4843

Hypothyroidism, strict autoimmune, 3 medication purchases required

936

4165

1.52

29.92

2.0

1.5

72.18

56.37

mu/l

1.13

836

3756

Infections of the skin and subcutaneous tissue

699

4338

1.60

29.62

1.5

1.6

70.33

67.95

mu/l

0.10

617

3926

Other specific joint derangements/joint disorders

843

3398

1.55

29.60

1.7

81.17

61.04

mu/l

1.10

747

3107

Elevated blood glucose level

134

460

2.98

29.52

1.7

1.4

79.57

79.43

mu/l

0.00

123

412

Primary hyperparathyroidism

170

663

2.62

29.35

1.6

1.4

45.99

54.90

mu/l

0.29

157

589

Soft tissue disorders

1119

3909

1.47

29.32

1.5

1.7

76.90

61.79

mu/l

0.90

999

3558

Rheumatism, unspecified

196

817

2.44

29.31

1.5

61.27

53.32

mu/l

0.30

176

740

Codes for special purposes

617

3769

1.64

28.88

1.6

57.42

63.39

mu/l

0.39

551

3399

Provisional assignment of new diseases of uncertain etiology

616

3764

1.63

28.81

1.6

57.50

63.47

mu/l

0.39

550

3394

Disorders of eyelid, lacrimal system and orbit

1001

4988

1.48

28.57

1.6

57.69

62.15

mu/l

0.26

898

4495

Other disorders of urethra and urinary system

789

3544

1.56

28.56

1.6

58.83

58.84

mu/l

0.00

699

3220

1283

4584

1.43

28.23

1.7

1.6

58.59

62.26

mu/l

0.25

1153

4136

Other/unspecified dorsalgia

438

2451

1.78

28.04

1.5

1.6

58.95

64.42

mu/l

0.26

389

2215

Diseases of pulp and periapical tissues, including avohilmo

1146

4100

1.45

28.02

1.6

71.07

66.12

mu/l

0.23

1032

3710

Osteoporosis

340

1634

1.94

27.90

2.0

1.3

56.33

59.86

mu/l

0.14

299

1457

Other neurological diseases

816

4162

1.53

27.70

1.5

64.56

60.02

mu/l

0.27

750

3711

Non-selective monoamine reuptake inhibitors

435

2372

1.78

27.48

1.4

1.5

70.49

54.31

mu/l

0.61

390

2141

Dental caries

318

1544

1.96

27.48

1.8

1.6

95.83

79.50

mu/l

0.32

287

1399

Psychiatric diseases

1080

3710

1.47

27.46

1.5

1.6

66.45

61.19

mu/l

0.26

965

3365

Pain (limb, back, neck, head abdominally)

755

2402

1.58

27.46

1.5

1.6

70.01

63.39

mu/l

0.23

682

2196

Caries of dentine

291

1403

2.02

27.42

1.8

1.6

92.69

76.09

mu/l

0.32

262

1271

Viral and other specified intestinal infections, including avohilmo

331

1668

1.93

27.22

2.1

1.6

82.27

69.96

mu/l

0.32

299

1519

Diabetic maculopathy, excluding more controls

141

520

2.76

27.15

2.1

1.4

93.02

54.54

mu/l

0.92

124

458

Abnormal findings on diagnostic imaging of other body structures

205

903

2.31

27.07

1.7

1.4

53.92

50.81

mu/l

0.11

192

807

Dermatitis

731

4653

1.55

27.01

1.5

1.6

69.27

60.04

mu/l

0.41

648

4201

Substance abuse, excluding more controls

615

3201

1.62

26.85

1.4

1.6

76.58

62.30

mu/l

0.52

539

2910

Unspecified kidney failure

132

474

2.83

26.74

1.5

1.4

108.01

59.59

mu/l

1.33

118

427

Symptoms and signs concerning food and fluid intake

143

537

2.70

26.47

1.4

58.81

87.88

mu/l

0.59

128

485

Visual disturbances and blindness

612

3853

1.60

26.22

1.7

1.5

58.02

63.54

mu/l

0.28

560

3452

Myocardial infarction

529

2214

1.68

26.18

1.3

1.5

83.02

60.58

mu/l

1.22

478

1974

Other anxiety disorders

545

2842

1.64

25.53

1.7

57.62

60.98

mu/l

0.17

489

2594

Other retinal disorders

721

3583

1.54

25.11

1.6

1.5

62.03

60.75

mu/l

0.05

643

3214

Viral and other specified intestinal infections

245

1161

2.08

25.10

2.2

1.6

87.45

78.71

mu/l

0.16

222

1051

Irritable bowel syndrome

332

1795

1.87

25.00

1.7

1.6

51.41

58.31

mu/l

0.37

299

1618

Acute upper respiratory infections

1161

4966

1.41

24.71

1.7

1.5

59.28

63.35

mu/l

0.34

1053

4473

Asthma-related pneumonia

410

2362

1.74

24.61

1.5

76.96

65.84

mu/l

0.32

370

2108

Visual disturbances

572

3605

1.60

24.58

1.7

1.5

59.21

64.59

mu/l

0.26

528

3226

ILD medications: immunosuppressive drugs

729

4374

1.52

24.58

1.6

74.72

65.87

mu/l

0.45

668

3964

Certain disorders involving the immune mechanism

243

1191

2.07

24.50

1.7

1.5

71.13

69.57

mu/l

0.03

221

1078

Asthma, hospital admissions 3, pneumonia

410

2365

1.74

24.50

1.5

76.96

65.81

mu/l

0.32

370

2110

Asthma-related pneumonia or sepsis

410

2365

1.74

24.50

1.5

76.96

65.81

mu/l

0.32

370

2110

Heart failure and coronary heart disease

445

1818

1.73

24.32

1.4

91.69

59.35

mu/l

1.76

391

1607

Other and unspecified dermatitis

615

3950

1.57

24.32

1.5

1.6

58.02

58.65

mu/l

0.03

543

3555

Other and unspecified effects of external causes

338

1857

1.84

24.20

1.6

98.15

65.50

mu/l

0.66

308

1686

Cystitis

915

3734

1.46

24.14

1.5

1.6

58.70

62.80

mu/l

0.21

803

3389

Atherosclerosis, excluding cerebral and coronary sclerosis

426

1946

1.73

24.06

1.3

1.4

127.92

48.35

mu/l

3.72

361

1734

Polycystic ovarian syndrome, consortium definition

817

3149

1.50

23.84

1.8

1.6

65.83

49.34

mu/l

1.69

723

2859

Undetermined asthma, excluding more controls

167

712

2.38

23.73

1.6

1.5

47.57

58.54

mu/l

0.40

151

648

Other systemic involvement of connective tissue (FG)

306

1611

1.88

23.59

1.6

1.5

46.40

53.20

mu/l

0.47

274

1438

Migraine without aura and triptan purchases

211

995

2.15

23.56

1.9

1.8

45.83

56.33

mu/l

0.47

196

906

Dialysis, with operation codes

160

673

2.42

23.55

1.4

1.5

115.23

53.37

mu/l

1.45

144

608

Gestational [pregnancy-induced] hypertension

293

1551

1.91

23.46

1.7

1.8

55.36

52.10

mu/l

0.14

271

1420

Other diseases of pancreas

128

489

2.68

23.16

1.4

43.36

72.29

mu/l

0.89

117

433

183

823

2.26

23.03

2.0

1.6

50.24

56.86

mu/l

0.29

164

750

Stroke, excluding SAH

641

3004

1.55

22.95

1.4

76.75

59.54

mu/l

1.18

571

2663

Adverse effects, not elsewhere classified

247

1248

2.00

22.90

1.6

78.69

65.33

mu/l

0.24

227

1122

Other general symptoms and signs

200

3.69

22.83

1.2

1.4

61.34

135.28

mu/l

0.66

183

Disorders of choroid and retina

896

4363

1.44

22.73

1.6

1.5

63.86

62.68

mu/l

0.05

789

3935

Shoulder lesions

823

3357

1.48

22.71

1.5

1.6

77.08

59.70

mu/l

1.03

741

3043

Somatoform disorder

214

1031

2.11

22.64

1.8

1.5

74.85

69.33

mu/l

0.12

191

928

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

139

559

2.53

22.61

1.8

1.4

46.61

76.25

mu/l

1.06

123

499

Symptoms and signs involving the skin and subcutaneous tissue

814

5308

1.46

22.47

1.6

60.48

62.76

mu/l

0.11

728

4793

Other reaction to severe stress, and adjustment disorders

421

2516

1.69

22.37

1.7

67.41

62.88

mu/l

0.14

379

2288

Systemic connective tissue disorders

405

2402

1.70

22.26

1.5

70.66

60.19

mu/l

0.29

363

2141

Certain infectious and parasitic diseases, including avohilmo

758

2535

1.51

22.18

1.6

1.5

74.50

56.93

mu/l

0.85

682

2303

Persons encountering health services for examination and investigation

638

2060

1.56

22.02

1.5

67.74

68.15

mu/l

0.01

584

1852

Benign neoplasm of colon, rectum, anus and anal canal

704

4002

1.50

21.97

1.4

67.60

59.90

mu/l

0.41

631

3576

Diseases of the eye and adnexa

839

2871

1.47

21.95

1.6

74.45

65.23

mu/l

0.37

758

2627

Chronic apical periodontitis

1220

5015

1.37

21.91

1.6

69.52

61.98

mu/l

0.44

1075

4555

Oxycodone

429

2209

1.67

21.66

1.7

1.5

66.49

55.78

mu/l

0.50

379

1975

Personality disorders, excluding more controls

287

1549

1.87

21.63

1.6

78.10

57.26

mu/l

0.51

258

1416

Malignant neoplasm of kidney, except renal pelvis

125

490

2.60

21.48

1.8

1.4

50.17

81.98

mu/l

0.99

110

440

Gout

305

1436

1.84

21.44

1.4

109.41

61.04

mu/l

1.50

263

1285

Undetermined asthma

167

745

2.27

21.41

1.6

1.5

47.57

63.14

mu/l

0.63

151

681

Stroke, including SAH

674

3224

1.51

21.39

1.4

76.00

59.37

mu/l

1.19

601

2862

Bronchitis

1203

5310

1.36

21.37

1.7

1.6

64.58

61.28

mu/l

0.19

1088

4792

Cervicalgia

253

1324

1.93

21.20

1.4

1.5

54.84

64.07

mu/l

0.44

232

1186

Carpal tunnel syndrome

697

4088

1.49

21.15

1.5

77.99

57.17

mu/l

1.03

623

3679

Rotator cuff syndrome

676

3109

1.51

21.09

1.5

1.6

68.52

59.20

mu/l

0.55

598

2816

Gonarthrosis [arthrosis of knee](FG)

809

3204

1.46

20.99

1.5

76.61

59.60

mu/l

0.86

726

2888

Diabetic nephropathy, excluding more controls

234

967

2.01

20.83

1.5

102.57

75.42

mu/l

0.77

207

881

Abnormal findings on diagnostic imaging of lung

518

3141

1.57

20.73

1.4

66.33

59.50

mu/l

0.32

466

2791

Mental and behavioural disorders due to psychoactive substance use

643

3945

1.50

20.71

1.4

1.6

83.38

66.45

mu/l

0.63

565

3570

Myocardial infarction, without ST-elevation

410

2237

1.67

20.61

1.2

1.4

80.97

60.72

mu/l

1.01

369

1984

Nephropathy related operations

158

703

2.29

20.52

1.3

1.5

109.75

66.99

mu/l

0.80

144

635

Dental pulpitis, including avohilmo

1031

4782

1.39

20.52

1.7

1.6

58.40

67.85

mu/l

0.87

931

4326

Other disorders of lacrimal gland

433

2675

1.63

20.37

1.8

1.5

59.97

57.53

mu/l

0.11

386

2409

Fall on same level

1250

4954

1.35

20.36

1.5

1.7

61.54

67.34

mu/l

0.40

1111

4515

Migraine with aura and triptan purchases

194

938

2.09

20.36

1.8

49.12

55.74

mu/l

0.25

181

854

Paralytic ileus and intestinal obstruction

280

1532

1.84

20.35

1.5

1.4

41.62

71.79

mu/l

2.63

249

1368

Diseases of the respiratory system

689

2303

1.51

20.32

1.5

1.6

65.02

64.52

mu/l

0.01

618

2103

Hypoglycaemia, other or unspecified

339

2.89

20.23

2.5

1.4

60.70

97.22

mu/l

0.55

304

Malignant neoplasm of urinary organs, including Hilmo

146

632

2.35

20.22

1.7

1.3

44.98

74.65

mu/l

1.20

130

566

Soft tissue disorders related to use, overuse and pressure

324

1858

1.76

20.19

1.5

92.66

54.80

mu/l

1.07

295

1667

Malignant neoplasm of urinary organs

131

541

2.47

20.18

1.8

1.4

47.84

77.73

mu/l

1.01

116

485

Urinary track infection

652

2163

1.52

19.91

1.5

1.7

53.77

61.39

mu/l

0.34

583

1966

Early onset COPD, excluding more controls

223

1142

1.97

19.88

1.3

1.4

75.26

71.92

mu/l

0.08

201

1028

Benign neoplasm: Colon

594

3713

1.51

19.80

1.4

70.78

59.66

mu/l

0.56

526

3322

Sequelae of external causes of morbidity and mortality

306

1737

1.78

19.79

1.4

1.5

51.96

63.87

mu/l

0.70

273

1557

Peripheral artery disease

436

2128

1.63

19.71

1.3

1.4

117.16

52.40

mu/l

2.87

375

1889

COPD (mode)

326

1453

1.76

19.69

1.3

1.4

72.39

66.67

mu/l

0.20

292

1310

Other disorders of glucose regulation and pancreatic internal secretion

110

423

2.65

19.67

2.4

1.4

57.80

102.61

mu/l

0.84

375

Ovarian cyst

381

1281

1.71

19.57

1.7

1.5

50.85

51.70

mu/l

0.03

347

1158

Hernia

1024

4969

1.37

19.52

1.4

1.6

74.16

62.99

mu/l

0.62

913

4493

Other diseases of urinary system

1036

4235

1.38

19.48

1.5

1.6

66.46

66.20

mu/l

0.01

910

3854

Pain in thoracic spine

187

908

2.09

19.44

1.5

1.6

75.10

61.90

mu/l

0.20

169

823

Insulin, fast-acting (human)

168

783

2.17

19.44

2.2

1.5

79.46

63.82

mu/l

0.55

151

710

Other arthritis (FG)

348

2058

1.71

19.41

1.4

1.5

68.52

56.82

mu/l

0.52

310

1839

Myocarditis

102

4.58

19.39

1.5

38.80

27.71

mu/l

0.56

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

121

491

2.51

19.38

1.5

1.4

53.53

81.21

mu/l

0.50

109

439

Benign thyroid growths and nodules

369

2055

1.68

19.36

1.5

1.4

47.50

54.14

mu/l

0.42

325

1841

Acute upper respiratory infections of multiple and unspecified sites

838

4334

1.42

19.35

1.9

1.6

67.90

66.46

mu/l

0.07

768

3903

Presence of other functional implants

637

2935

1.49

19.22

1.4

54.59

60.37

mu/l

0.35

548

2635

Myalgia

281

1570

1.81

19.18

1.7

1.6

69.83

52.63

mu/l

0.79

248

1418

Gout, FINNGEN

305

1733

1.76

19.17

1.4

109.41

61.01

mu/l

1.51

263

1539

Persons encountering health services for specific procedures, not carried out

121

499

2.47

18.73

2.0

1.5

119.15

60.98

mu/l

0.58

109

449

Substance abuse

615

3876

1.48

18.71

1.4

1.6

76.58

67.37

mu/l

0.30

539

3511

Gout, idiopatic and unspecified

268

1488

1.82

18.70

1.3

1.4

108.41

61.49

mu/l

1.23

232

1314

Non-ischemic cardiomyopathy

332

1538

1.73

18.68

1.3

1.5

63.20

53.35

mu/l

0.48

292

1373

Other joint disorders

921

3448

1.40

18.63

1.7

69.21

63.56

mu/l

0.24

823

3154

Persons with potential health hazards related to communicable diseases

405

2494

1.62

18.58

1.7

1.8

59.27

67.37

mu/l

0.44

367

2278

Disturbances of skin sensation

330

1949

1.71

18.55

1.6

68.85

60.08

mu/l

0.26

299

1764

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

574

3717

1.50

18.48

1.5

1.6

57.26

68.08

mu/l

0.64

523

3370

Amenorrhoea

317

2.86

18.47

3.0

1.8

81.81

47.38

mu/l

1.50

290

Cervical disc disorders

388

2392

1.63

18.45

1.6

1.5

64.97

64.28

mu/l

0.02

352

2159

Urticaria and erythema

412

2577

1.61

18.45

1.8

1.6

48.36

65.78

mu/l

1.42

370

2338

Other and unspecified drugs and medicaments

116

474

2.49

18.35

1.5

1.4

55.24

74.03

mu/l

0.30

104

422

Other noninfective gastroenteritis and colitis

280

1584

1.78

18.30

1.8

1.5

73.52

70.51

mu/l

0.08

257

1425

Noninfective enteritis and colitis

509

3343

1.53

18.26

1.7

1.6

70.82

65.81

mu/l

0.22

463

3005

Other symptoms and signs involving the digestive system and abdomen

197

1000

1.99

18.14

1.6

1.5

56.81

74.65

mu/l

0.56

176

896

Benign neoplasm of other and ill-defined parts of digestive system

219

1154

1.92

18.11

1.9

1.4

52.70

62.58

mu/l

0.40

193

1036

Nonorganic sleeping disorders, excluding more controls

230

1232

1.88

18.01

1.6

72.93

65.74

mu/l

0.18

209

1124

Gonarthrosis

688

2673

1.46

17.99

1.5

80.77

60.12

mu/l

0.93

618

2432

Clear cell adenocarcinoma of kidney

258

3.07

17.95

1.9

1.4

38.25

99.25

mu/l

1.68

236

Other systemic involvement of connective tissue

311

1827

1.72

17.86

1.6

1.5

45.95

61.13

mu/l

1.27

278

1625

Other diseases of upper respiratory tract

1161

4537

1.34

17.84

1.5

1.6

63.06

64.76

mu/l

0.09

1033

4116

Other chronic obstructive pulmonary disease, including avohilmo

557

3063

1.50

17.80

1.2

1.4

71.49

64.11

mu/l

0.39

494

2726

Periodontitis

1081

5144

1.34

17.79

1.5

1.6

70.98

62.32

mu/l

0.44

977

4638

Other specified/unspecified arthritis

307

1800

1.72

17.74

1.4

1.5

70.98

57.29

mu/l

0.56

271

1622

Malignant neoplasm, wide definition

939

3989

1.38

17.64

1.7

1.6

59.84

67.85

mu/l

0.42

848

3619

Malignant neoplasm, including Hilmo

937

3983

1.38

17.60

1.7

1.6

59.67

67.68

mu/l

0.42

847

3614

Disorders of lacrimal system

500

3248

1.52

17.58

1.8

1.5

56.87

57.34

mu/l

0.02

445

2913

Chronic periodontitis, including avohilmo

1078

5145

1.34

17.54

1.5

1.6

70.49

62.43

mu/l

0.40

975

4639

Hyperhidrosis

124

4.05

17.53

1.5

1.4

180.65

109.51

mu/l

0.27

112

Diabetic nephropathy

236

1273

1.86

17.50

1.5

101.66

81.49

mu/l

0.52

209

1147

Cervicocranial syndrome

135

602

2.28

17.50

1.5

55.24

71.42

mu/l

0.37

117

545

Myocardial infarction, strict

456

2068

1.57

17.44

1.3

1.4

78.55

61.61

mu/l

0.76

413

1843

Other blood glucose lowering drugs, excl. Insulins

174

859

2.05

17.37

1.2

1.4

121.95

50.33

mu/l

2.41

150

757

Extracorporeal dialysis

301

2.85

17.33

1.4

61.09

74.67

mu/l

0.23

268

Congenital malformations, deformations and chromosomal abnormalities, including avohilmo

696

4469

1.43

17.27

1.7

73.91

65.38

mu/l

0.33

636

4045

Irregular menses

525

2619

1.51

17.24

2.0

1.7

70.23

51.61

mu/l

1.55

472

2393

Disorders of skin appendages

551

3712

1.49

17.16

1.6

59.98

62.92

mu/l

0.17

503

3356

Care involving dialysis

109

447

2.49

17.15

1.4

63.71

71.13

mu/l

0.14

396

Vascular disorders of the intestines

308

2.81

17.11

1.2

1.4

154.86

74.16

mu/l

0.73

278

Disorders of synovium and tendon

576

3325

1.48

17.08

1.5

1.6

68.22

58.80

mu/l

0.35

516

3013

Congenital malformations, deformations and chromosomal abnormalities

630

4151

1.45

16.99

1.8

1.7

75.79

65.01

mu/l

0.39

575

3772

Abnormal results of function studies

117

498

2.39

16.94

2.0

1.5

93.55

58.05

mu/l

0.34

104

447

Type 1 diabetes, definitions combined

113

472

2.42

16.90

3.1

1.7

60.15

55.01

mu/l

0.12

107

434

Other symptoms and signs involving cognitive functions and awareness

483

2825

1.52

16.80

1.5

59.57

61.25

mu/l

0.07

435

2518

Diseases of the digestive system

472

3087

1.53

16.79

1.6

1.5

49.14

67.83

mu/l

1.85

418

2761

Disorders of conjunctiva

916

5240

1.36

16.79

1.7

1.6

79.76

61.55

mu/l

0.92

830

4733

Diaphragmatic hernia

392

2481

1.59

16.79

1.4

78.04

54.97

mu/l

1.18

344

2220

Injuries to the knee and lower leg

1274

5287

1.31

16.77

1.5

1.6

65.69

63.81

mu/l

0.10

1138

4791

Arthropathies

933

3453

1.37

16.70

1.8

1.7

70.13

64.05

mu/l

0.26

843

3159

Type 1 diabetes, strict (exclude DM2)

112

469

2.42

16.67

3.1

1.7

60.66

55.26

mu/l

0.13

106

431

Chronic rhinitis, nasopharyngitis and pharyngitis

371

2321

1.61

16.67

1.8

1.6

80.49

67.16

mu/l

0.44

318

2095

Phobic anxiety disorders

154

736

2.11

16.65

1.9

1.7

90.03

70.72

mu/l

0.29

134

679

Gout, strict definition

199

1045

1.93

16.65

1.3

1.4

135.72

65.88

mu/l

1.43

171

925

Falls/tendency to fall

1143

4326

1.33

16.64

1.5

1.7

64.91

68.36

mu/l

0.19

1021

3944

COPD

447

2357

1.55

16.54

1.3

1.4

79.05

63.78

mu/l

0.83

397

2094

Other abnormal findings of blood chemistry

238

3.06

16.54

1.2

1.4

56.69

75.79

mu/l

0.32

219

Transient ischemic attack

531

2849

1.49

16.46

1.4

72.75

58.75

mu/l

0.78

491

2526

Dialysis

163

3.52

16.42

1.5

1.3

47.86

70.63

mu/l

0.53

150

Other symptoms and signs involving the urinary system

125

555

2.29

16.41

1.4

56.83

73.76

mu/l

0.41

110

498

Diseases of the musculoskeletal system and connective tissue

533

1770

1.52

16.39

1.5

1.7

83.67

66.12

mu/l

0.52

474

1632

Dysphagia

266

1534

1.75

16.36

1.5

1.4

54.34

66.67

mu/l

0.39

233

1366

Other sleep disorders

125

556

2.28

16.31

1.6

1.5

52.47

58.56

mu/l

0.17

115

489

Generalized anxiety disorder

184

948

1.96

16.20

1.8

1.7

48.16

57.90

mu/l

0.41

162

870

Acute sinusitis

571

3573

1.46

16.17

1.8

1.6

62.11

67.34

mu/l

0.28

515

3222

Chronic pancreatitis

150

721

2.11

16.16

1.6

1.4

49.79

69.82

mu/l

0.78

130

651

Disorders of lens

712

3132

1.42

16.11

1.5

56.77

68.51

mu/l

1.02

632

2837

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

100

407

2.50

16.01

1.8

1.4

82.74

65.98

mu/l

0.26

362

Diseases of the ear and mastoid process

1220

4688

1.31

16.01

1.6

61.46

67.29

mu/l

0.42

1090

4264

Other chronic obstructive pulmonary disease

425

2254

1.55

15.91

1.3

1.4

76.47

63.87

mu/l

0.62

378

2000

Follow-up examination after treatment for conditions other than malignant neoplasms

422

1804

1.57

15.87

1.5

59.22

62.48

mu/l

0.10

384

1611

Asthma and allergy, excluding more controls

140

651

2.14

15.81

1.6

1.7

65.18

51.51

mu/l

0.40

124

595

Panic disorder

166

835

2.01

15.76

1.7

54.78

64.31

mu/l

0.31

150

765

Other diseases of blood and blood-forming organs

363

2.58

15.75

1.6

1.4

74.49

84.26

mu/l

0.13

329

Allergic asthma (mode), excluding more controls

233

1277

1.79

15.63

1.5

1.6

81.50

57.99

mu/l

0.90

208

1169

Polyneuropathies and other disorders of the peripheral nervous system

237

1343

1.78

15.56

1.4

61.49

62.84

mu/l

0.04

218

1197

Senile cataract

654

2795

1.43

15.54

1.5

58.37

69.83

mu/l

0.87

582

2533

Urticaria

333

2067

1.62

15.51

1.8

1.6

48.92

62.08

mu/l

0.82

297

1875

Arthrosis

738

2896

1.40

15.44

1.6

76.16

61.50

mu/l

0.65

672

2639

Asthma and allergy

140

657

2.12

15.43

1.6

1.7

65.18

55.99

mu/l

0.24

124

603

Unspecified haematuria

423

2245

1.54

15.43

1.6

1.4

55.18

69.51

mu/l

0.86

374

2008

Other disorders of skin and subcutaneous tissue

777

4799

1.37

15.35

1.7

1.5

75.07

59.12

mu/l

1.01

693

4320

Polyuria

235

1336

1.78

15.26

1.7

1.4

44.43

61.86

mu/l

1.31

208

1199

Cyst of kidney

387

2.50

15.23

1.3

1.4

68.42

78.01

mu/l

0.13

344

Ovarian dysfunction

305

2.69

15.18

3.6

1.3

79.08

61.81

mu/l

0.32

276

Ischaemic Stroke, excluding all haemorrhages

559

2842

1.46

15.10

1.4

79.28

59.73

mu/l

1.27

496

2519

Unknown and unspecified causes of morbidity

312

2.67

15.08

1.5

1.4

78.06

77.33

mu/l

0.01

278

Mixed hyperlipidaemia

148

3.52

15.03

2.0

1.3

76.83

105.39

mu/l

0.24

131

Other diseases of anus and rectum

310

1899

1.64

15.00

1.5

58.78

63.09

mu/l

0.15

277

1696

Abnormal findings on examination of urine, without diagnosis

209

3.09

14.98

1.9

1.3

55.16

53.28

mu/l

0.04

189

Substance use, excluding alcohol

227

1286

1.78

14.94

1.2

1.6

118.97

68.01

mu/l

0.79

195

1173

Conduction disorders

287

1376

1.68

14.90

1.3

1.5

77.42

53.95

mu/l

1.09

256

1241

Enthesopathies of lower limb, excluding foot

257

1510

1.72

14.86

1.5

64.30

64.05

mu/l

0.01

231

1368

Deforming dorsopathies

303

1858

1.64

14.83

1.5

58.64

65.37

mu/l

0.27

271

1674

Neuromuscular dysfunction of bladder

116

522

2.26

14.82

1.4

41.08

58.80

mu/l

0.57

104

469

Abnormal involuntary movements

155

783

2.00

14.61

1.4

1.5

76.09

56.76

mu/l

0.39

138

696

Other or unspecified ileus, impaction or obstruction

190

1026

1.87

14.61

1.6

1.4

43.88

73.10

mu/l

1.50

167

922

Other and unspecified tonsillitis

347

1822

1.59

14.60

1.9

1.7

59.30

75.79

mu/l

0.99

321

1665

Malignant neoplasm

895

3919

1.34

14.54

1.7

1.6

61.08

67.07

mu/l

0.28

806

3552

Other and unspecified polyneuropathies, also in other diseases

210

1173

1.81

14.53

1.4

63.05

62.02

mu/l

0.03

194

1043

Malignant neoplasm

894

3915

1.34

14.51

1.7

1.6

60.72

67.12

mu/l

0.30

804

3549

Sicca syndrome [Sjögren]

112

502

2.27

14.48

1.6

1.4

49.83

50.07

mu/l

0.01

103

453

Sequelae with surgical and medical care as external cause

232

1336

1.75

14.46

1.3

1.4

47.89

62.70

mu/l

1.09

210

1194

All influenza

279

1687

1.67

14.46

1.7

1.5

81.95

70.03

mu/l

0.36

255

1520

Gonarthrosis,primary

925

4198

1.33

14.44

1.4

1.5

71.88

61.07

mu/l

0.55

836

3764

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

246

2.59

14.43

1.3

1.5

56.27

59.18

mu/l

0.05

220

Other acute lower respiratory infections

541

3597

1.44

14.36

1.5

1.6

69.86

67.06

mu/l

0.08

484

3242

Acute pharyngitis

169

876

1.93

14.30

2.3

1.5

44.35

83.32

mu/l

2.67

156

793

Allergic asthma (mode)

233

1312

1.75

14.30

1.5

1.6

81.50

60.10

mu/l

0.78

208

1204

Disorders resulting from impaired renal tubular function

174

3.25

14.21

1.4

1.3

100.63

51.37

mu/l

0.80

159

Missing teeth due to accident, extraction or parodontitis

663

4292

1.39

14.09

1.6

1.5

62.53

59.25

mu/l

0.15

573

3863

Thyrotoxicosis, other and/or unspecified

221

1265

1.76

14.07

1.9

1.4

55.39

58.24

mu/l

0.13

197

1137

Disorders of vestibular function (Vertigo)

502

3384

1.45

14.06

1.5

52.31

58.45

mu/l

0.34

454

3018

Other diseases of blood and blood-forming organs, wide

247

1459

1.71

14.06

1.8

1.4

56.98

73.15

mu/l

0.69

225

1310

Osteoporosis with pathological fracture (FG)

408

2.40

14.05

1.8

1.3

78.12

42.50

mu/l

0.76

364

Focal epilepsy

229

1324

1.74

14.04

1.6

1.5

59.17

70.75

mu/l

0.43

210

1183

L04AD Calcineurin inhibitors

133

647

2.09

13.96

1.8

1.5

96.26

85.08

mu/l

0.12

125

593

Aortic aneurysm

217

1215

1.77

13.86

1.4

52.84

48.90

mu/l

0.16

198

1078

ILD medications: azathioprine

164

861

1.93

13.83

1.7

1.6

74.76

60.49

mu/l

0.51

148

782

L01XX Other antineoplastic agents

286

2.68

13.82

3.1

1.4

64.59

71.68

mu/l

0.08

257

Venous thromboembolism

545

3700

1.43

13.77

1.6

1.4

63.24

59.97

mu/l

0.14

491

3295

Thyrotoxicosis

281

1728

1.64

13.70

2.1

1.5

61.05

59.27

mu/l

0.07

246

1550

Gout, unspecified

211

1202

1.77

13.68

1.3

1.4

112.72

60.52

mu/l

1.09

179

1064

Glomerulonephritis

116

541

2.18

13.60

1.3

1.4

81.78

71.03

mu/l

0.17

485

Ulcer of lower limb, not elsewhere classified

162

853

1.92

13.56

1.4

81.80

60.06

mu/l

0.82

140

759

Necrosis of pulp, including avohilmo

629

4506

1.39

13.55

1.6

50.67

69.89

mu/l

2.32

569

4079

Other disorders of bladder

137

682

2.03

13.51

1.5

1.4

75.20

60.70

mu/l

0.24

120

612

Implicit fungal Sepsis, including avohilmo

373

2.43

13.45

1.4

80.45

45.83

mu/l

0.76

328

Noninfectious colitis NAS

152

787

1.95

13.38

1.8

1.5

65.58

80.38

mu/l

0.34

139

700

Nontoxic multinodular goitre

209

1196

1.77

13.36

1.5

1.3

45.15

52.68

mu/l

0.35

188

1078

Personality disorders

287

1786

1.62

13.33

1.6

1.7

78.10

62.54

mu/l

0.35

258

1633

Behavioural syndromes associated with physiological disturbances and physical factors

1000

5224

1.30

13.27

1.6

69.71

64.14

mu/l

0.27

912

4720

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

274

1665

1.64

13.26

1.7

90.50

58.50

mu/l

0.71

243

1521

Kidney transplant status

258

2.73

13.23

1.4

63.78

82.10

mu/l

0.28

238

Focal epilepsy, mode (most common among epilepsy diagnosis)

201

1140

1.78

13.23

1.6

1.5

60.17

72.57

mu/l

0.40

185

1020

Heart failure and bmi 25plus

374

1630

1.54

13.16

1.4

93.49

56.55

mu/l

2.07

318

1463

Fracture of rib(s), sternum and thoracic spine

319

2043

1.57

13.12

1.4

67.12

62.84

mu/l

0.14

286

1817

Immunodeficiencies

248

2.76

13.12

1.7

1.4

104.35

112.86

mu/l

0.06

226

Focal epilepsy, strict definition

209

1204

1.75

13.04

1.7

1.5

59.29

70.71

mu/l

0.38

194

1075

Chronic gastritis

272

1680

1.63

13.03

1.8

1.4

66.53

61.59

mu/l

0.17

235

1498

Azathioprine

164

879

1.89

13.02

1.7

1.6

74.76

61.45

mu/l

0.47

148

797

Vitamin deficiency, wide

221

2.86

13.01

1.5

1.4

59.11

47.47

mu/l

0.31

198

Vitamin deficiency

221

2.86

13.01

1.5

1.4

59.11

47.47

mu/l

0.31

198

Cutaneous abscess, furuncle and carbuncle

284

1776

1.61

12.95

1.5

1.6

59.90

71.11

mu/l

0.54

248

1598

Intestinal stricture

316

2026

1.57

12.94

1.5

1.4

52.08

68.70

mu/l

0.92

283

1806

Hernia of abdominal wall

471

3281

1.44

12.87

1.4

1.5

91.82

62.13

mu/l

1.39

424

2937

Spondylolisthesis/Spondylolysis

204

1173

1.76

12.84

1.5

68.55

64.06

mu/l

0.11

182

1052

Supplementary factors related to causes of morbidity and mortality classified elsewhere

336

2190

1.55

12.79

1.5

60.04

64.18

mu/l

0.16

299

1975

Solid cancers, including Hilmo

886

3930

1.32

12.77

1.7

1.6

58.38

64.71

mu/l

0.32

801

3562

Thiazolidinediones

122

595

2.08

12.76

1.3

1.4

128.71

50.94

mu/l

2.13

105

518

Unstable angina pectoris

343

1752

1.55

12.70

1.3

1.5

91.93

55.76

mu/l

1.07

306

1552

Familial hypercholesterolemia

128

636

2.03

12.67

1.4

154.80

58.71

mu/l

1.37

114

568

Faecal incontinence

108

504

2.17

12.67

1.5

1.4

46.48

66.14

mu/l

0.44

449

Non-allergic asthma (mode), excluding more controls

185

1028

1.80

12.64

1.4

1.5

52.66

61.47

mu/l

0.35

171

930

Extrapyramidal and movement disorders

397

2687

1.49

12.62

1.5

1.4

64.05

61.93

mu/l

0.05

354

2398

Other cataract

453

2319

1.46

12.57

1.4

52.36

66.66

mu/l

1.03

396

2089

Cardiac murmurs and other cardiac sounds

429

2.26

12.57

1.3

1.5

50.11

72.10

mu/l

0.41

379

Cerebral palsy and other paralytic syndromes

123

605

2.06

12.56

1.5

1.4

91.49

89.91

mu/l

0.02

107

545

Monoamine oxidase A inhibitors

136

694

1.98

12.55

1.5

1.4

61.12

59.36

mu/l

0.03

119

626

Chronic periodontitis, complicated

597

4239

1.38

12.52

1.5

75.11

62.68

mu/l

0.44

544

3794

Injuries to the thorax

465

3250

1.44

12.42

1.4

1.5

67.22

67.75

mu/l

0.02

419

2897

Conjunctivitis

808

4945

1.32

12.40

1.7

1.6

78.75

59.43

mu/l

0.90

728

4474

Post-traumatic stress disorder

412

2.28

12.38

2.2

1.6

61.60

64.26

mu/l

0.04

377

Subjective visual disturbances

281

1774

1.60

12.35

1.7

1.5

52.48

61.57

mu/l

0.41

257

1589

Pre-eclampsia or poor fetal growth

308

1976

1.56

12.35

1.8

63.48

53.74

mu/l

0.37

274

1799

Abnormal weight loss

112

536

2.12

12.34

1.4

56.48

69.29

mu/l

0.24

100

477

Hypercalcemia

234

2.76

12.29

3.2

1.3

65.57

75.93

mu/l

0.10

209

Acute bronchitis

412

2768

1.47

12.27

1.5

74.28

65.63

mu/l

0.23

372

2488

Cardiodefibrillation

340

2238

1.53

12.22

1.3

1.4

68.42

63.86

mu/l

0.16

301

1990

Sleep disorders

959

5132

1.29

12.21

1.6

70.82

63.07

mu/l

0.40

873

4629

Cellulitis

241

1470

1.65

12.20

1.5

69.20

62.72

mu/l

0.18

206

1323

Nontoxic goitre/thyroid nodule

313

2032

1.55

12.19

1.5

1.4

47.06

61.96

mu/l

1.10

278

1815

Intracerebral haemorrhage

126

632

2.01

12.18

1.3

1.4

51.80

67.19

mu/l

0.36

115

557

Weight loss

119

586

2.06

12.15

1.4

57.63

65.76

mu/l

0.15

107

518

Cluster headache, wide

159

3.14

12.15

1.5

29.59

45.34

mu/l

0.94

138

Mental and behavioural disorders due to alcohol

502

3401

1.41

12.11

1.4

1.6

70.43

69.47

mu/l

0.02

442

3080

Pulmonary heart disease, diseases of pulmonary circulation

315

2050

1.55

12.09

1.7

1.4

55.81

62.98

mu/l

0.27

286

1826

Benign neoplasm of brain and other parts of central nervous system

330

2.44

12.08

1.5

1.4

42.52

71.93

mu/l

0.81

294

Mouth breathing

415

2856

1.46

12.05

1.5

51.04

75.59

mu/l

2.32

373

2567

Any event in cancer register

938

4238

1.30

12.03

1.7

1.6

60.95

66.36

mu/l

0.26

852

3847

Viral pneumonia

143

754

1.92

11.98

1.4

1.5

82.30

71.27

mu/l

0.19

125

669

Pulmonary heart disease

294

1889

1.57

11.96

1.7

1.4

56.55

62.14

mu/l

0.19

267

1688

Other disorders of eyelid

451

2977

1.44

11.96

1.4

60.21

58.11

mu/l

0.06

406

2654

COPD related to multimorbidity

374

2127

1.49

11.96

1.3

1.4

78.06

63.15

mu/l

0.68

334

1890

Ventral hernia

252

1563

1.63

11.94

1.4

1.5

103.11

55.90

mu/l

1.43

229

1403

Benign neoplasm of meninges

121

604

2.03

11.92

1.7

1.4

44.78

59.56

mu/l

0.35

103

536

Carbimazole or st.post thyroidectomy, condition for graves disease

234

1426

1.66

11.92

1.9

1.5

54.62

61.36

mu/l

0.29

203

1286

Collagenous colitis

109

524

2.11

11.89

1.6

1.4

74.03

80.63

mu/l

0.09

101

466

Factors influencing health status and contact with health services

264

805

1.65

11.86

1.4

1.5

71.30

74.81

mu/l

0.05

238

747

Type 1 diabetes, strict definition, subgroup 1

344

2.38

11.84

2.6

1.7

44.94

61.52

mu/l

0.82

319

Pulmonary embolism

294

1894

1.56

11.83

1.7

1.4

56.55

61.97

mu/l

0.18

267

1694

Type 1 diabetes, strict definition

370

2.32

11.74

2.6

1.7

45.59

59.57

mu/l

0.69

343

Menorrhagia

336

1219

1.55

11.70

1.6

1.5

52.11

52.57

mu/l

0.02

303

1100

Type of accident

311

2035

1.54

11.69

1.5

60.98

64.91

mu/l

0.14

277

1835

Injuries to the abdomen, lower back, lumbar spine and pelvis

412

2812

1.45

11.64

1.5

84.03

61.68

mu/l

0.68

362

2523

Specific personality disorders

242

1496

1.63

11.63

1.5

1.7

64.60

60.20

mu/l

0.12

218

1377

Other disorders of ear

952

4802

1.28

11.62

1.5

1.6

58.98

67.16

mu/l

0.58

839

4345

Need for other prophylactic measures

312

2.45

11.60

1.8

1.4

65.46

98.81

mu/l

0.43

276

Radiculopathy

166

927

1.81

11.60

1.4

55.78

64.14

mu/l

0.26

151

828

Disorders of adult personality and behaviour

294

1905

1.55

11.56

1.6

1.7

80.21

62.76

mu/l

0.40

267

1741

Hyperkinetic disorders, excluding more controls

124

586

1.99

11.53

1.8

1.9

54.10

66.54

mu/l

0.49

115

546

Diseases of inner ear

558

3901

1.37

11.50

1.5

51.10

60.23

mu/l

0.65

505

3479

Cervicobrachial syndrome

230

1408

1.65

11.50

1.7

1.5

58.04

61.70

mu/l

0.11

206

1274

Pruritus

130

675

1.95

11.44

1.6

1.5

49.19

48.58

mu/l

0.02

114

607

Other extrapyramidal and movement disorders in other diseases

266

1690

1.59

11.43

1.5

1.4

78.85

61.15

mu/l

0.41

243

1518

Pacemaker

336

2086

1.51

11.32

1.3

1.4

88.09

54.38

mu/l

1.18

300

1855

Isolated proteinuria

130

3.32

11.31

1.3

1.4

50.63

57.25

mu/l

0.11

118

566

3707

1.37

11.29

1.4

1.6

75.38

68.41

mu/l

0.20

503

3350

Diseases of salivary glands

347

2342

1.49

11.27

1.7

1.5

58.17

64.31

mu/l

0.27

306

2100

Intestinal malabsorption

245

2.62

11.25

1.7

1.4

32.71

66.00

mu/l

0.83

222

Nonorganic sleeping disorders

230

1417

1.64

11.23

1.6

1.7

72.93

71.68

mu/l

0.03

209

1282

Solid cancers

851

3849

1.30

11.22

1.7

1.6

58.36

65.14

mu/l

0.33

769

3486

Non-allergic asthma (mode)

185

1068

1.73

11.14

1.4

1.5

52.66

61.80

mu/l

0.37

171

967

Conjunctivitis (acute, non atopic)

299

1953

1.53

11.12

1.7

1.5

101.58

61.51

mu/l

0.87

274

1771

Other congenital malformations

465

2.13

11.06

1.9

1.5

55.00

88.13

mu/l

0.71

418

Meniscus derangement

554

2678

1.38

11.05

1.6

1.5

60.84

65.86

mu/l

0.16

494

2441

AV-block

165

791

1.79

11.04

1.3

1.5

71.70

45.21

mu/l

1.66

142

705

COPD, hospital admissions

423

2495

1.44

11.04

1.3

1.4

76.73

63.34

mu/l

0.67

376

2212

Atopic dermatitis, strict definition with reimbursement

306

1941

1.52

10.97

1.6

1.7

92.29

61.22

mu/l

0.81

279

1779

Other and unspecified nerve root and plexus disorders, also in other diseases

226

1396

1.63

10.95

1.4

1.5

50.70

55.71

mu/l

0.23

206

1260

Adjustment and management of implanted device

179

1041

1.73

10.90

1.4

64.85

58.97

mu/l

0.17

164

915

Other bacterial intestinal infections

183

1071

1.72

10.89

1.9

1.4

74.45

75.93

mu/l

0.03

162

955

Disorders of vitreous body

527

3664

1.38

10.89

1.5

1.4

55.14

60.69

mu/l

0.38

467

3281

Mycoses, including avohilmo

953

5729

1.27

10.89

1.6

76.13

62.11

mu/l

0.72

848

5194

Trochanteric bursitis

162

918

1.78

10.83

1.5

77.47

50.05

mu/l

0.87

146

829

Mental and behavioural disorders due to sedatives or hypnotics

360

2.28

10.80

1.2

1.5

44.32

56.47

mu/l

0.43

326

Other bacterial intestinal infections, including avohilmo

236

1480

1.61

10.74

1.9

1.4

69.13

72.85

mu/l

0.10

209

1326

COPD, early/later onset

425

2513

1.43

10.73

1.3

1.4

76.47

63.19

mu/l

0.67

378

2229

Candidiasis, including avohilmo

317

2123

1.50

10.72

1.9

1.6

73.01

58.39

mu/l

0.43

280

1904

Disorders of vitreous body and globe

536

3724

1.37

10.72

1.5

1.4

55.14

60.81

mu/l

0.39

476

3335

Insomnia

935

5128

1.27

10.71

1.5

1.6

69.45

61.47

mu/l

0.41

852

4627

Injuries to the ankle and foot

756

4974

1.30

10.70

1.5

1.7

65.92

65.18

mu/l

0.04

666

4526

Excessive, frequent and irregular menstruation

367

1324

1.49

10.65

1.7

1.6

50.31

52.21

mu/l

0.08

326

1197

Malignant neoplasm of thyroid gland, including Hilmo

421

2.17

10.60

2.0

1.4

37.89

64.23

mu/l

0.95

380

Mental and behavioural disorders due to alcohol, excluding acute intoxication

431

3037

1.41

10.59

1.4

1.5

62.79

74.62

mu/l

0.37

378

2736

Extreme obesity with alveolar hypoventilation

212

2.70

10.58

1.3

108.07

54.85

mu/l

0.65

192

Other complications of surgical and medical care, not elsewhere classified

112

569

1.99

10.55

1.6

1.5

98.01

86.45

mu/l

0.13

100

508

Vitamin B12 deficiency anaemia

105

521

2.04

10.55

2.1

1.4

73.02

43.55

mu/l

0.70

467

Alcohol use disorder, Swedish definition

530

3539

1.37

10.54

1.5

1.6

74.83

69.47

mu/l

0.14

472

3193

Thoracic aortic aneurysm

149

831

1.81

10.53

1.4

41.77

52.03

mu/l

0.54

137

745

Type1 diabetes, definitions combined, early onset

325

2.33

10.50

3.3

1.8

45.33

71.01

mu/l

1.36

297

Oxicams

214

729

1.68

10.47

1.5

1.6

72.59

49.23

mu/l

0.48

193

651

L04AA Selective immunosuppressants

240

1522

1.59

10.45

1.5

64.76

64.55

mu/l

0.00

219

1377

588

3819

1.34

10.45

1.5

1.6

80.93

67.29

mu/l

0.46

524

3453

Peripheral arterial reconstruction

155

878

1.78

10.37

1.2

1.4

141.08

59.20

mu/l

2.25

131

778

Special screening examination for other diseases and disorders

124

655

1.91

10.36

1.8

1.5

72.21

61.91

mu/l

0.20

116

581

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

931

5746

1.26

10.35

1.8

1.6

58.55

65.17

mu/l

0.47

834

5205

Other diseases of pleura

416

2557

1.42

10.34

1.5

1.4

73.77

67.53

mu/l

0.25

377

2261

Gastroduodenal ulcer

240

1521

1.58

10.31

1.3

1.4

78.51

69.47

mu/l

0.20

209

1354

Malignant neoplasm of thyroid gland

387

2.21

10.30

2.0

1.4

39.15

65.29

mu/l

0.85

350

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

202

1068

1.66

10.30

1.8

2.0

54.94

71.03

mu/l

0.67

184

984

Personal history of other diseases and conditions

119

619

1.93

10.30

1.8

1.7

83.76

68.13

mu/l

0.19

109

565

Contact with and exposure to communicable diseases

296

1962

1.51

10.29

1.7

1.8

55.63

68.03

mu/l

0.59

269

1808

Gingivitis and periodontal diseases

991

4061

1.26

10.25

1.5

1.6

68.48

62.27

mu/l

0.30

885

3668

Benign paroxysmal vertigo

308

2072

1.50

10.23

1.4

50.66

61.30

mu/l

0.42

276

1846

Restless leg syndrome

156

890

1.77

10.22

1.6

1.5

99.58

56.73

mu/l

0.66

139

799

Urolithiasis

308

2073

1.50

10.19

1.5

1.4

68.44

67.71

mu/l

0.02

282

1844

Cerebral aneurysm, nonruptured

104

522

2.02

10.17

1.3

1.5

76.53

60.74

mu/l

0.32

470

Leisure time condition

189

1140

1.67

10.10

1.4

1.5

52.71

60.12

mu/l

0.24

166

1022

Intracranial injury

584

4088

1.34

10.08

1.6

63.28

64.91

mu/l

0.07

526

3687

Retention of urine

307

1663

1.50

10.06

1.5

1.4

71.47

63.93

mu/l

0.23

267

1488

External causes of morbidity and mortality

641

2411

1.34

10.06

1.5

1.7

74.66

63.36

mu/l

0.27

571

2196

Other diseases of stomach and duodenum

340

2.27

10.01

1.6

1.4

61.49

70.10

mu/l

0.14

307

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

170

968

1.72

10.00

1.5

1.6

83.51

79.41

mu/l

0.05

153

881

DVT of lower extremities and pulmonary embolism

399

2820

1.42

9.94

1.6

1.4

61.38

59.59

mu/l

0.06

363

2505

Diseases of male genital organs

454

1627

1.41

9.93

1.6

1.5

74.00

85.44

mu/l

0.43

415

1475

Nontraumatic intracranial haemmorrhage

188

1138

1.66

9.90

1.3

1.4

51.38

59.87

mu/l

0.28

170

1017

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly, including avohilmo

179

1039

1.69

9.87

1.4

1.6

80.48

78.07

mu/l

0.03

161

942

Diseases of the myoneural junction and muscle

132

725

1.84

9.85

1.5

1.4

56.03

70.74

mu/l

0.41

115

645

Female infertility, associated with anovulation

355

2.22

9.83

2.9

1.9

46.83

46.90

mu/l

0.00

331

Cluster headache, strict

147

2.98

9.81

1.5

1.4

29.59

47.15

mu/l

0.98

128

Other diseases of intestine

162

946

1.73

9.79

1.4

72.91

64.09

mu/l

0.18

149

856

Budesonide

151

866

1.76

9.73

1.6

1.5

67.19

59.09

mu/l

0.20

136

779

Speech and linguistic disorders, excluding more controls

357

2.18

9.73

1.6

45.47

97.09

mu/l

1.18

330

Benign neoplasm: Colon, unspecified

257

1685

1.54

9.69

1.3

1.4

60.46

65.38

mu/l

0.17

230

1508

Other arthrosis

526

2605

1.36

9.67

1.6

1.5

63.47

62.51

mu/l

0.04

478

2370

Other disorders of white blood cells

264

2.43

9.66

1.7

1.3

40.56

80.78

mu/l

0.98

237

Mycoses

289

1943

1.50

9.66

1.9

1.5

67.70

62.69

mu/l

0.13

256

1746

Agoraphobia

138

3.03

9.62

1.5

1.6

154.02

50.68

mu/l

0.51

128

Artificial joint operation, meniscal resection

914

4652

1.26

9.62

1.4

1.5

65.45

64.72

mu/l

0.03

830

4179

Chronic sinusitis

430

3108

1.39

9.59

1.6

60.95

67.52

mu/l

0.30

382

2804

Sequelae of cerebrovascular disease

331

1947

1.46

9.55

1.3

1.4

80.01

57.09

mu/l

1.02

293

1737

Triptan medication for migraine, min. 3 purchases

575

3235

1.33

9.53

1.7

50.90

61.99

mu/l

1.07

528

2940

Later onset COPD, excluding more controls

198

926

1.64

9.50

1.2

1.4

78.80

60.87

mu/l

0.63

173

832

Nephrotic syndrome

134

3.05

9.49

1.2

1.3

130.89

63.74

mu/l

0.56

121

KRA_PSY_EATING, excluding more controls

344

2.21

9.47

2.3

1.8

67.36

80.10

mu/l

0.15

313

Pre-eclampsia or eclampsia

218

1387

1.58

9.42

1.8

1.6

74.94

53.67

mu/l

0.67

196

1255

Abnormal serum enzyme levels

277

1789

1.50

9.41

1.5

1.4

65.03

66.07

mu/l

0.03

253

1588

Fungal Sepsis

190

2.68

9.40

1.5

1.3

59.37

49.55

mu/l

0.18

170

Abnormalities of gait and mobility

123

671

1.85

9.40

1.3

1.5

113.23

62.94

mu/l

0.58

112

593

Other external causes of accidental injury

801

3136

1.28

9.39

1.5

1.7

82.12

64.95

mu/l

0.59

714

2856

Postprocedural musculoskeletal disorders, not elsewhere classified

389

2.14

9.37

1.5

1.4

64.28

62.55

mu/l

0.03

348

Diseases of pulp and periapical tissues and dental caries

616

2385

1.33

9.37

1.5

68.72

72.52

mu/l

0.10

543

2147

Aortic valve malfunction, age under 60 years

106

552

1.95

9.36

1.4

118.79

74.50

mu/l

0.52

507

Dissociative [conversion] disorders

179

2.73

9.36

1.7

1.6

46.65

85.28

mu/l

0.67

168

Pain and other conditions associated with female genital organs and menstrual cycle

200

1036

1.62

9.35

1.7

37.81

54.34

mu/l

1.57

176

943

Transport accidents

472

2886

1.37

9.35

1.6

1.7

71.94

65.16

mu/l

0.20

433

2630

Congenital malformations of the urinary system

287

2.34

9.32

1.4

1.5

48.54

103.41

mu/l

0.78

257

Asthma mixed form (mode), excluding more controls

208

2.58

9.31

1.6

1.4

28.96

55.02

mu/l

0.88

184

Accidents

800

3136

1.28

9.30

1.5

1.7

83.17

64.95

mu/l

0.64

714

2856

Left ventricular outflow tract obstruction (LVOTO), broad definition

111

589

1.91

9.27

1.4

1.5

116.60

86.96

mu/l

0.31

541

Other pleural conditions

103

533

1.95

9.25

1.7

1.4

85.26

78.02

mu/l

0.11

473

Caries of dentine, including avohilmo

748

2970

1.29

9.24

1.5

1.6

69.66

69.19

mu/l

0.01

657

2688

Congenital malformations of the urinary system, including avohilmo

307

2.28

9.24

1.4

1.5

47.52

99.77

mu/l

0.79

273

Appendectomy

657

4841

1.30

9.19

1.6

53.30

66.44

mu/l

1.15

603

4364

Other problems related to primary support group, including family circumstances

116

608

1.87

9.17

1.9

1.7

61.51

78.90

mu/l

0.32

105

556

Transplanted organ and tissue status

107

563

1.92

9.16

1.5

97.02

64.26

mu/l

0.43

516

Disorders of psychological development

117

585

1.87

9.14

1.6

1.7

53.25

82.52

mu/l

0.83

107

536

Psychotic depression

302

2.28

9.14

2.2

1.5

26.98

49.27

mu/l

1.30

277

Viral hepatitis, IBD co-morbidity

164

2.77

9.13

1.6

79.66

67.69

mu/l

0.10

149

conjunctival haemorrhage

434

2.06

9.09

2.0

1.4

89.70

53.18

mu/l

0.50

390

Disorders of sclera, cornea, iris and ciliary body

551

4178

1.32

9.09

1.7

1.6

50.29

65.59

mu/l

2.29

503

3747

Coxibs

242

812

1.57

9.07

1.4

1.7

113.13

48.57

mu/l

1.26

209

731

Other enthesopathies

299

2051

1.47

9.04

1.6

94.46

57.65

mu/l

0.98

268

1855

Implicit fungal Sepsis

177

2.70

9.01

1.5

1.3

55.95

50.54

mu/l

0.09

157

Bacterial intestinal infections, IBD co-morbidities

180

1106

1.64

9.00

1.8

1.4

75.63

73.02

mu/l

0.05

158

991

Other disorders of eye and adnexa

150

879

1.72

9.00

1.7

1.5

103.66

61.44

mu/l

0.91

138

790

Hypermobility syndrome

273

2.34

8.99

2.2

1.7

34.91

61.60

mu/l

0.79

254

Other disorders of bone

202

1278

1.59

8.96

1.6

1.5

61.77

65.49

mu/l

0.11

181

1154

Diplopia

138

792

1.76

8.93

1.8

1.4

65.47

65.34

mu/l

0.00

129

705

Early onset COPD

223

1445

1.56

8.92

1.3

1.4

75.26

66.77

mu/l

0.23

201

1289

Dermatographic urticaria

364

2.14

8.90

1.6

32.72

66.40

mu/l

1.28

336

Other shoulder lesions

105

555

1.91

8.88

1.8

1.5

124.36

39.86

mu/l

0.84

506

Disorders of ocular muscles, binocular movement, accommodation and refraction

480

3548

1.35

8.87

1.7

1.6

49.56

66.40

mu/l

2.25

430

3218

Postmenopausal osteoporosis with pathological fracture

385

2.11

8.85

1.8

1.3

55.01

46.24

mu/l

0.15

339

Aneurysms, operations, SAH

164

989

1.67

8.85

1.4

65.35

63.53

mu/l

0.04

149

891

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

384

2731

1.39

8.82

1.6

1.7

60.11

61.00

mu/l

0.03

331

2501

Symptoms and signs involving speech and voice

334

2352

1.43

8.81

1.5

44.05

61.96

mu/l

1.71

290

2105

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

262

1740

1.50

8.79

1.9

1.8

58.98

66.24

mu/l

0.27

232

1597

Benign neoplasm: Cerebral meninges

105

558

1.91

8.76

1.7

1.4

47.12

51.82

mu/l

0.09

497

Idiopathic gout

509

1.95

8.75

1.1

1.4

133.46

67.60

mu/l

0.60

454

Disease of hard tissues of teeth, NOS

530

2073

1.34

8.74

1.6

1.5

64.39

68.77

mu/l

0.14

484

1876

Calculus of kidney and ureter

282

1927

1.47

8.74

1.5

1.4

71.87

67.47

mu/l

0.15

259

1716

Injuries to the head

1128

5501

1.22

8.72

1.5

1.6

71.63

63.54

mu/l

0.36

1009

4986

Benign neoplasm: Caecum

117

645

1.84

8.70

1.5

1.4

78.24

71.44

mu/l

0.10

108

573

Other gastritis (incl. Duodenitis)

218

1414

1.55

8.69

1.6

1.4

85.08

63.80

mu/l

0.48

192

1260

Cluster headache, wide,, including avohilmo

271

2.32

8.69

1.4

1.5

41.96

69.43

mu/l

0.62

247

Sequelae of other external causes

303

2.24

8.66

1.4

79.61

74.80

mu/l

0.05

271

Smoking dependency

100

526

1.93

8.61

1.3

1.5

200.61

65.14

mu/l

1.05

481

Primary gonarthrosis, bilateral

505

3183

1.33

8.58

1.4

82.87

57.49

mu/l

1.26

468

2839

Persistent mood disorders

188

1183

1.60

8.55

1.6

1.5

103.71

63.27

mu/l

0.66

169

1071

Mental and behavioural disorders due to tobacco

100

528

1.92

8.52

1.3

1.5

200.61

64.47

mu/l

1.06

482

Pre-eclampsia

197

1255

1.58

8.52

1.7

67.92

54.89

mu/l

0.38

178

1139

Atopic dermatitis, strict definition

284

1909

1.46

8.50

1.6

1.8

95.67

66.82

mu/l

0.66

260

1749

Other disorders of nervous system

359

2.12

8.42

1.5

69.56

81.69

mu/l

0.19

322

Diabetes mellitus in pregnancy

296

1289

1.47

8.42

1.9

2.0

53.92

48.78

mu/l

0.17

277

1182

Triptan medication for migraine, single purchase ok

784

4226

1.26

8.41

1.7

1.6

49.38

64.63

mu/l

2.24

721

3821

Migraine, single triptan purchase ok & required. ICD-code if available is included

784

4226

1.26

8.41

1.7

1.6

49.38

64.63

mu/l

2.24

721

3821

Alcohol use disorder, ICD-based

390

2843

1.38

8.40

1.4

1.6

64.71

74.39

mu/l

0.26

342

2559

Asthma mixed form (mode)

219

2.45

8.40

1.6

1.4

28.96

70.47

mu/l

1.49

195

Gonarthrosis, primary, with knee surgery

558

3324

1.31

8.35

1.4

68.81

57.31

mu/l

0.72

516

2964

Artrosis, including avohilmo

796

3464

1.26

8.32

1.6

78.95

65.70

mu/l

0.59

722

3139

Thyrotoxicosis with diffuse goitre

141

831

1.71

8.32

2.6

1.4

51.80

51.50

mu/l

0.01

123

747

Sarcoidosis

138

809

1.72

8.32

1.7

1.5

70.67

62.43

mu/l

0.15

122

727

Anaemia in chronic diseases classified elsewhere

102

3.21

8.29

1.2

1.3

90.90

45.00

mu/l

0.59

Other congenital malformations, including avohilmo

127

728

1.76

8.26

1.8

1.5

55.91

84.96

mu/l

0.87

119

652

Other diseases of the digestive system

286

1982

1.45

8.25

1.4

48.91

70.02

mu/l

1.23

252

1770

Conjunctivitis (acute, non atopic), including avohilmo

1021

5050

1.22

8.24

1.6

62.91

63.36

mu/l

0.02

923

4567

Other diseases of the respiratory system

185

1171

1.59

8.23

1.3

1.4

82.49

68.23

mu/l

0.34

172

1040

Other respiratory disorders and diseases

185

1171

1.59

8.23

1.3

1.4

82.49

68.23

mu/l

0.34

172

1040

Haemorrhoids and perianal venous thrombosis

311

2174

1.43

8.21

1.5

71.65

64.79

mu/l

0.26

281

1942

Coxarthrosis [arthrosis of hip](FG)

518

2700

1.32

8.20

1.4

1.5

61.17

58.21

mu/l

0.15

473

2421

Disorders of continuity of bone

107

585

1.85

8.19

1.7

1.4

75.32

59.18

mu/l

0.28

527

Inflammatory diseases of female pelvic organs

633

3372

1.29

8.18

1.7

53.54

51.83

mu/l

0.07

561

3060

Disorders of refraction and accommodation

286

1979

1.45

8.16

1.7

1.6

56.89

68.54

mu/l

0.68

253

1802

Polyarthrosis

214

1260

1.54

8.13

1.6

1.4

48.35

56.61

mu/l

0.32

199

1132

Other and/or unspecified nontoxic goitre

482

1.93

8.05

1.4

1.3

59.41

47.25

mu/l

0.39

433

Heartburn

113

632

1.80

8.03

1.3

1.4

56.45

86.05

mu/l

0.71

104

566

Fenamates

139

551

1.73

8.02

1.6

49.98

45.62

mu/l

0.20

128

491

Other disorders of conjunctiva

144

863

1.68

8.01

2.0

1.4

77.03

57.01

mu/l

0.42

133

772

Umbilical hernia

265

1824

1.46

7.96

1.3

1.5

89.39

61.12

mu/l

0.80

237

1639

GI-bleeding

283

1971

1.44

7.96

1.4

50.17

70.22

mu/l

1.11

246

1760

Bipolar affective disorders

179

1135

1.59

7.92

1.6

115.76

58.02

mu/l

0.84

161

1040

Other diseases of hard tissues of teeth

531

2087

1.32

7.92

1.5

75.15

73.41

mu/l

0.04

465

1889

Dislocation, sprain and strain of joints and ligaments at neck level

151

920

1.65

7.88

1.7

1.6

52.28

60.61

mu/l

0.23

133

832

Complications of internal orthopaedic prosthetic devices, implants and grafts

220

1464

1.51

7.84

1.4

75.86

59.99

mu/l

0.38

197

1302

Acetic acid derivatives and related substances

234

796

1.53

7.79

1.5

1.6

112.88

48.45

mu/l

1.25

205

716

Fissure and fistula of anal and rectal regions

224

1506

1.50

7.60

1.6

1.5

100.31

67.31

mu/l

0.71

205

1355

COPD, hospital admission 2, with asthma infections

281

1692

1.44

7.59

1.2

1.4

72.33

63.58

mu/l

0.30

252

1502

Other diseases of biliary tract

478

1.90

7.58

1.4

49.36

69.65

mu/l

0.54

417

Speech and linguistic disorders

431

1.93

7.52

1.7

1.6

45.53

92.78

mu/l

1.30

393

Sulfonylureas

267

1470

1.45

7.50

1.2

1.4

98.32

53.73

mu/l

1.75

229

1297

Enterocolitis due to Clostridium difficile

103

573

1.81

7.48

1.6

1.4

79.77

87.73

mu/l

0.10

511

Voice disturbances

267

1864

1.44

7.48

1.5

42.76

62.85

mu/l

1.60

232

1679

Enlarged lymph nodes

144

879

1.65

7.48

1.7

1.4

53.44

78.01

mu/l

0.72

132

802

COPD-related respiratory insufficiency

109

618

1.78

7.43

1.3

1.4

100.60

73.81

mu/l

0.45

552

Poisoning by drugs, medicaments and biological substances

229

1556

1.48

7.39

1.5

1.6

83.63

66.04

mu/l

0.28

202

1420

Cluster headache, strict, including avohilmo

252

2.25

7.39

1.4

1.5

43.23

72.60

mu/l

0.61

231

Benign neoplasm: Stomach

103

576

1.81

7.38

2.0

1.4

47.72

63.23

mu/l

0.46

506

Chronic nephritic syndrome

172

2.54

7.37

1.2

1.3

73.75

53.75

mu/l

0.33

156

Congenital malformations and deformations of the musculoskeletal system, including avohilmo

109

616

1.77

7.36

1.7

1.6

46.01

83.02

mu/l

1.27

104

562

Other diseases of lip and oral mucosa

427

3227

1.33

7.34

1.8

1.5

60.44

61.69

mu/l

0.03

374

2902

Benign neoplasm: Pancreas

138

2.74

7.31

2.4

1.3

40.96

89.05

mu/l

0.59

125

Primary ovarian failure

3.29

7.31

6.4

1.4

87.86

103.19

mu/l

0.10

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

550

4116

1.28

7.29

1.7

1.6

63.14

55.45

mu/l

0.31

489

3731

Diseases of oral cavity, salivary glands and jaws

528

2088

1.31

7.29

1.4

1.5

73.59

73.38

mu/l

0.00

466

1890

Trigeminal neuralgia

319

2.10

7.28

1.4

1.5

58.76

47.96

mu/l

0.18

290

Melanocytic naevi

310

2234

1.40

7.26

1.6

34.65

63.70

mu/l

6.06

282

2012

Diseases of peritoneum

102

572

1.80

7.24

1.5

1.4

45.61

67.33

mu/l

0.78

513

Obsessive-compulsive disorder

326

2.08

7.24

2.1

1.7

86.25

62.12

mu/l

0.31

298

Periapical abscess

464

3559

1.31

7.18

1.5

70.76

67.78

mu/l

0.08

424

3200

Temporomandibular joint disorders, including avohilmo

439

3234

1.32

7.17

2.2

1.7

50.16

58.17

mu/l

0.56

394

2939

Coxarthrosis

476

2344

1.31

7.16

1.4

1.5

62.58

60.43

mu/l

0.10

434

2120

Cardiomyopathy

148

920

1.62

7.15

1.3

1.5

102.16

50.33

mu/l

0.81

135

829

Algoneurodystrophy

175

2.51

7.14

1.6

1.4

47.43

82.40

mu/l

0.54

161

Other benign neoplasms of skin

356

2631

1.36

7.13

1.5

54.77

60.75

mu/l

0.24

320

2343

Myeloproliferative diseases

453

1.90

7.12

1.3

1.4

56.29

74.82

mu/l

0.27

405

Gastric ulcer

161

1023

1.58

7.12

1.3

1.4

100.80

60.38

mu/l

0.94

141

912

Postprocedural disorders of nervous system

390

1.97

7.12

1.8

1.6

39.04

66.47

mu/l

0.97

352

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

100

561

1.80

7.10

1.6

1.4

82.02

68.80

mu/l

0.18

502

Other and unspecified injuries of lower leg

411

1.94

7.10

1.5

67.92

53.76

mu/l

0.35

370

Blepharochalasis

284

2025

1.41

7.10

1.3

1.4

45.96

61.57

mu/l

1.04

254

1817

Other and unspecified urticaria

193

1279

1.52

7.07

1.8

1.6

41.18

61.47

mu/l

1.72

176

1158

Dislocation, sprain and strain of joints and ligaments of knee

609

4369

1.26

7.07

1.4

1.7

79.99

66.59

mu/l

0.58

555

3971

Tinnitus

234

1612

1.46

7.07

1.6

1.5

85.22

65.64

mu/l

0.50

207

1456

Other/unspecified enthesopathies of lower limb, excluding foot

377

1.98

7.07

1.6

1.5

36.48

65.30

mu/l

0.93

342

Hyperkinetic disorders

126

735

1.68

7.07

1.8

53.64

61.01

mu/l

0.30

117

676

Papillary adenocarcinoma of thyroid gland

290

2.14

7.05

1.7

1.4

35.65

68.68

mu/l

0.85

264

Vascular diseases of the intestine

158

2.57

7.03

1.2

86.26

39.31

mu/l

0.67

139

Ocular pain

491

1.85

7.01

1.7

1.5

77.23

59.34

mu/l

0.39

439

Trigger finger

148

926

1.61

7.01

1.5

81.77

48.60

mu/l

0.39

129

836

Other necrotizing vasculopathies (FG)

284

2.14

7.00

1.6

1.4

176.71

46.91

mu/l

0.72

254

Misadventures to patients during surgical and medical care

142

880

1.63

6.99

1.5

1.4

61.21

67.12

mu/l

0.18

127

791

Astigmatism

324

2.06

6.97

1.4

1.6

43.79

72.86

mu/l

0.79

296

Cholecystitis

127

766

1.67

6.95

1.7

1.4

78.47

63.44

mu/l

0.33

120

675

Superficial injury of lower leg

256

1799

1.43

6.95

1.6

64.55

60.61

mu/l

0.11

222

1629

Invasive ventilation

373

1.98

6.93

1.8

1.4

80.38

91.86

mu/l

0.15

330

Dental operations

568

2280

1.28

6.93

1.5

73.24

69.11

mu/l

0.10

495

2060

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

274

1950

1.41

6.92

1.7

90.50

62.01

mu/l

0.59

243

1780

Emotionally unstable personality disorder

114

669

1.72

6.92

1.4

1.7

71.87

54.00

mu/l

0.38

611

Liquid cancers

263

1757

1.42

6.90

1.3

1.4

50.44

67.74

mu/l

0.84

235

1583

Vitreous haemorrhage

102

582

1.77

6.86

1.7

1.4

73.82

70.27

mu/l

0.06

518

Oter anti-inflammatory and antirheumatic agents, non-steroids

186

661

1.55

6.86

1.6

1.5

47.53

43.70

mu/l

0.20

171

588

All influenza (not pneumonia)

139

861

1.63

6.85

1.8

1.5

89.17

66.94

mu/l

0.49

129

779

Injuries to the shoulder and upper arm

844

5359

1.22

6.85

1.5

1.6

56.15

65.25

mu/l

0.86

766

4830

Other and unspecified rosacea

525

1.81

6.80

1.7

1.5

66.29

60.63

mu/l

0.11

475

Internal derangement of knee

356

2627

1.35

6.75

1.6

74.82

63.17

mu/l

0.33

321

2384

Disturbance of activity and attention

118

687

1.69

6.72

1.9

1.8

54.16

61.43

mu/l

0.27

109

631

Injuries to the neck

222

1531

1.46

6.69

1.6

61.05

62.75

mu/l

0.04

196

1383

Eating disorders

519

1.80

6.69

2.6

1.7

114.64

73.50

mu/l

0.32

469

Social phobias

448

1.87

6.68

2.1

1.7

38.29

69.30

mu/l

1.53

408

Liquid cancers, including Hilmo

322

2082

1.37

6.68

1.4

62.51

66.62

mu/l

0.13

291

1871

Other disorders of the musculoskeletal system and connective tissue

147

930

1.59

6.67

1.5

1.4

62.03

63.87

mu/l

0.04

125

831

Use of pramipexole

209

1427

1.47

6.65

1.4

84.51

58.81

mu/l

0.45

181

1279

Poisoning by medicine

202

1370

1.48

6.64

1.6

84.90

66.52

mu/l

0.25

175

1252

Allergic urticaria

471

1.85

6.64

1.7

1.6

68.28

60.82

mu/l

0.10

428

Other postsurgical states

352

1.98

6.60

1.7

1.5

56.71

101.15

mu/l

0.68

319

D07AA Corticosteroids, weak (group I)

141

884

1.60

6.59

1.3

1.6

50.08

72.58

mu/l

0.82

128

802

Benign neoplasm: Rectum, anus and anal canal

193

1302

1.49

6.53

1.4

46.14

63.22

mu/l

0.83

177

1167

Degeneration of macula and posterior pole

432

2555

1.31

6.53

1.4

58.64

59.90

mu/l

0.03

383

2285

Sequelae of injuries, of poisoning and of other consequences of external causes

228

1589

1.44

6.52

1.4

1.5

68.86

64.90

mu/l

0.08

207

1437

Leiomyoma of uterus

613

2738

1.26

6.50

1.6

47.87

54.60

mu/l

0.48

548

2472

Other/unspecified disorders of vestibular function

202

2.31

6.48

1.5

1.4

25.46

80.40

mu/l

1.25

182

Panniculitis affecting regions of neck and back

165

2.46

6.47

1.6

1.4

48.52

68.97

mu/l

0.32

148

Chronic laryngitis and laryngotracheitis

139

875

1.60

6.46

1.5

1.4

94.15

69.42

mu/l

0.28

119

787

Open wound of lower leg

147

938

1.58

6.44

1.6

1.5

61.38

62.67

mu/l

0.04

128

843

Unspecified fall

483

3709

1.28

6.43

1.6

1.5

63.59

65.32

mu/l

0.07

424

3340

Hemiplegia

228

2.22

6.43

1.4

147.56

74.85

mu/l

0.55

207

Rosacea

127

783

1.64

6.43

1.7

1.5

73.09

64.10

mu/l

0.18

118

706

Allergic conjunctivitis

571

4384

1.26

6.42

1.7

1.6

65.77

57.66

mu/l

0.33

507

3984

Other and unspecified disorders of white blood cells

197

2.32

6.39

1.6

1.4

48.66

74.46

mu/l

0.40

179

Other necrotizing vasculopathies

371

1.94

6.36

1.5

1.3

157.02

60.45

mu/l

0.61

337

Benign neoplasm: Rectum

174

1157

1.51

6.34

1.3

1.4

46.49

65.63

mu/l

0.85

159

1039

Open wound of forearm

515

1.78

6.32

1.3

1.5

71.24

84.74

mu/l

0.17

450

Fibroblastic disorders

204

1401

1.46

6.31

1.3

1.5

52.40

54.36

mu/l

0.06

175

1262

Problems related to lifestyle

102

597

1.72

6.30

1.4

1.6

116.64

64.75

mu/l

0.40

546

Cramp and spasm

224

2.22

6.28

1.6

1.4

84.71

70.37

mu/l

0.09

206

Endometriosis

299

1260

1.39

6.27

1.6

47.81

52.03

mu/l

0.23

273

1139

Autoimmune hepatitis, wide definition

218

2.23

6.25

3.1

1.3

47.89

52.30

mu/l

0.10

192

Diabetic retinopathy, excluding more controls

320

1313

1.37

6.25

1.6

76.56

75.32

mu/l

0.03

282

1193

Acute pancreatitis

178

1194

1.50

6.21

1.4

65.48

65.61

mu/l

0.00

164

1065

Impotence

278

2.08

6.20

1.5

1.4

73.33

73.88

mu/l

0.01

254

Ptosis of eyelid

111

668

1.68

6.20

1.6

1.4

106.64

63.84

mu/l

0.43

101

601

Autoimmune hyperthyroidism

312

2.01

6.19

2.5

1.3

64.36

47.03

mu/l

0.57

282

Melanocytic naevi, other sites/unspecified

468

1.81

6.17

1.8

1.5

33.67

74.20

mu/l

1.62

424

Dental caries, including avohilmo

668

2764

1.24

6.12

1.5

1.6

68.24

71.02

mu/l

0.08

588

2496

Adenomyosis (Endometriosis of uterus)

128

800

1.61

6.10

1.7

1.5

37.72

54.57

mu/l

1.38

116

710

Iron deficiency anaemia secondary to blood loss (chronic)

141

904

1.57

6.08

1.4

1.5

66.61

64.13

mu/l

0.05

119

814

Gestational diabetes (for exclusion)

317

1612

1.36

6.07

1.9

66.43

51.74

mu/l

0.59

294

1479

Unspecified mental disorder

373

2847

1.31

6.05

1.5

1.6

63.04

65.85

mu/l

0.07

328

2574

Spontaneous rupture of synovium and tendon

471

1.80

6.04

1.4

89.92

32.66

mu/l

1.43

425

Erosion of teeth , including avohilmo

259

1873

1.39

6.03

2.1

1.7

52.50

63.82

mu/l

0.82

232

1705

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

248

2.13

6.02

1.3

1.4

86.35

95.04

mu/l

0.07

224

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

259

1166

1.40

6.00

2.5

1.9

67.48

50.06

mu/l

0.74

244

1071

Osteomyelitis

316

1.98

5.99

1.4

81.39

73.64

mu/l

0.10

278

Other inflammation of eyelid

139

892

1.57

5.98

1.7

1.5

62.55

59.96

mu/l

0.06

129

805

Viral infections of the central nervous system, including avohilmo

422

1.84

5.98

1.7

1.4

29.53

83.82

mu/l

1.39

376

Second line medication for Crohn's disease

562

4517

1.25

5.96

1.6

70.96

65.64

mu/l

0.23

508

4061

Injury, poisoning and certain other consequences of external causes

493

1934

1.28

5.94

1.6

1.7

87.76

60.62

mu/l

0.57

441

1765

Exposure to other specified factors

792

5653

1.21

5.94

1.6

73.77

64.15

mu/l

0.43

714

5119

Infective dermatitis

110

669

1.66

5.92

1.3

1.4

89.83

52.86

mu/l

0.55

103

608

Alzheimer’s disease, strict definition

1157

0.58

5.91

1.2

1.3

40.88

58.42

mu/l

0.73

1014

Follicular cysts of skin and subcutaneous tissue

175

1183

1.49

5.91

1.6

1.5

51.79

66.77

mu/l

0.74

156

1067

Fracture of lower leg, including ankle

529

4153

1.25

5.91

1.4

1.6

60.01

64.83

mu/l

0.26

479

3751

Viral infections characterized by skin and mucous membrane lesions

403

3120

1.30

5.87

2.1

1.5

64.38

68.47

mu/l

0.13

367

2797

Other obstetric conditions, not elsewhere classified

265

1206

1.39

5.84

2.5

1.9

67.62

49.32

mu/l

0.82

248

1107

Zoster [herpes zoster], including avohilmo

497

3813

1.26

5.84

1.6

1.5

60.32

59.47

mu/l

0.03

448

3413

Reimbursement for rheumatic diseases

545

4356

1.25

5.81

1.5

52.71

60.13

mu/l

0.54

498

3903

Dermatophytosis

131

836

1.58

5.79

1.6

1.4

49.37

65.72

mu/l

0.64

118

748

Viral infections of the central nervous system

384

1.87

5.76

1.7

1.4

30.77

88.50

mu/l

1.32

342

Other and unspecified myopathies

464

1.78

5.74

1.3

1.4

62.02

84.47

mu/l

0.42

414

Presence of cardiac and vascular implants and grafts

371

2087

1.31

5.72

1.2

1.4

75.71

63.89

mu/l

0.43

326

1874

Decubitus ulcer and pressure area

301

1.98

5.70

1.1

1.3

58.74

73.97

mu/l

0.33

262

Achilles tendinitis

103

623

1.67

5.68

1.2

1.5

82.55

63.42

mu/l

0.37

562

Other coagulation defects

386

1.86

5.67

1.6

1.5

38.78

89.00

mu/l

1.03

345

Fracture of lumbar spine and pelvis

200

1396

1.44

5.65

1.3

1.4

70.54

56.86

mu/l

0.43

173

1243

L04AX Other immunosuppressants

542

4370

1.24

5.64

1.6

71.81

64.96

mu/l

0.30

488

3929

Abscess of anal and rectal regions

475

1.76

5.60

1.2

1.5

117.87

67.96

mu/l

0.37

433

Other and unspecified disorders of vitreous body

418

3203

1.28

5.59

1.5

1.4

52.10

59.00

mu/l

0.45

374

2862

Eating disorder

423

1.81

5.59

2.3

1.7

67.36

88.03

mu/l

0.28

384

Superficial injury of ankle and foot

116

726

1.61

5.58

1.5

1.6

75.54

69.24

mu/l

0.11

109

663

Fracture of foot, except ankle

235

1696

1.39

5.58

1.5

1.6

74.13

64.54

mu/l

0.27

205

1542

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

203

2.20

5.57

2.2

1.6

70.28

60.83

mu/l

0.13

189

Diagnoses used for exclusion with ILD

223

1596

1.40

5.56

1.8

1.4

63.83

64.88

mu/l

0.03

198

1432

Pain associated with micturition

113

704

1.62

5.55

1.7

1.5

64.67

74.91

mu/l

0.18

102

628

Other viral diseases, including avohilmo

351

2666

1.31

5.54

1.9

1.7

69.32

69.29

mu/l

0.00

326

2429

Use of anticholinesterases

145

1672

0.67

5.53

1.3

1.4

46.25

61.28

mu/l

0.53

118

1476

N06DA Anticholinesterases

145

1672

0.67

5.53

1.3

1.4

46.25

61.28

mu/l

0.53

118

1476

Emotional disorders and disorders of social functioning with onset specific to childhood

205

2.17

5.52

1.9

1.7

48.91

110.83

mu/l

0.74

185

Intestinal adhesions without obstruction

433

1.79

5.52

1.4

41.42

61.27

mu/l

0.65

389

Myeloproliferative diseases (CML excluded)

397

1.83

5.52

1.4

62.95

75.07

mu/l

0.14

358

Dystonia

305

1.96

5.51

1.4

49.50

49.04

mu/l

0.01

275

Conductive and sensorineural hearing loss

746

4115

1.21

5.49

1.4

1.5

46.94

65.80

mu/l

2.55

657

3708

Inflammatory disease of uterus

134

871

1.55

5.49

1.7

36.14

48.47

mu/l

1.11

114

784

Neuralgia and neuritis, unspecified

271

2.02

5.48

1.4

33.10

32.95

mu/l

0.01

247

COPD, hospital admissions 1, only main diagnosis

285

1822

1.35

5.48

1.3

1.4

91.82

63.50

mu/l

1.27

251

1617

Other viral diseases, not elsewhere classified

167

1134

1.48

5.45

2.0

1.6

78.79

72.93

mu/l

0.11

155

1027

Other and unspecified visual disturbances

102

623

1.65

5.44

1.6

1.4

70.25

62.58

mu/l

0.11

555

Malignant melanoma

142

937

1.53

5.43

1.5

1.4

48.79

67.25

mu/l

0.62

127

842

Respiratory insufficiency

376

1.84

5.43

1.3

1.4

101.70

59.03

mu/l

0.64

332

Car occupant injured in other and unspecified transport accidents

171

1172

1.47

5.43

1.6

89.77

66.30

mu/l

0.30

153

1062

Other and unspecified mood [affective] disorders

356

1.87

5.42

1.5

1.6

42.81

57.29

mu/l

0.56

323

Candidiasis

135

882

1.54

5.41

2.4

1.5

81.93

61.41

mu/l

0.29

121

791

COPD, hospital admissions 3, with asthma pneumonia sepsis

218

1335

1.41

5.38

1.3

1.4

74.39

65.44

mu/l

0.24

195

1180

Other noninflammatory disorders of uterus, except cervix

201

939

1.44

5.36

1.5

1.4

61.05

52.58

mu/l

0.32

180

840

Melanocytic naevi of trunk

117

742

1.59

5.35

1.5

30.68

67.51

mu/l

2.65

103

668

Atopic dermatitis

562

3636

1.23

5.34

1.7

86.31

62.25

mu/l

0.94

512

3303

Seropositive rheumatoid arthritis

219

1566

1.40

5.33

1.4

44.08

53.49

mu/l

0.63

201

1399

Somnolence, stupor and coma

194

2.19

5.30

2.0

1.3

54.08

78.33

mu/l

0.36

172

Brain meningioma

282

1.98

5.28

1.4

49.49

61.53

mu/l

0.14

254

Emotional disorders starting during childhood or adolecense, excluding more controls

169

2.26

5.27

1.9

1.7

48.92

60.63

mu/l

0.37

155

Sensorineural hearing loss

704

3896

1.21

5.26

1.4

1.5

48.45

65.25

mu/l

1.95

619

3509

Mental disorders, not otherwise specified

455

1.75

5.25

1.6

41.52

52.95

mu/l

0.58

414

Other medical care

440

2928

1.26

5.24

1.7

1.4

57.61

64.28

mu/l

0.35

392

2611

Medial epicondylitis

215

2.12

5.24

1.9

1.5

86.33

34.13

mu/l

1.17

201

Delirium, not induced by alcohol and other psychoactive substances

105

651

1.62

5.22

1.6

1.4

102.42

71.88

mu/l

0.45

573

Unspecified misadventure during surgical and medical care

297

1.94

5.22

1.5

1.4

50.63

81.71

mu/l

0.71

264

Other disorders of optic [2nd] nerve and visual pathways

311

1.92

5.22

1.4

120.91

75.24

mu/l

0.33

278

Calcific aortic valvular stenosis, operated

233

1634

1.38

5.22

1.3

1.4

99.53

57.02

mu/l

1.27

214

1440

Calcific aortic valvular stenosis

233

1634

1.38

5.22

1.3

1.4

99.53

57.02

mu/l

1.27

214

1440

Cholangitis (primary sclerosing, PSC)

304

1.93

5.22

1.3

1.4

126.17

76.99

mu/l

0.35

271

Hypertrophy of breast in women and men

186

1306

1.43

5.21

1.7

1.5

50.89

60.11

mu/l

0.37

165

1175

Diseases of appendix

709

5291

1.20

5.20

1.6

63.67

65.23

mu/l

0.06

642

4785

Lesion of ulnar nerve

128

835

1.54

5.19

1.4

1.5

66.67

55.00

mu/l

0.34

112

760

Brain meningioma, including Hilmo

291

1.95

5.18

1.4

48.55

61.00

mu/l

0.15

261

Dentofacial anomalies [including malocclusion]

695

4526

1.20

5.18

2.1

1.6

54.29

63.78

mu/l

0.88

628

4099

Parkinson's disease, excluding more controls

103

586

1.63

5.16

1.2

1.5

34.08

56.21

mu/l

1.34

524

Schizophrenia or delusion, excluding more controls

259

1902

1.35

5.11

1.3

1.6

74.16

62.98

mu/l

0.22

226

1727

Postprocedural disorders of digestive system, not elsewhere classified

165

2.28

5.10

1.7

1.3

53.78

138.16

mu/l

0.71

150

Appendicitis, broad definition

702

5263

1.20

5.10

1.6

63.89

65.31

mu/l

0.05

636

4761

Colectomy operation

151

1024

1.48

5.09

1.6

1.4

64.82

63.37

mu/l

0.03

140

915

Alzheimer disease

129

1388

0.66

5.09

1.2

1.4

40.89

62.95

mu/l

1.03

109

1221

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

277

2084

1.33

5.08

1.6

65.94

64.22

mu/l

0.04

255

1890

Benign neoplasm: Transverse colon

104

651

1.61

5.06

1.4

79.57

70.59

mu/l

0.09

580

Localized swelling, mass and lump of skin and subcutaneous tissue

299

2276

1.32

5.06

1.7

1.5

59.74

63.74

mu/l

0.13

270

2043

Herpesviral [herpes simplex] infections

108

682

1.60

5.06

2.2

1.5

65.10

57.46

mu/l

0.11

100

609

Scleritis and episcleritis

336

1.87

5.06

1.3

1.5

64.91

65.57

mu/l

0.01

309

Haemorrhage, not elsewhere classified

153

2.31

5.04

1.2

1.3

54.41

60.31

mu/l

0.09

136

Otalgia

468

1.72

5.04

1.5

1.6

64.87

83.12

mu/l

0.23

422

Crohn disease

116

747

1.56

4.99

1.7

1.6

71.46

70.54

mu/l

0.01

105

673

Malignant melanoma of skin

112

716

1.58

4.99

1.5

1.4

48.94

69.01

mu/l

0.54

102

645

Alzheimer disease, including avohilmo

161

1602

0.69

4.98

1.2

1.4

31.39

61.77

mu/l

3.25

132

1418

Other condition

134

892

1.51

4.96

1.6

1.5

72.23

62.05

mu/l

0.22

123

803

Calcific aortic valvular stenosis, diagnosis (helper)

231

1633

1.37

4.94

1.3

1.4

100.14

57.06

mu/l

1.28

212

1439

Operations 2 for CAVS

231

1633

1.37

4.94

1.3

1.4

100.14

57.06

mu/l

1.28

212

1439

Other local infections of skin and subcutaneous tissue

585

1.64

4.94

1.4

65.07

86.02

mu/l

0.36

528

Explicit bacterial Sepsis

524

1.67

4.92

1.4

67.63

66.63

mu/l

0.02

463

Papulosquamous disorders

370

2908

1.28

4.92

1.6

1.5

61.82

64.41

mu/l

0.10

329

2599

Other viral diseases, not elsewhere classified, including avohilmo

248

1834

1.35

4.91

2.0

1.7

77.67

67.59

mu/l

0.27

229

1666

Impingement syndrome of shoulder

212

1541

1.38

4.89

1.4

1.5

78.75

60.44

mu/l

0.33

193

1386

177

1162

1.43

4.88

1.3

1.4

31.38

56.27

mu/l

2.17

154

1026

Unspecific neurodegenerative disorder

206

1936

0.73

4.85

1.2

1.4

40.33

59.53

mu/l

1.29

173

1722

Inflammatory bowel disease

291

2222

1.32

4.84

1.5

1.6

71.63

65.27

mu/l

0.21

266

2013

Vasomotor and allergic rhinitis

345

2631

1.29

4.83

1.6

1.7

67.47

69.50

mu/l

0.04

308

2397

Disorders of muscles

581

1.63

4.83

1.4

1.5

46.57

45.47

mu/l

0.04

530

Calcific aortic valvular stenosis, including rheumatic fever

231

1639

1.36

4.81

1.3

1.4

100.14

56.88

mu/l

1.29

212

1445

Other and unspecified glaucoma

349

1.82

4.80

1.3

88.77

71.88

mu/l

0.20

302

Ulcerative colitis, NAS

123

811

1.53

4.78

1.5

80.67

70.91

mu/l

0.18

111

730

Rheumatoid arthritis

285

1920

1.32

4.78

1.5

56.39

54.52

mu/l

0.07

258

1732

Injuries to the wrist and hand

984

5622

1.16

4.76

1.6

61.91

63.50

mu/l

0.10

885

5088

Malignant neoplasm of eye, brain and central nervous system, including Hilmo

350

1.82

4.76

1.7

1.4

38.99

87.31

mu/l

1.56

316

Other peripheral vertigo

530

1.66

4.75

1.4

22.39

58.25

mu/l

2.32

469

Childhood asthma (age<16), excluding more controls

463

1.63

4.75

2.0

1.8

95.68

60.37

mu/l

0.32

429

Polymyalgia rheumatica

114

741

1.55

4.73

1.4

46.41

66.78

mu/l

0.83

101

657

Congenital malformations of the circulatory system

132

859

1.50

4.73

1.4

1.6

98.20

79.02

mu/l

0.23

118

782

Acute pancreatitis (for exclusion)

178

1264

1.42

4.73

1.4

65.48

64.40

mu/l

0.03

164

1130

Uterine polyps

254

1102

1.35

4.73

1.7

1.5

60.68

53.48

mu/l

0.14

227

991

Other eating disorders

217

2.05

4.72

2.7

1.6

80.17

109.21

mu/l

0.22

199

Hyperplasia of prostate

280

1187

1.33

4.71

1.5

1.4

72.12

78.10

mu/l

0.15

253

1062

Retinal vascular disorders

103

655

1.58

4.71

1.4

56.16

63.67

mu/l

0.14

580

Keratitis

333

2599

1.29

4.70

1.9

1.5

52.72

66.11

mu/l

1.24

307

2333

Benign lipomatous neoplasm

272

2067

1.32

4.70

1.6

1.5

79.24

61.72

mu/l

0.41

255

1847

Perforation of tympanic membrane

539

1.65

4.70

1.6

1.5

56.73

72.62

mu/l

0.36

478

Speech therapy

237

1766

1.35

4.69

1.4

1.5

51.12

60.52

mu/l

0.37

222

1583

Polycystic ovarian syndrome

225

2.02

4.66

2.1

1.3

77.59

50.62

mu/l

0.40

204

Other disorders of patella

159

1110

1.44

4.65

1.7

1.5

90.74

55.49

mu/l

0.89

136

1008

Malignant melanoma, including Hilmo

153

1061

1.45

4.64

1.5

1.4

45.99

64.62

mu/l

0.71

138

954

Traumatic subdural haemorrhage

577

1.60

4.62

1.4

1.5

39.95

53.12

mu/l

0.62

521

Hypermetropia

383

1.76

4.60

1.2

1.6

39.47

104.48

mu/l

1.39

352

Other skin changes

181

1296

1.40

4.60

1.4

45.92

61.04

mu/l

0.88

158

1164

Acute appendicitis

654

5094

1.19

4.60

1.6

65.22

66.27

mu/l

0.04

594

4611

Alzheimer’s disease (Late onset)

1050

0.61

4.59

1.2

1.3

39.74

61.20

mu/l

0.89

916

Redundant prepuce, phimosis and paraphimosis

174

1217

1.41

4.59

1.8

1.5

109.27

86.62

mu/l

0.52

155

1105

Degenerative diseases of the nervous system

160

1629

0.70

4.59

1.2

1.4

37.24

61.90

mu/l

2.08

131

1447

Other abnormal immunological findings in serum

110

2.50

4.58

2.0

1.3

43.71

62.79

mu/l

0.27

102

Myopia

116

763

1.53

4.58

1.8

1.6

61.46

74.47

mu/l

0.34

105

697

Coeliac disease

109

708

1.55

4.56

2.1

1.5

53.99

63.07

mu/l

0.27

635

Traumatic subarachnoid haemorrhage

141

2.29

4.56

1.1

1.5

143.59

47.00

mu/l

0.59

122

Benign neoplasm: Descending colon

400

1.74

4.55

1.3

1.4

146.21

86.73

mu/l

0.46

360

Malignant melanoma of skin, including Hilmo

128

862

1.49

4.52

1.5

1.3

45.19

66.78

mu/l

0.73

118

777

Biological medication for rheuma

161

1133

1.43

4.52

1.6

62.09

66.39

mu/l

0.11

152

1034

Vasculitis limited to skin, not elsewhere classified

123

2.40

4.52

1.2

1.3

35.36

67.26

mu/l

0.65

112

Crohn's disease NAS

320

1.83

4.51

1.5

31.55

65.40

mu/l

1.14

286

Acute appendicitis, no complications

510

4170

1.22

4.50

1.6

1.7

72.21

68.69

mu/l

0.10

461

3787

Hydronephrosis

600

1.59

4.49

1.9

1.5

49.62

49.07

mu/l

0.01

537

Injuries to unspecified part of trunk, limb or body region

577

1.61

4.48

1.5

68.98

71.10

mu/l

0.03

514

Ulcerative colitis

217

1608

1.36

4.47

1.5

1.6

69.33

68.82

mu/l

0.01

201

1448

Prurigo nodularis

130

2.35

4.47

1.2

1.3

82.01

60.33

mu/l

0.17

119

Coagulation defects, purpura and other haemorrhagic conditions

170

1211

1.41

4.46

1.6

1.5

60.43

69.18

mu/l

0.26

158

1083

Campylobacter enteritis

130

2.34

4.46

2.5

1.4

71.79

61.21

mu/l

0.15

121

Injury of unspecified body region

410

1.72

4.44

1.5

1.4

71.00

61.49

mu/l

0.12

367

Noninflammatory disorders of female genital tract

340

1328

1.29

4.43

1.6

54.53

52.32

mu/l

0.05

302

1201

Thyrotoxicosis with toxic multinodular goitre

337

1.80

4.42

1.5

1.4

84.89

60.60

mu/l

0.33

302

Retinal vascular occlusion

101

650

1.56

4.42

1.4

56.67

63.76

mu/l

0.13

575

Torsion of ovary, ovarian pedicle and fallopian tube

106

2.49

4.41

2.5

1.6

64.02

58.80

mu/l

0.07

Multiple delivery

584

0.44

4.40

1.5

1.7

56.63

67.87

mu/l

0.31

525

Other viral diseases

258

1959

1.32

4.39

1.9

1.6

68.60

68.34

mu/l

0.01

240

1777

Lichen simplex chronicus and prurigo

360

1.77

4.38

1.5

1.4

60.29

52.27

mu/l

0.12

323

Iridocyclitis

204

1504

1.36

4.36

1.5

47.76

66.87

mu/l

1.43

187

1351

Abdominal aortic aneurysm (AAA)

364

1.75

4.36

1.3

1.4

86.86

61.32

mu/l

0.44

320

Explicit bacterial Sepsis, including avohilmo

542

1.62

4.36

1.4

67.63

65.36

mu/l

0.04

479

Other inflammatory liver diseases

339

1.79

4.33

2.7

1.5

47.56

74.76

mu/l

0.62

308

Acute laryngitis and tracheitis

628

1.56

4.29

1.8

1.6

83.08

75.93

mu/l

0.12

565

Myasthenia gravis

2.75

4.29

1.4

1.2

42.51

73.36

mu/l

0.39

Childhood asthma (age<16)

476

1.58

4.28

2.0

1.8

95.68

61.55

mu/l

0.31

441

Alkalosis

7.52

4.27

3.6

1.2

54.72

15.22

mu/l

—

238

1543

1.33

4.26

1.3

1.4

44.44

62.21

mu/l

0.87

208

1362

Other specified/unspecified soft tissue disorders

226

1.97

4.26

1.2

1.4

69.35

31.45

mu/l

0.43

205

Diabetic retinopathy, strict definition

203

1331

1.36

4.26

1.9

1.6

77.95

83.95

mu/l

0.14

178

1196

Chronic ulcer of skin, not elsewhere classified

356

1.76

4.24

1.8

1.4

83.36

65.86

mu/l

0.27

312

Dementia in Alzheimer disease

782

0.56

4.23

1.2

1.3

61.39

57.84

mu/l

0.05

689

Bulimia nervosa (incl. atypical)

146

2.22

4.23

1.7

45.43

56.95

mu/l

0.39

133

Other and unspecified local infections of skin and subcutaneous tissue

547

1.60

4.22

1.4

65.03

86.70

mu/l

0.35

490

Gluteal tendinitis

234

1.95

4.22

1.7

1.4

61.47

52.29

mu/l

0.10

212

Other/unspecified enthesopathies, not elsewhere classified

448

1.66

4.18

1.6

1.5

92.97

34.69

mu/l

1.22

405

220

1.96

4.17

1.6

1.3

28.00

66.14

mu/l

1.62

195

Disorders of breast

465

3361

1.22

4.16

1.6

43.22

54.19

mu/l

1.24

420

3039

Fracture of neck

285

1.84

4.16

1.4

1.3

38.68

80.75

mu/l

1.09

248

Bronchitis, not specified as acute or chronic

449

1.66

4.14

1.3

1.4

72.88

66.59

mu/l

0.08

401

Chondropathies

133

920

1.45

4.14

1.4

1.5

68.62

61.84

mu/l

0.14

121

832

Maltreatment syndromes

243

1.91

4.12

1.5

1.6

198.07

81.24

mu/l

0.40

221

Herpesviral [herpes simplex] infections, including avohilmo

237

1805

1.32

4.09

2.0

1.6

49.78

60.05

mu/l

0.36

215

1627

Benign neoplasm: Ascending colon

130

899

1.46

4.07

1.3

1.4

65.23

65.21

mu/l

0.00

112

805

Visual impairment including blindness (binocular or monocular)

331

1.77

4.06

1.5

1.4

46.15

73.16

mu/l

0.67

293

Other inflammation of eyelid, including avohilmo

411

3348

1.23

4.06

1.6

54.66

60.67

mu/l

0.34

375

3042

Other specified and unspecified personality disorders

498

1.62

4.06

1.5

41.54

55.23

mu/l

0.75

453

Dermatophytosis, including avohilmo

610

5052

1.19

4.05

1.6

79.44

63.25

mu/l

0.58

545

4560

Viral pneumonia (unknown virus, not influenza)

354

1.74

4.04

1.5

1.4

70.44

68.88

mu/l

0.02

317

Graves disease, strict definition

585

1.57

4.04

2.2

1.5

62.18

57.73

mu/l

0.13

533

Parkinson's disease, strict definition, excluding more controls

552

1.56

4.02

1.3

1.5

35.34

52.76

mu/l

0.92

494

Sequelae of injuries of upper limb

578

1.57

4.02

1.4

87.90

74.77

mu/l

0.12

518

Hypertrophy of breast

161

1160

1.40

4.01

1.7

1.5

50.29

58.26

mu/l

0.28

143

1050

Malignant neoplasm of skin, including Hilmo

470

2589

1.22

4.01

1.4

49.17

60.55

mu/l

0.45

415

2327

Any dementia

192

1783

0.74

4.00

1.2

1.4

56.72

58.83

mu/l

0.05

162

1582

Fracture of shoulder and upper arm

325

2581

1.26

4.00

1.4

1.5

56.79

62.78

mu/l

0.28

295

2299

Tonsillectomy and adenotomy

508

2931

1.21

4.00

1.8

1.7

68.79

63.76

mu/l

0.22

462

2692

Poor fetal growth

105

698

1.51

4.00

1.8

2.0

34.53

53.75

mu/l

1.42

646

Anterior Iridocyclitis

176

1288

1.37

3.99

1.6

1.5

49.41

68.29

mu/l

1.17

163

1160

Suicide or other Intentional self-harm

215

1622

1.33

3.98

1.5

1.6

88.34

66.04

mu/l

0.35

188

1475

Mixed and other personality disorders

439

1.65

3.98

1.4

1.6

128.80

60.01

mu/l

0.48

400

Use of donepezil

1076

0.62

3.98

1.3

34.80

58.57

mu/l

1.23

947

Other and unspecified vascular occlusions

493

1.61

3.98

1.4

44.28

68.41

mu/l

0.47

434

Unspecified acute lower respiratory infection

133

929

1.44

3.95

1.6

1.5

65.20

66.42

mu/l

0.02

115

838

Otitis externa

206

1547

1.34

3.94

1.5

66.86

67.12

mu/l

0.01

184

1391

Olecranon bursitis

327

1.76

3.94

1.5

136.35

43.38

mu/l

1.00

299

Flat foot [pes planus] (acquired)

589

1.56

3.93

1.6

1.4

47.47

57.78

mu/l

0.36

529

Glaucoma suspect

321

2555

1.26

3.92

1.5

1.4

73.34

62.80

mu/l

0.38

284

2274

Female infertility

245

1119

1.32

3.92

2.2

1.6

56.29

54.64

mu/l

0.06

225

1016

Preparatory care for dialysis

206

1.96

3.89

1.4

65.11

87.51

mu/l

0.23

187

Fall on same level involving ice and snow

543

4563

1.19

3.88

1.5

1.6

53.18

62.90

mu/l

0.73

493

4099

Seronegative rheumatoid arthritis

101

671

1.51

3.88

1.8

1.4

74.08

52.69

mu/l

0.43

606

Other hearing loss

229

1694

1.31

3.87

1.5

1.4

41.41

70.62

mu/l

2.53

204

1521

Other diseases of arteries and capillaries

466

1.62

3.86

1.2

1.5

92.28

42.38

mu/l

1.28

421

Episcleritis

300

1.79

3.85

1.3

1.5

56.89

68.40

mu/l

0.18

276

Other noninfective disorders of lymphatic vessels and lymph nodes

186

2.01

3.85

1.5

1.4

31.94

47.62

mu/l

0.63

167

Single delivery by forceps and vacuum extractor

628

0.60

3.85

1.7

2.1

90.67

61.58

mu/l

0.27

578

Other and unspecified disorders of autonomic nervous system

4.83

3.82

1.5

1.2

22.70

21.48

mu/l

0.08

Emotional disorders starting during childhood or adolescence

205

1.95

3.82

1.8

1.6

49.24

64.82

mu/l

0.63

183

Paracetamol or NSAID medication

122

416

1.48

3.81

1.4

1.9

70.07

62.33

mu/l

0.12

110

380

Superficial injury of abdomen, lower back and pelvis

135

953

1.42

3.80

1.8

1.5

69.81

65.25

mu/l

0.08

121

850

Glaucoma

497

3522

1.20

3.79

1.5

1.4

67.00

60.37

mu/l

0.31

446

3132

Endometriosis of pelvic peritoneum

137

880

1.42

3.79

1.7

1.6

42.62

56.33

mu/l

0.89

130

798

Fall involving bed

140

2.17

3.78

1.1

1.3

49.44

60.42

mu/l

0.16

121

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

896

4938

1.15

3.77

1.5

1.6

66.99

62.92

mu/l

0.18

803

4455

Zoster [herpes zoster]

162

1183

1.38

3.74

1.8

1.4

72.19

64.56

mu/l

0.16

152

1054

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

141

1006

1.41

3.74

1.6

109.47

69.43

mu/l

0.43

121

915

Peritonsillar abscess

181

1345

1.35

3.74

1.9

1.6

53.51

65.03

mu/l

0.52

159

1229

Polyp of the female genital tract

257

1124

1.30

3.71

1.6

1.5

60.08

52.89

mu/l

0.14

230

1012

5-aminosalicylic acid

184

1373

1.35

3.70

1.6

63.30

64.83

mu/l

0.05

166

1245

Palmar fascial fibromatosis [Dupuytren]

118

817

1.45

3.70

1.3

1.4

56.95

49.23

mu/l

0.18

726

Fall on and from stairs and steps

236

1827

1.30

3.66

1.4

1.5

62.86

63.45

mu/l

0.02

213

1645

Haemolytic anaemias

169

2.04

3.66

2.4

1.4

47.00

56.69

mu/l

0.20

151

Other specific arthropathies, wide

2.51

3.65

1.7

1.4

42.90

46.64

mu/l

0.06

Benign neoplasm of middle ear and respiratory system

419

1.64

3.64

1.6

1.4

124.86

87.33

mu/l

0.19

379

Juvenile arthritis (FINNGEN)

197

1.95

3.63

2.0

1.6

47.40

53.77

mu/l

0.22

178

Other female pelvic inflammatory diseases

144

1039

1.39

3.60

1.7

1.5

61.11

50.20

mu/l

0.31

128

931

Fracture of skull and facial bones

194

1466

1.33

3.60

1.5

74.36

65.83

mu/l

0.18

168

1325

Psoriasis

261

2052

1.28

3.60

1.7

1.5

70.26

65.86

mu/l

0.14

232

1840

Other abnormal uterine and vaginal bleeding

192

1034

1.34

3.59

1.5

62.75

50.57

mu/l

0.46

175

924

Stomatitis and related lesions

178

1329

1.35

3.59

1.8

1.5

100.11

58.85

mu/l

0.53

158

1192

Amputation of toe

352

1.69

3.58

1.2

1.3

106.63

90.68

mu/l

0.19

313

Inflammatory diseases of the central nervous system

452

1.60

3.58

1.5

51.00

68.76

mu/l

0.54

408

Malignant neoplasm of skin

441

2472

1.21

3.56

1.4

50.25

60.49

mu/l

0.36

385

2222

Disorders of optic nerve and visual pathways

509

1.56

3.52

1.6

1.5

100.45

62.34

mu/l

0.37

461

Otitis externa, unspecified

101

686

1.48

3.52

1.6

54.79

63.49

mu/l

0.16

618

Assault

116

810

1.44

3.50

1.5

1.7

105.85

75.76

mu/l

0.41

104

744

Other diseases of peritoneum

243

1.83

3.50

1.6

1.4

24.88

73.43

mu/l

1.37

221

Peripheral artery operations in Hilmo

614

1.51

3.48

1.2

1.4

95.99

49.36

mu/l

1.66

552

Spasmodic torticollis

174

1.98

3.41

1.5

1.4

46.67

84.33

mu/l

0.51

161

Kela-code for severe mental illness

316

2559

1.24

3.39

1.5

1.6

67.90

66.56

mu/l

0.03

275

2322

Psoriatic and enteropathic arthropathies

101

692

1.47

3.39

1.6

1.5

83.07

52.58

mu/l

0.72

626

Hypertrophic disorders of skin

305

1.72

3.38

1.9

1.6

71.54

57.25

mu/l

0.15

274

Injury of intra-abdominal organs

127

2.16

3.38

1.8

1.3

166.68

63.54

mu/l

0.66

115

Haemorrhage in early pregnancy

238

1812

1.28

3.37

1.6

1.7

69.79

51.83

mu/l

0.58

213

1641

Acute and subacute iridocyclitis

164

1223

1.35

3.36

1.6

1.5

49.02

67.89

mu/l

1.09

151

1102

Familial hypercholesterolemia, with ischemic heart disease

460

1.58

3.35

1.2

1.5

153.44

64.67

mu/l

1.08

400

Striking against or struck by other objects

293

2353

1.25

3.35

1.5

1.6

90.99

69.73

mu/l

0.57

264

2128

Arterial embolism and thrombosis

239

1.81

3.34

1.3

126.60

55.84

mu/l

0.53

207

Amiodarone users

548

1.53

3.34

1.3

1.4

59.77

80.02

mu/l

0.52

493

Covid-19 suspected case

185

1406

1.32

3.33

1.5

1.6

53.93

71.63

mu/l

0.63

172

1281

Other juvenile arthritis

176

1.95

3.30

2.0

1.6

43.77

56.14

mu/l

0.45

159

Other bursopathies

112

787

1.43

3.29

1.4

1.5

41.86

49.28

mu/l

0.52

715

Retinal detachments and breaks

297

2399

1.24

3.28

1.6

1.4

59.71

62.79

mu/l

0.12

248

2146

Other disorders starting during childhood or adolecense, excluding more controls

181

1.91

3.28

1.7

73.66

116.99

mu/l

0.31

166

Adhesive capsulitis of shoulder

143

1049

1.37

3.27

1.7

1.5

107.22

53.67

mu/l

0.80

130

952

Acute nasopharyngitis (common cold)

104

716

1.45

3.27

1.6

1.5

71.42

86.36

mu/l

0.25

647

Overexertion and strenuous or repetitive movements

584

1.50

3.25

1.5

43.60

69.11

mu/l

0.87

527

Other congenital malformations of skin, including avohilmo

441

1.58

3.22

1.5

70.84

83.94

mu/l

0.19

400

Hypertrophic scar

272

1.74

3.22

1.8

1.5

75.78

59.74

mu/l

0.15

243

Other degenerative diseases of the nervous system

203

1139

1.30

3.20

1.3

1.5

55.19

57.35

mu/l

0.04

169

1020

Pleural effusion

120

861

1.40

3.15

1.5

1.4

89.16

64.44

mu/l

0.50

106

758

Female infertility, cervical, vaginal, other or unspecified origin

221

1101

1.29

3.13

2.1

1.6

56.13

54.44

mu/l

0.06

203

1000

Scoliosis

437

1.57

3.11

1.4

1.6

49.78

48.62

mu/l

0.03

395

Use of other anti-dementia drugs

110

1237

0.71

3.10

1.2

1.3

31.68

59.09

mu/l

2.09

1078

Use of memantine

110

1237

0.71

3.10

1.2

1.3

31.68

59.09

mu/l

2.09

1078

Otitis media, unspecified

557

1.48

3.10

1.7

72.13

89.22

mu/l

0.26

507

Colonic or urogenital fistula

234

1856

1.27

3.07

1.6

1.5

98.42

63.67

mu/l

0.81

214

1670

Macular cyst

153

1.99

3.06

1.2

27.04

51.71

mu/l

0.84

133

Acute suppurative otitis media

215

1571

1.28

3.06

1.9

1.8

51.17

72.07

mu/l

1.30

197

1445

Tubulo-interstitial nephritis, not specified as acute or chronic

299

1.68

3.05

1.8

1.4

50.10

49.93

mu/l

0.00

274

Ménière disease

544

1.50

3.04

1.4

72.89

63.65

mu/l

0.17

485

Benign neoplasm: Skin of trunk

203

1.84

3.04

1.4

1.3

43.29

76.63

mu/l

0.56

185

IBD patients in KELA-register

192

1488

1.30

3.03

1.5

1.6

65.17

68.43

mu/l

0.10

175

1354

Allergic purpura

133

2.05

3.03

1.5

1.4

53.08

56.71

mu/l

0.05

122

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

201

1519

1.29

3.02

2.3

1.3

71.70

63.87

mu/l

0.20

183

1368

Any death

443

3652

0.85

2.99

1.6

1.4

78.75

60.83

mu/l

1.11

382

3271

Congenital malformations of heart and great arteries

106

729

1.42

2.99

1.5

1.6

160.39

84.53

mu/l

0.56

663

Preterm labour and delivery

228

1809

1.26

2.99

1.7

39.19

49.92

mu/l

1.29

206

1635

Allergic rhinitis

261

2077

1.24

2.97

1.7

61.81

66.93

mu/l

0.17

233

1900

Allergic contact dermatitis

115

829

1.39

2.97

1.8

1.5

90.22

53.98

mu/l

1.01

103

744

Emphysema

364

1.60

2.95

1.2

1.4

95.18

86.46

mu/l

0.10

324

Specific development disorders of speech and language

269

1.70

2.94

1.7

1.6

32.72

98.06

mu/l

1.16

246

Ganglion

175

1346

1.30

2.94

1.5

1.6

47.07

49.89

mu/l

0.08

160

1221

Essential (haemorrhagic) thrombocythaemia

191

1.85

2.94

1.1

1.4

33.63

86.02

mu/l

1.01

176

Corneal ulcer

158

1199

1.32

2.93

2.2

1.5

48.35

67.58

mu/l

1.29

148

1079

Other noninflammatory disorders of vulva and perineum

541

1.49

2.92

1.5

1.6

52.76

57.68

mu/l

0.13

487

Cervical polyps

582

1.47

2.92

1.5

1.4

66.61

54.75

mu/l

0.24

521

Spondyloarthritis

138

1027

1.35

2.92

1.6

1.4

50.98

63.04

mu/l

0.48

124

926

Suppurative and unspecified otitis media

301

2183

1.22

2.91

1.8

48.97

69.34

mu/l

1.68

275

1994

Other/unspecified synovitis and tenosynovitis

673

1.43

2.91

1.3

1.5

55.54

46.90

mu/l

0.22

615

Female genital prolapse

243

1073

1.26

2.91

1.4

1.5

35.65

53.27

mu/l

1.23

215

962

Disorders of puberty

2.73

2.90

3.7

1.2

81.11

38.08

mu/l

0.60

Alcohol dependence

216

1710

1.27

2.90

1.4

1.5

47.68

70.98

mu/l

2.32

186

1539

Other osteochondropathies

366

1.60

2.90

1.7

1.5

55.79

83.69

mu/l

0.55

332

Psoriasis vulgaris

157

1193

1.32

2.89

1.8

1.5

66.13

64.38

mu/l

0.04

137

1079

Lesion of lateral popliteal nerve

244

1.74

2.87

1.5

24.96

61.73

mu/l

1.68

222

Superficial injury of head

202

1586

1.28

2.87

1.4

1.5

49.96

63.27

mu/l

0.62

176

1436

Other diseases of gallbladder

222

1.77

2.86

1.5

1.4

62.21

75.29

mu/l

0.11

199

Salpingitis and oophoritis

157

1196

1.32

2.85

1.7

1.5

75.60

53.32

mu/l

0.31

139

1077

Embolic stroke

193

1.83

2.84

1.2

1.3

180.03

61.91

mu/l

0.80

167

Crohn disease (strict definition, require KELA, min 2 HDR)

337

1.61

2.83

1.6

1.5

61.73

69.64

mu/l

0.12

299

Nail disorders

472

1.51

2.83

1.9

1.5

65.41

61.35

mu/l

0.07

420

Sacroiliitis, not elsewhere classified

223

1.76

2.82

2.1

1.6

50.55

53.05

mu/l

0.04

204

Polycystic ovarian syndrome, broad definition

529

1.48

2.81

1.4

1.5

51.06

51.65

mu/l

0.01

483

Rheumatoid arthritis, including avohilmo

329

2735

1.21

2.80

1.5

53.34

61.19

mu/l

0.40

298

2444

Spondylopathies (FG)

110

796

1.39

2.80

1.7

1.6

49.69

54.02

mu/l

0.14

720

Unspecified/other endometriosis

471

1.50

2.79

1.7

50.09

51.91

mu/l

0.05

433

Cystic fibrosis

8.72

2.78

1.2

65.42

35.35

mu/l

—

Mucosal proctocolitis

104

747

1.40

2.77

1.6

68.88

75.42

mu/l

0.16

676

Disorders in reading

2.34

2.76

1.7

1.3

45.93

51.61

mu/l

0.14

Rash and other nonspecific skin eruption

540

1.47

2.75

1.7

1.5

68.96

54.81

mu/l

0.22

482

Diseases of external ear

308

2551

1.21

2.74

1.5

76.95

62.49

mu/l

0.51

274

2286

Bullous disorders

271

1.67

2.72

1.5

1.4

102.21

73.76

mu/l

0.30

241

Other maternal disorders predominantly related to pregnancy

504

2712

1.16

2.71

1.7

69.21

52.86

mu/l

0.95

462

2454

Later onset COPD

202

1281

1.27

2.71

1.2

1.4

77.85

65.15

mu/l

0.40

177

1131

Benign neoplasm: Skin of other and unspecified parts of face

600

1.44

2.70

1.3

1.4

30.38

68.53

mu/l

2.01

531

Tumor necrosis factor alpha inhibitors

135

1017

1.33

2.67

1.5

1.6

60.45

67.29

mu/l

0.16

127

925

Propionic acid derivatives

213

846

1.27

2.66

1.5

1.7

40.95

51.28

mu/l

0.82

187

764

Pollen allergy

152

1149

1.31

2.65

1.7

66.60

66.13

mu/l

0.01

139

1059

Bell's palsy

678

1.41

2.64

1.5

119.18

53.83

mu/l

0.63

610

Septal defects

313

1.61

2.64

1.5

58.21

104.90

mu/l

0.63

282

Pyogenic arthritis

344

1.58

2.62

1.3

1.4

44.13

53.37

mu/l

0.27

310

Crohn disease (strict definition, require KELA)

345

1.58

2.60

1.6

1.5

61.73

69.78

mu/l

0.12

307

Congenital malformations of cardiac septa

334

1.58

2.59

1.5

55.12

100.53

mu/l

0.67

303

Injuries to the elbow and forearm

657

4966

1.14

2.59

1.6

60.17

64.41

mu/l

0.16

594

4476

Haemangioma, any site

482

1.48

2.59

1.6

1.4

64.64

78.86

mu/l

0.19

436

Chronic diseases of tonsils and adenoids

719

4013

1.13

2.57

1.7

1.6

67.37

67.54

mu/l

0.01

655

3644

Osteonecrosis

346

1.57

2.57

1.5

1.4

32.91

78.44

mu/l

1.33

311

Other Crohn's disease

362

1.56

2.56

1.4

1.5

40.03

66.46

mu/l

0.74

323

Streptococcal septicaemia

467

1.49

2.55

1.4

1.3

52.57

72.33

mu/l

0.55

417

Embolic stroke with flimmer

2.15

2.55

1.2

1.4

115.93

34.80

mu/l

1.04

Vestibular neuronitis

509

1.46

2.53

1.6

1.4

47.97

72.50

mu/l

0.69

458

Bacterial, viral and other infectious agents

468

1.48

2.53

1.8

1.5

100.32

66.33

mu/l

0.42

424

Inflammatory bowel disease, strict (require KELA)

192

1528

1.26

2.52

1.5

1.6

65.17

67.58

mu/l

0.07

175

1393

Generalized epilepsy

195

1.76

2.47

1.2

1.5

39.89

129.36

mu/l

0.96

175

Injury of muscle and tendon at shoulder and upper arm level

304

2544

1.20

2.47

1.4

1.5

53.01

70.23

mu/l

1.23

271

2269

Vulvovaginal ulceration/inflammation in other diseases

390

1.52

2.46

1.7

1.5

55.73

51.32

mu/l

0.05

350

Benign neoplasm: Sigmoid colon

159

1242

1.29

2.45

1.4

74.64

62.75

mu/l

0.35

137

1114

Other keratitis

680

1.39

2.44

2.4

1.5

75.71

68.59

mu/l

0.16

611

Lateral epicondylitis

113

842

1.35

2.44

1.4

1.6

139.12

47.76

mu/l

1.05

104

769

Sulfasalazine

234

1911

1.23

2.44

1.4

1.5

52.05

66.33

mu/l

0.70

216

1715

Acute alcohol intoxication

200

1607

1.25

2.43

1.4

1.5

97.27

65.47

mu/l

0.45

172

1448

Single spontaneous delivery

260

1666

0.82

2.43

1.5

1.7

33.63

56.31

mu/l

3.12

239

1493

Benign mammary dysplasia

120

904

1.33

2.42

1.8

1.4

47.85

57.24

mu/l

0.26

110

812

Hordeolum and other deep inflammation of eyelid

312

1.58

2.41

1.4

1.5

22.41

73.70

mu/l

2.05

280

Other secondary gonarthrosis

273

1.62

2.41

1.4

42.22

47.96

mu/l

0.18

245

Use of antiglaucoma preparations and miotics

400

1.51

2.41

1.6

1.3

48.90

69.17

mu/l

0.51

344

Pediculosis, acariasis and other infestations, including avohilmo

141

1087

1.30

2.40

1.5

1.6

58.44

71.89

mu/l

0.44

128

985

Demyelinating diseases of the central nervous system

482

1.46

2.40

1.4

1.6

85.19

65.86

mu/l

0.14

439

Fibrosis and cirrhosis of liver

434

1.48

2.37

1.5

1.4

139.13

64.76

mu/l

0.64

384

Superficial injury of wrist and hand

175

1389

1.26

2.37

1.7

1.6

47.85

63.98

mu/l

0.85

165

1258

Fall on and from ladder

410

1.50

2.36

1.3

1.4

45.24

75.28

mu/l

0.95

367

Other and unspecified haemorrhagic conditions

2.29

2.36

1.8

1.3

51.74

77.60

mu/l

0.27

Biomechanical lesions, not elsewhere classified

252

1.64

2.34

1.2

1.4

56.69

72.99

mu/l

0.19

229

Seropositive rheumatoid arthritis, wide

219

1786

1.23

2.34

1.4

44.08

63.12

mu/l

1.52

201

1596

Recurrent aphthous stomatitis , including avohilmo

120

909

1.33

2.34

2.0

1.5

128.10

52.23

mu/l

0.69

104

807

Phlebitis and thrombophlebitis (not including DVT)

193

1553

1.25

2.33

1.4

1.5

71.79

57.40

mu/l

0.42

171

1399

Endovascular or surgical operations to intracerebral aneurysms

315

1.57

2.33

1.2

1.4

61.68

77.63

mu/l

0.22

282

Adalimumab

602

1.40

2.33

1.8

1.6

73.16

63.89

mu/l

0.13

547

Scabies, including avohilmo

120

910

1.32

2.32

1.4

1.6

62.25

75.10

mu/l

0.34

107

830

Speech disturbances, not elsewhere classified

494

1.45

2.32

1.6

1.4

48.65

83.19

mu/l

1.06

441

Diabetic maculopathy

139

1016

1.30

2.31

2.1

1.6

93.49

82.19

mu/l

0.20

122

912

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

511

1.44

2.31

1.3

1.6

68.69

61.47

mu/l

0.09

461

Antenatal screening

122

897

0.76

2.31

1.8

1.9

38.96

50.90

mu/l

0.71

116

823

Dementia

248

2049

0.83

2.31

1.2

1.4

60.96

58.59

mu/l

0.07

210

1819

Benign neoplasm: Choroid

372

1.52

2.31

1.6

1.4

23.22

64.51

mu/l

1.80

334

Plantar fascial fibromatosis

604

1.40

2.29

1.5

1.6

49.84

46.90

mu/l

0.09

551

Other enthesopathy of foot (+metatarsalgia)

638

1.39

2.28

1.6

1.5

38.26

47.60

mu/l

0.59

584

Unspecified jaundice

200

1.71

2.28

1.5

1.4

46.50

102.15

mu/l

0.82

176

Atypical facial pain

293

1.58

2.28

1.4

64.73

47.68

mu/l

0.34

268

Streptococcal septicaemia, including avohilmo

479

1.45

2.28

1.4

1.3

52.57

71.50

mu/l

0.53

428

Deviated nasal septum

267

2224

1.20

2.28

1.5

74.57

74.00

mu/l

0.01

241

2006

Vasomotor rhinitis (mode)

406

1.49

2.27

1.7

1.5

144.60

53.86

mu/l

0.56

366

Urethral stricture

270

1.60

2.26

1.5

1.3

64.49

77.88

mu/l

0.14

243

Artificial opening status

294

1.58

2.25

1.6

1.5

47.87

91.97

mu/l

0.62

265

Nutritional marasmus

5.86

2.25

1.2

1.0

448.96

18.41

mu/l

—

Seborrhoeic dermatitis

598

1.40

2.24

1.6

1.4

71.49

72.75

mu/l

0.02

537

Superficial injury of thorax

122

933

1.31

2.24

1.3

1.5

64.41

59.98

mu/l

0.08

112

836

Amputation

498

1.43

2.22

1.3

1.5

96.74

52.57

mu/l

1.16

446

Benign neoplasm: Skin of eyelid, including canthus

126

969

1.31

2.22

1.5

1.4

69.62

59.60

mu/l

0.17

117

866

Acute lymphadenitis

295

1.57

2.22

1.7

1.6

191.55

69.49

mu/l

0.80

268

Presbycusis

667

1.37

2.21

1.3

1.4

31.92

58.71

mu/l

1.68

594

Metatarsalgia

575

1.40

2.20

1.6

1.5

39.43

47.15

mu/l

0.41

525

Sequelae of infectious and parasitic diseases, including avohilmo

377

1.49

2.18

1.6

1.4

62.45

74.17

mu/l

0.21

342

Delivery

265

1671

0.83

2.18

1.5

1.7

33.70

56.25

mu/l

3.12

242

1497

Purpura and other haemorrhagic conditions

104

781

1.34

2.17

1.5

76.82

66.99

mu/l

0.23

700

Skin changes due to chronic exposure to nonionizing radiation

307

2356

1.18

2.16

1.3

1.4

42.74

61.30

mu/l

1.18

276

2083

Corns and callosities

362

1.50

2.15

1.6

1.5

69.55

72.25

mu/l

0.04

329

Other ulcerative colitis

290

1.56

2.14

1.6

1.4

98.03

49.35

mu/l

0.94

262

326

2501

1.17

2.14

1.4

42.55

60.55

mu/l

1.23

294

2212

Outcome of delivery

676

0.72

2.14

1.5

2.0

85.94

51.39

mu/l

0.43

628

Injury of muscle and tendon at hip and thigh level

638

1.37

2.13

1.8

1.5

38.63

70.18

mu/l

1.46

574

Other specified disorders of muscle

130

1.86

2.13

1.1

1.3

42.31

34.45

mu/l

0.16

120

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

522

3574

1.14

2.12

1.8

1.6

58.26

58.22

mu/l

0.00

474

3231

Palindromic rheumatism

2.49

2.12

1.3

1.2

38.31

60.52

mu/l

0.32

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

355

1.50

2.12

1.9

1.6

83.00

66.46

mu/l

0.16

320

Calcific tendinitis of shoulder

323

1.53

2.11

1.2

1.4

55.56

33.14

mu/l

0.36

296

Open wound of head

465

3829

1.14

2.11

1.4

1.5

77.37

67.93

mu/l

0.18

417

3458

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

372

1.49

2.10

1.6

86.37

67.33

mu/l

0.23

333

Duodenal ulcer

563

1.39

2.10

1.4

34.24

85.14

mu/l

1.61

496

Degenerative macular diseases

657

1.36

2.10

1.3

1.4

38.64

59.71

mu/l

0.91

582

Benign neoplasm of ovary

146

1156

1.27

2.08

1.5

1.4

30.49

59.40

mu/l

3.70

136

1031

Primary_lymphoid and hematopoietic malignant neoplasms

186

1514

1.23

2.07

1.3

1.4

46.46

68.75

mu/l

1.28

169

1351

Diseases of tongue

333

1.51

2.06

1.8

1.3

66.43

54.89

mu/l

0.20

303

Viral pneumonia (known virus, not influenza)

139

1.82

2.06

1.8

1.3

154.42

128.56

mu/l

0.09

125

Ulcerative rectosigmoiditis

440

1.44

2.05

1.6

1.5

55.66

78.15

mu/l

0.52

403

Nummular dermatitis

474

1.42

2.04

1.9

1.4

152.15

55.54

mu/l

0.64

427

Other hammer toe(s) (acquired)

144

1036

1.27

2.04

1.3

1.4

49.59

57.48

mu/l

0.19

132

929

Superficial injury of shoulder and upper arm

712

1.34

2.04

1.2

1.5

53.49

65.11

mu/l

0.32

636

Strabismus

215

1774

1.21

2.04

1.6

41.22

72.73

mu/l

3.22

197

1603

Synovial cyst of popliteal space [Baker]

392

1.46

2.02

1.6

1.4

36.12

29.40

mu/l

0.41

352

Open wound of wrist and hand

383

3214

1.15

2.02

1.7

1.6

50.79

69.66

mu/l

2.34

340

2905

Suppurative and necrotic conditions of lower respiratory tract

271

1.56

2.01

1.5

1.4

93.20

82.78

mu/l

0.08

244

Other fall from one level to another

178

1447

1.23

2.00

1.5

72.12

72.91

mu/l

0.02

161

1306

Haemangioma and lymphangioma, any site

518

1.40

2.00

1.6

1.4

64.53

79.12

mu/l

0.21

469

Schizophrenia, schizotypal and delusional disorders

261

2203

1.19

2.00

1.3

1.6

73.73

67.33

mu/l

0.12

228

2003

Toxic liver disease

2.17

2.00

1.6

1.3

60.12

79.87

mu/l

0.19

Psoriatic arthropathies

621

1.36

1.98

1.6

1.4

88.80

55.93

mu/l

0.64

561

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

212

1758

1.21

1.98

1.4

43.88

63.21

mu/l

1.52

196

1573

Malignant neoplasm of bladder, including Hilmo

562

1.37

1.98

1.3

72.51

81.78

mu/l

0.13

504

Other peripheral vascular diseases

427

1.44

1.98

1.8

1.5

53.56

38.01

mu/l

0.54

382

Arthropathic psoriasis

673

1.34

1.97

1.6

1.5

84.26

66.98

mu/l

0.28

610

Other respiratory diseases principally affecting the interstitium

131

1032

1.27

1.96

1.3

1.4

48.41

63.72

mu/l

0.61

119

913

Fracture at wrist and hand level

297

2532

1.17

1.95

1.8

1.6

78.63

66.79

mu/l

0.34

265

2288

Excessive earwax

557

4501

1.12

1.95

1.6

1.5

62.05

62.60

mu/l

0.02

489

4042

Other/unspecified seropositive rheumatoid arthritis

213

1771

1.21

1.94

1.4

43.88

62.97

mu/l

1.50

196

1585

Event of undetermined intent

330

1.49

1.94

1.3

1.5

77.55

67.04

mu/l

0.11

299

Disorders of puberty, all

2.14

1.93

3.5

1.6

97.41

63.22

mu/l

0.38

Benign lipomatous neoplasm of other sites/unspecified

463

1.41

1.92

1.5

1.4

71.40

73.74

mu/l

0.03

409

Thyroiditis

413

1.44

1.92

2.2

1.5

107.84

59.85

mu/l

0.71

376

Spondylopathies in diseases classified elsewhere

2.28

1.92

1.5

1.1

65.15

86.15

mu/l

0.16

Schizophrenia or delusion

259

2194

1.18

1.92

1.3

1.6

74.16

67.70

mu/l

0.12

226

1994

Other puerperal infections

405

1.44

1.91

2.0

1.9

51.18

64.36

mu/l

0.35

369

Other psoriatic arthropathies

608

1.36

1.91

1.6

1.5

90.42

65.45

mu/l

0.39

551

Nontoxic single thyroid nodule

422

1.43

1.91

1.8

1.3

36.61

43.61

mu/l

0.24

379

Diseases of middle ear and mastoid

487

3522

1.13

1.90

1.7

55.20

64.54

mu/l

0.63

443

3186

Suggestive for eosinophilic asthma

515

1.39

1.90

1.6

1.4

40.13

66.06

mu/l

0.90

455

Procreative management

296

2086

1.17

1.89

1.8

1.7

59.70

67.51

mu/l

0.18

274

1903

Inflammatory disorders of male genital organs, not elsewhere classified

2.34

1.89

1.3

29.63

41.93

mu/l

0.52

Psoriatic arthropathies, ICD10

627

1.35

1.88

1.6

1.5

88.80

64.56

mu/l

0.39

568

Oral leukoplakia and other epithelial disorders of tongue and oral cavity , including avohilmo

526

1.38

1.85

1.9

1.4

63.76

69.06

mu/l

0.08

473

Other and unspecified nonorganic psychotic disorders

151

1219

1.24

1.85

1.3

1.7

49.56

66.09

mu/l

0.84

132

1117

Other appendicitis

467

1.40

1.84

1.5

1.4

37.15

55.94

mu/l

0.67

416

Labour and delivery complicated by fetal stress [distress]

121

998

0.79

1.84

2.9

2.1

51.63

45.86

mu/l

0.31

113

914

Nasal polyp

150

1211

1.24

1.84

1.5

48.45

70.57

mu/l

0.86

129

1090

Other diseases of oesophagus

519

1.37

1.82

1.4

1.3

66.74

89.32

mu/l

0.26

456

Postpartum haemorrhage due to retained placenta

704

0.69

1.80

1.7

1.8

42.48

53.69

mu/l

0.30

652

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

249

1.54

1.80

1.7

69.62

99.06

mu/l

0.26

227

MS-disease / Multiple Sclerosis

403

1.42

1.78

1.4

1.6

92.78

62.99

mu/l

0.19

366

Pediculosis, acariasis and other infestations

312

1.48

1.78

1.2

1.5

34.19

93.25

mu/l

1.67

286

Dementia, including avohilmo

278

2208

0.86

1.77

1.2

1.4

62.56

58.06

mu/l

0.15

237

1966

Postmenopausal bleeding

219

957

1.20

1.77

1.4

41.78

54.88

mu/l

0.59

191

857

Amputation of foot

102

1.88

1.77

1.4

1.3

171.99

66.12

mu/l

0.65

Macular pucker

127

1012

1.26

1.77

1.7

1.4

56.53

63.11

mu/l

0.17

114

904

Benign neoplasm of eye and adnexa

626

1.33

1.75

1.6

1.4

32.07

63.33

mu/l

1.42

562

Diabetic retinopathy

379

2059

1.15

1.75

1.6

1.5

73.45

80.06

mu/l

0.24

330

1856

Complications of other internal prosthetic devices, implants and grafts

209

1.59

1.74

1.2

1.4

109.71

75.71

mu/l

0.21

186

Scabies

233

1.55

1.73

1.1

1.5

32.34

86.89

mu/l

1.39

214

Mixed specific developmental disorders

1.91

1.73

1.5

1.7

58.50

198.56

mu/l

0.72

Injuries to the hip and thigh

396

3129

1.14

1.72

1.6

1.5

46.02

62.13

mu/l

1.88

356

2787

Other mental disorders due to brain damage and dysfunction and to physical disease

680

1.31

1.72

1.7

1.4

62.27

66.43

mu/l

0.05

598

Bacterial, viral and other infectious agents, including avohilmo

516

1.36

1.72

1.8

1.6

98.76

66.27

mu/l

0.41

467

Viral haemorrhagic fevers, not elsewhere classified/unspecified, including avohilmo

124

988

1.26

1.72

1.3

1.5

140.53

63.66

mu/l

0.48

107

887

Postpartum haemorrhage

138

1405

0.81

1.71

1.9

61.62

48.09

mu/l

0.39

124

1282

Malignant neoplasm of pancreas, including Hilmo

457

1.38

1.71

1.5

1.4

36.50

74.96

mu/l

1.70

414

Abrasion of teeth

316

2749

1.15

1.71

1.8

1.5

47.02

61.09

mu/l

1.29

284

2462

6-mercaptopurine

171

1.65

1.71

1.9

1.5

65.56

111.81

mu/l

0.35

150

Other embolism and thrombosis

103

804

1.29

1.70

1.4

46.63

57.18

mu/l

0.43

727

Other or ill-defined heart diseases

250

1.53

1.70

2.0

1.5

85.12

48.22

mu/l

0.47

223

Abnormal spermatozoa

699

1.31

1.70

1.6

1.4

58.87

74.97

mu/l

0.29

632

Atrophic disorders of skin

131

1054

1.25

1.69

1.8

1.5

47.31

52.99

mu/l

0.24

114

946

Special screening examination for infectious and parasitic diseases

169

1014

1.22

1.69

2.2

1.7

57.22

64.46

mu/l

0.26

155

929

Excessive attrition of teeth

545

4856

1.11

1.68

1.7

1.6

52.10

65.65

mu/l

1.31

492

4387

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified, including avohilmo

376

1.42

1.68

2.9

1.6

49.96

83.15

mu/l

0.63

339

Follow-up examination after treatment for malignant neoplasms

527

1.35

1.68

1.5

1.4

83.63

66.42

mu/l

0.24

459

Alcohol abuse, main dg, excluding more controls

110

868

1.27

1.67

1.6

1.5

89.90

59.38

mu/l

0.25

783

Any dementia, excluding more controls

189

1551

0.83

1.67

1.2

1.4

57.06

53.18

mu/l

0.11

159

1380

Coxarthrosis, primary

500

3717

1.12

1.67

1.4

62.51

59.44

mu/l

0.15

457

3307

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

248

2123

1.17

1.67

1.6

1.5

51.14

66.51

mu/l

0.94

234

1894

Tongue abnormality

342

1.44

1.66

1.8

1.4

66.93

59.77

mu/l

0.10

307

Other disorders starting during childhood or adolescence

233

1.54

1.66

1.7

73.66

106.76

mu/l

0.27

211

Congenital malformations of the respiratory system

1.95

1.65

1.3

62.69

181.14

mu/l

0.52

Other articular cartilage disorders

120

1.77

1.63

1.1

1.6

210.80

56.02

mu/l

0.85

109

Endometriosis diagnosis and infertility diagnosis occurring together

634

1.31

1.63

1.5

1.7

45.14

53.89

mu/l

0.31

583

Inflammatory diseases of prostate (prostatitis)

660

1.31

1.63

1.6

1.4

64.46

79.73

mu/l

0.34

589

Convergent concomitant strabismus

294

1.47

1.62

1.8

1.6

34.48

95.85

mu/l

1.02

271

Other obstructed labour

428

1.39

1.62

1.2

1.6

63.25

44.61

mu/l

0.34

390

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

420

1.39

1.61

1.4

61.26

62.05

mu/l

0.01

378

Fitting and adjustment of other devices

284

2167

1.16

1.61

1.3

1.4

54.00

60.22

mu/l

0.26

255

1923

Crohn disease (strict definition, all UC cases excluded)

262

1.50

1.61

1.5

43.16

70.80

mu/l

0.59

234

Hallux rigidus

113

900

1.26

1.61

1.4

37.60

65.94

mu/l

1.27

100

808

Subarachnoid haemorrhage

549

1.33

1.60

1.4

47.72

68.32

mu/l

0.57

484

Ectopic pregnancy

145

1189

1.22

1.59

1.6

74.83

55.70

mu/l

0.49

130

1083

Actinic keratosis

289

2284

1.15

1.59

1.3

1.4

40.86

60.76

mu/l

1.24

260

2020

Viral warts

568

1.33

1.57

1.9

1.5

67.32

72.30

mu/l

0.06

509

Other and unspecified abdominal hernia

191

1.58

1.57

1.4

36.86

69.56

mu/l

0.60

169

Congenital malformations of the respiratory system, including avohilmo

1.87

1.56

1.3

64.01

165.70

mu/l

0.49

Assault by bodily force

448

1.37

1.56

1.4

1.6

56.67

73.89

mu/l

0.34

406

Viral hepatitis

372

1.40

1.56

1.6

1.5

73.71

68.17

mu/l

0.05

340

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

388

2318

1.13

1.55

1.3

1.4

47.52

60.01

mu/l

0.42

336

2084

Unspecified privation

613

1.31

1.55

1.4

1.5

106.79

70.34

mu/l

0.53

550

Cardiomyopathies, Primary/intrinsic

613

1.31

1.55

1.3

1.5

129.91

46.81

mu/l

0.70

553

Lung cancer and mesothelioma

134

925

1.23

1.55

1.4

92.75

62.91

mu/l

0.54

112

830

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

148

1220

1.22

1.55

1.8

1.3

71.50

65.55

mu/l

0.12

130

1096

Diabetic neuropathy

114

910

1.25

1.54

1.5

75.82

88.65

mu/l

0.39

102

816

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

146

1202

1.22

1.54

1.8

1.7

37.50

50.48

mu/l

1.46

130

1085

Other specified/unspecified bacterial intestinal infections

356

1.41

1.54

2.0

1.4

62.77

62.58

mu/l

0.00

319

Other viral hepatitis

306

1.45

1.54

1.5

78.09

71.62

mu/l

0.05

281

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

125

1013

1.24

1.54

1.5

1.6

55.68

70.49

mu/l

0.59

114

919

Fracture of femur

196

1493

1.19

1.54

1.5

1.4

46.45

60.32

mu/l

0.88

172

1318

Examination and encounter for administrative purposes

441

1.37

1.54

1.3

1.4

57.49

67.43

mu/l

0.25

393

Lupus nephritis

3.41

1.53

1.0

1.1

85.72

24.03

mu/l

—

Basal cell carcinoma, including Hilmo

375

2246

1.13

1.53

1.3

1.4

46.58

60.13

mu/l

0.45

325

2018

Anti-inflammatory and antirheumatic products, non-steroids

200

846

1.19

1.53

1.4

1.7

64.81

51.28

mu/l

0.39

180

764

In situ neoplasms

319

2805

1.14

1.51

1.4

1.5

58.88

58.31

mu/l

0.02

286

2511

Use of rivastigmine

814

0.75

1.51

1.2

1.3

53.71

61.15

mu/l

0.11

715

Other specified/unspecified systemic involvement of connective tissue

316

1.43

1.50

1.8

1.4

44.52

63.33

mu/l

0.44

289

Unspecified lump in breast

128

1045

1.23

1.48

1.7

1.5

30.38

56.65

mu/l

2.82

120

938

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

351

1.40

1.47

1.2

1.7

41.18

68.12

mu/l

1.18

321

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

108

867

1.25

1.47

1.7

1.5

55.44

63.45

mu/l

0.16

100

780

Malignant neoplasm of digestive organs, including Hilmo

336

2179

1.14

1.46

1.4

69.75

61.90

mu/l

0.24

300

1953

Leukaemia of unspecified cell type

2.40

1.46

1.2

44.13

92.87

mu/l

—

Ulcerative colitis (strict definition, require KELA)

129

1056

1.23

1.46

1.5

54.60

69.26

mu/l

0.61

118

958

Hallux valgus (acquired)

274

1705

1.15

1.46

1.5

52.71

55.16

mu/l

0.08

245

1553

Female infertility, uterine origin

3.19

1.45

1.2

1.3

375.82

38.49

mu/l

—

Sudden idiopathic hearing loss

594

1.30

1.44

1.7

1.4

55.87

71.11

mu/l

0.37

534

Open wound of ankle and foot

594

1.30

1.44

1.5

69.68

78.86

mu/l

0.21

529

Endometriosis ASRM stages 1,2

140

1158

1.21

1.44

1.7

1.6

41.78

57.06

mu/l

1.09

133

1047

Myocardial infarction, with ST-elevation

115

932

1.24

1.43

1.3

1.4

85.54

73.75

mu/l

0.20

102

829

Sequelae of infectious and parasitic diseases

370

1.38

1.43

1.7

1.4

60.41

71.62

mu/l

0.19

337

Eustachian salpingitis and obstruction

447

1.35

1.43

1.2

1.7

75.75

83.31

mu/l

0.10

408

Endometriosis of rectovaginal septum and vagina

396

1.37

1.42

1.5

1.4

70.50

58.98

mu/l

0.18

356

Reactive arthropathies, FINNGEN

362

1.39

1.42

1.4

92.22

52.94

mu/l

0.41

329

Bacterial pneumoniae

317

2456

1.13

1.41

1.3

1.5

72.71

65.00

mu/l

0.26

281

2198

Anogenital herpesviral [herpes simplex] infection, including avohilmo

631

1.29

1.41

1.7

24.71

64.94

mu/l

4.09

574

Perioral dermatitis

103

1.76

1.41

1.7

1.4

111.51

48.13

mu/l

0.32

Cardiomyopathy (excluding other)

640

1.29

1.41

1.3

1.5

126.85

54.39

mu/l

0.60

576

Exposure to other and unspecified animate mechanical forces

157

1.60

1.41

1.7

1.4

49.62

61.21

mu/l

0.19

145

Other retinal artery occlusion

1.79

1.39

1.2

116.15

50.23

mu/l

0.72

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

137

1135

1.21

1.39

1.5

1.6

57.54

71.21

mu/l

0.57

125

1033

malignant neoplasm of female genital organs, including Hilmo

139

1099

1.21

1.38

1.3

1.4

54.43

57.11

mu/l

0.06

125

990

Certain conditions originating in the perinatal period

360

1.36

1.38

2.2

1.8

96.21

102.32

mu/l

0.05

330

Pleural plaque

424

1.35

1.38

1.3

72.54

76.72

mu/l

0.06

367

Viral hepatitis, including avohilmo

407

1.36

1.38

1.5

69.28

67.86

mu/l

0.01

370

L02BA Anti-estrogens

1150

0.80

1.37

1.6

1.5

43.58

55.89

mu/l

0.62

1035

Acute and transient psychotic disorders

696

1.27

1.37

1.3

1.6

53.06

66.02

mu/l

0.36

633

Other strabismus

168

1415

1.19

1.37

1.6

34.07

73.04

mu/l

3.96

153

1286

Benign neoplasm of mouth and pharynx

626

1.28

1.36

1.3

1.4

58.42

68.09

mu/l

0.21

561

Pedal cyclist injured in collision with motor vehicle

162

0.49

1.36

1.4

1.3

92.44

61.84

mu/l

—

147

Raynaud syndrome

521

1.31

1.36

2.1

1.5

70.73

62.29

mu/l

0.18

479

Fentanyl

485

1.32

1.35

1.7

1.3

42.36

45.16

mu/l

0.11

423

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

199

1.52

1.35

1.7

1.3

244.36

76.84

mu/l

0.44

182

Abscess of lung

1.89

1.35

1.1

1.3

30.77

77.81

mu/l

—

Secondary and unspecified malignant neoplasm of lymph nodes

452

1.33

1.35

1.4

44.16

75.52

mu/l

0.96

402

Basal cell carcinoma

357

2168

1.12

1.35

1.4

47.31

59.40

mu/l

0.36

307

1947

Melanocytic naevi of other and unspecified parts of face

324

1.40

1.34

1.7

1.5

22.32

65.91

mu/l

1.77

294

Personal history of medical treatment

2.06

1.34

1.1

1.3

92.45

215.33

mu/l

0.31

Orchitis and epididymitis

470

1.32

1.33

1.8

1.5

113.19

80.29

mu/l

0.35

424

Bacterial pneumonia, not elsewhere classified

295

2287

1.13

1.33

1.3

1.5

69.93

63.78

mu/l

0.19

264

2044

Parkinson's disease, including avohilmo

111

906

1.23

1.32

1.2

1.4

32.93

64.75

mu/l

2.08

802

Acute alcohol intoxication, ICD10

156

1316

1.19

1.32

1.4

1.5

113.77

68.40

mu/l

0.52

135

1189

Maternal care related to the fetus and amniotic cavity and possible delivery problems

294

1951

0.88

1.31

1.7

46.74

58.76

mu/l

0.80

268

1785

Varicose veins

517

3555

1.10

1.31

1.4

1.5

59.91

57.00

mu/l

0.09

452

3191

Benign neoplasm: Peripheral nerves and autonomic nervous system

1.86

1.30

3.0

1.3

26.42

74.82

mu/l

0.74

Vascular syndromes of brain in cerebrovascular disorders

201

1.50

1.30

2.1

1.3

64.45

65.31

mu/l

0.01

177

Sequelae of injuries of lower limb

543

1.29

1.3

1.5

24.54

68.78

mu/l

2.52

488

Agranulocytosis

667

1.26

1.29

1.9

1.4

50.63

80.16

mu/l

0.83

596

Arthropod-borne viral fevers and viral haemorrhagic fevers, including avohilmo

134

1118

1.20

1.28

1.3

1.5

130.87

63.10

mu/l

0.45

116

1004

Acute epiglottitis

1.95

1.28

1.8

1.4

58.92

92.26

mu/l

0.32

Other noninflammatory disorders of vagina

430

1.33

1.28

2.6

1.4

64.45

54.59

mu/l

0.15

387

Ulcerative colitis (strict definition, all Crohn cases excluded)

108

883

1.23

1.28

1.4

1.5

64.64

71.12

mu/l

0.14

801

Reactive arthropathies

510

1.30

1.26

1.3

1.5

78.16

48.43

mu/l

0.43

461

Malignant neoplasm of bone and articular cartilage, including Hilmo

1.76

1.26

1.4

1.3

40.11

80.98

mu/l

0.61

Disorders of parathyroid gland, other and/or unspecified

2.26

1.25

2.3

1.1

68.74

122.67

mu/l

—

Tuberculosis, IBD comorbidity

312

1.38

1.24

1.4

43.88

77.28

mu/l

0.80

276

Other malignant neoplasms of skin (=non-melanoma skin cancer)

366

2230

1.12

1.23

1.3

1.4

47.84

60.40

mu/l

0.39

313

2005

Ethmoidectomy

808

1.23

1.21

1.6

1.5

67.92

62.71

mu/l

0.09

735

Disorders of tooth development and eruption

124

840

1.20

2.2

1.6

58.13

80.33

mu/l

0.74

105

769

malignant neoplasm of male genital organs

196

1018

1.16

1.20

1.8

1.4

71.93

73.80

mu/l

0.04

172

909

Other viral hepatitis, including avohilmo

331

1.37

1.20

1.5

1.6

76.07

75.76

mu/l

0.00

303

Memory loss

505

1.29

1.20

1.7

1.3

74.00

72.02

mu/l

0.02

447

Endometriosis of ovary

123

966

1.20

1.6

1.5

52.46

56.20

mu/l

0.13

113

865

malignant neoplasm of male genital organs, including Hilmo

201

1044

1.16

1.20

1.8

1.4

70.31

73.58

mu/l

0.07

175

933

Idiopathic thrombocytopenic purpura

133

1.59

1.17

1.3

101.16

66.93

mu/l

0.41

123

Entropion and trichiasis of eyelid

419

1.32

1.17

1.4

73.96

75.23

mu/l

0.01

373

Malignant neoplasm of small intestine, including Hilmo

149

1.55

1.17

1.6

1.3

126.50

107.07

mu/l

0.10

134

Bacterial pneumonia (organism specified)

335

2724

1.11

1.17

1.4

1.5

71.22

63.61

mu/l

0.27

297

2421

Postpartum hemorraghe, all women as controls

138

1587

0.85

1.17

1.9

61.62

50.88

mu/l

0.29

124

1462

Colorectal cancer, including Hilmo

195

1578

1.15

1.17

1.3

58.36

62.66

mu/l

0.15

173

1417

Other menopausal disorders

214

1038

1.15

1.16

1.7

1.5

50.41

55.17

mu/l

0.15

198

936

Childhood allergy (age < 16)

593

1.24

1.16

1.8

2.0

80.00

79.10

mu/l

0.01

547

Tuberculosis, wide

316

1.37

1.16

1.4

43.88

77.01

mu/l

0.80

278

FESS (DNB20)

776

1.23

1.16

1.6

1.5

70.03

63.37

mu/l

0.11

706

Obstructed labour due to malposition and malpresentation of fetus

126

1385

0.84

1.16

1.6

1.9

95.86

50.77

mu/l

0.77

119

1265

Medicines for HER+ breast cancer

251

2637

0.88

1.15

1.4

1.5

42.09

52.19

mu/l

0.79

225

2363

Carcinoma in situ of other and unspecified digestive organs

232

1.43

1.15

1.9

1.3

57.63

80.07

mu/l

0.34

206

Carcinoma in situ of colon

150

1.54

1.15

2.3

1.4

56.63

70.67

mu/l

0.22

135

Anomalies of dental arch relationship, including avohilmo

149

1148

1.18

1.15

3.0

1.5

70.08

62.98

mu/l

0.16

140

1044

Cysts of oral region, not elsewhere classified

309

1.37

1.14

1.3

1.4

76.85

79.89

mu/l

0.03

278

Lyme disease, including avohilmo

223

2530

0.88

1.13

1.5

65.78

63.45

mu/l

0.06

197

2268

Lyme disease

223

2530

0.88

1.13

1.5

65.78

63.45

mu/l

0.06

197

2268

Pneumonia due to Streptococcus pneumoniae

183

1.48

1.13

1.2

1.4

94.04

66.00

mu/l

0.37

167

Nonsuppurative otitis media

164

1224

1.16

1.12

1.7

1.8

75.54

75.05

mu/l

0.01

148

1114

Other (seronegative) rheumatoid arthritis, wide

143

1220

1.17

1.11

1.7

1.4

64.45

65.23

mu/l

0.02

127

1101

Other disorders of veins

348

3096

1.11

1.5

67.87

55.08

mu/l

0.33

312

2791

Convalescence

285

1.37

1.10

1.6

1.4

41.34

67.73

mu/l

0.60

254

Von Willebrand disease

1.84

1.10

1.6

1.4

37.63

49.64

mu/l

0.25

Calcaneal spur

1.84

1.10

1.1

1.4

58.90

41.28

mu/l

0.23

Malignant neoplasm of prostate, including Hilmo

193

990

1.15

1.09

1.8

1.3

71.64

73.67

mu/l

0.04

168

890

Inflammatory disease of cervix uteri

346

1.34

1.09

1.2

1.4

62.64

35.94

mu/l

0.49

306

Other interstitial pulmonary diseases

104

864

1.21

1.09

1.3

1.4

50.31

64.68

mu/l

0.44

762

Other disorders of skin and subcutaneous tissue, not elsewhere classified

104

864

1.21

1.09

1.5

1.4

134.45

62.72

mu/l

0.76

772

Spirochaetal infections, other/unspecified, including avohilmo

226

2554

0.88

1.09

1.5

65.41

63.13

mu/l

0.06

200

2292

Other and unspecified disorders of adult personality and behaviour

2.22

1.09

1.1

1.3

208.89

42.26

mu/l

—

Malignant neoplasm of prostate

188

966

1.15

1.09

1.8

1.3

73.26

74.49

mu/l

0.02

165

869

Other spirochaetal diseases

226

2552

0.88

1.08

1.5

64.94

63.15

mu/l

0.05

200

2289

ILD, hospital admissions

103

856

1.21

1.08

1.3

1.4

50.61

64.26

mu/l

0.41

755

Other spirochaetal diseases, including avohilmo

230

2593

0.89

1.07

1.5

64.27

63.01

mu/l

0.03

204

2329

Colorectal adenocarcinoma

143

1208

1.17

1.07

1.3

64.79

65.29

mu/l

0.01

125

1082

Other disorders of breast

106

885

1.20

1.06

1.5

50.02

58.78

mu/l

0.31

794

Pedal cyclist injured in transport accident

173

1504

1.15

1.06

1.7

1.5

58.87

65.60

mu/l

0.20

161

1353

Interstitial lung disease endpoints

104

867

1.20

1.06

1.3

1.4

50.31

64.49

mu/l

0.43

763

Interstitial lung disease

104

867

1.20

1.06

1.3

1.4

50.31

64.49

mu/l

0.43

763

Premature separation of placenta [abruptio placentae]

129

1.56

1.06

1.6

1.7

35.62

80.84

mu/l

0.61

117

Viral haemorrhagic fevers, not elsewhere classified/unspecified

427

1.29

1.05

1.4

62.17

78.35

mu/l

0.29

385

Delivery, wide proxy

217

1304

0.88

1.03

1.5

1.7

55.07

46.15

mu/l

0.16

195

1169

Conductive hearing loss, unspecified

455

1.28

1.03

1.4

1.5

39.01

68.86

mu/l

1.06

413

Other melanin hyperpigmentation

114

1.59

1.03

1.2

1.3

43.15

74.88

mu/l

0.46

103

Valvular operations

715

1.22

1.03

1.2

1.5

83.05

48.36

mu/l

0.58

644

Chalazion

652

1.23

1.03

1.4

1.5

62.40

59.70

mu/l

0.06

584

Exposure to other and unspecified inanimate mechanical forces

421

1.29

1.01

1.4

1.5

66.76

75.89

mu/l

0.16

380

Viral warts, including avohilmo

168

1465

1.15

1.00

1.6

64.82

69.69

mu/l

0.11

150

1317

L02BG Aromatase inhibitors

203

2264

0.88

1.00

1.4

42.22

51.68

mu/l

0.61

185

2014

Liveborn infants according to place of birth

2.23

0.99

2.2

1.5

448.60

456.93

mu/l

—

Exclusion endpoint for supernumerary teeth

1.82

0.99

1.8

1.3

21.68

183.20

mu/l

0.53

Tuberculosis, wide, including avohilmo

326

1.32

0.99

1.4

43.88

76.01

mu/l

0.79

288

Postmenopausal atrophic vaginitis

204

979

1.14

0.98

1.4

49.94

54.27

mu/l

0.10

183

879

Presence of other devices

168

1445

1.15

0.97

1.3

1.4

51.47

66.26

mu/l

0.56

143

1299

Glucosamine medication

369

2689

1.10

0.97

1.5

1.4

50.05

59.68

mu/l

0.69

328

2388

Other benign neoplasm of uterus: Corpus uteri

1.82

0.97

1.0

1.2

21.06

41.69

mu/l

—

Periodontal disease, other/unspecified

132

1.52

0.97

1.5

1.4

63.61

58.93

mu/l

0.06

123

Medical abortion

528

2644

1.08

0.97

1.6

1.7

54.61

50.33

mu/l

0.24

475

2401

Liposarcoma, including Hilmo

1.82

0.97

1.2

187.98

114.60

mu/l

—

Complications predominantly related to the puerperium

200

1770

1.13

0.97

1.7

54.69

55.17

mu/l

0.02

180

1607

Other and unspecified iridocyclitis

241

1.38

0.96

1.3

1.4

42.96

75.71

mu/l

0.67

218

Malignant neoplasm of colon, including Hilmo

128

1094

1.17

0.96

1.3

64.49

67.21

mu/l

0.06

116

974

Acute appendicitis, with complications

144

1248

1.16

0.95

1.5

41.00

63.32

mu/l

2.01

133

1122

Personality and behavioural disorders due to brain disease, damage and dysfunction

1.79

0.94

1.6

1.3

40.15

68.79

mu/l

0.30

Parkinson's disease

103

870

1.19

0.94

1.2

1.4

34.08

65.67

mu/l

1.89

773

Benign leiomyoma with endometriosis

123

1055

1.17

0.94

1.4

30.23

56.41

mu/l

2.70

115

951

Malignant neoplasm of small intestine

109

1.57

0.94

1.2

1.3

69.44

88.10

mu/l

0.13

100

Pregnancy with abortive outcome

550

2659

1.08

0.94

1.5

1.7

49.42

50.24

mu/l

0.04

499

2414

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

444

1.26

0.93

1.6

35.22

45.28

mu/l

0.56

406

Long labour

142

1385

0.87

0.93

1.9

1.8

45.38

48.29

mu/l

0.15

134

1260

Alcoholic liver disease

589

1.23

0.92

1.2

1.4

130.89

73.48

mu/l

0.53

535

Dysplasia of cervi uteri

168

1035

1.14

0.92

2.0

1.6

60.92

55.20

mu/l

0.15

155

940

Alcoholic gastritis

1.76

0.90

1.1

1.3

65.68

51.77

mu/l

0.15

Spontaneous abortion

378

2322

1.09

0.90

1.7

61.32

52.73

mu/l

0.32

337

2114

Inflammatory disorders of breast

367

1.29

0.90

2.0

1.5

58.04

57.23

mu/l

0.02

334

Endometriosis of fallopian tube

2.09

0.90

1.5

1.3

5.72

33.51

mu/l

—

Right ventricular outflow tract obstruction

2.09

0.90

2.5

1.2

460.92

378.82

mu/l

—

Carcinoma in situ of skin

465

1.25

0.89

1.4

44.94

59.24

mu/l

0.36

410

Lichen planus

829

1.19

0.89

1.5

1.4

41.65

66.38

mu/l

1.12

741

Supervision of high-risk pregnancy

122

852

0.86

0.89

2.0

1.9

57.31

52.15

mu/l

0.13

117

781

Other/unspecified reactive arthropathies

341

1.30

0.89

1.4

1.5

102.32

60.53

mu/l

0.36

311

DVT of lower extremities

137

1191

1.15

0.89

1.4

63.78

54.60

mu/l

0.22

124

1075

Maternal care for other conditions predominantly related to pregnancy

144

1224

1.15

0.89

1.9

85.83

51.09

mu/l

0.86

131

1117

Normotensive glaucoma

511

1.24

0.88

1.3

52.60

66.60

mu/l

0.29

441

Use of disulfiram, acamprosate or naltrexone

520

1.23

0.88

1.5

78.79

81.63

mu/l

0.04

472

Other and unspecified hypertrophic disorders of skin

2.02

0.87

2.3

1.1

34.95

64.36

mu/l

—

Nonsuppurative otitis media, including avohilmo

242

1885

1.11

0.87

1.8

1.7

67.38

71.42

mu/l

0.12

221

1715

Infections with a predominantly sexual mode of transmission

228

2046

1.11

0.87

1.8

66.83

61.71

mu/l

0.14

209

1864

Medical treatment for female infertility

145

1257

1.14

0.86

2.5

2.0

78.91

54.80

mu/l

0.52

133

1163

Traumatic ischaemia of muscle

1.68

0.85

1.6

1.3

71.77

73.33

mu/l

0.01

Ovarian hyperstimulation (induction)

1.68

0.85

3.5

1.6

149.34

41.94

mu/l

0.36

Other and unspecified mononeuropathies of lower limb

145

1.46

0.85

2.0

1.5

114.46

54.13

mu/l

0.35

133

Osteomalacia

1.80

0.85

1.4

1.2

69.98

45.76

mu/l

—

Colon adenocarcinoma

687

1.20

0.84

1.3

74.45

68.64

mu/l

0.09

616

Other and unspecified intracranial injuries

129

1.48

0.83

1.5

1.3

18.35

63.47

mu/l

1.35

115

497

1.23

0.83

2.1

2.0

56.87

46.13

mu/l

0.35

461

Abscess of external ear

1.71

0.83

2.1

1.2

48.93

64.04

mu/l

0.14

Other congenital malformations of peripheral vascular system

1.71

0.83

1.8

1.2

74.91

208.62

mu/l

0.41

Fracture of forearm

475

3974

1.07

0.82

1.7

1.5

57.35

60.82

mu/l

0.10

427

3576

Postpartum hemorraghe, parous women as controls

138

1316

0.88

0.82

1.9

61.62

52.92

mu/l

0.22

124

1213

Effects of foreign body entering through natural orifice

180

1604

1.12

0.82

2.2

1.6

68.47

74.89

mu/l

0.16

164

1449

Complications of labour and delivery

471

2811

0.93

0.82

1.5

1.6

68.56

49.88

mu/l

0.79

425

2540

Fourth [trochlear] nerve palsy

105

1.53

0.82

1.3

55.02

63.55

mu/l

0.10

Malignant neoplasm of pancreas

364

1.27

0.81

1.6

1.4

40.28

81.14

mu/l

1.33

331

Malignant neoplasm of corpus uteri, including Hilmo

581

1.21

0.81

1.2

1.3

43.47

54.22

mu/l

0.35

519

Other disorders of the genitourinary system

820

1.17

0.80

1.7

1.4

61.03

54.52

mu/l

0.12

735

Superficial injury of hip and thigh

105

903

1.16

0.80

1.6

1.5

44.50

64.16

mu/l

0.63

797

Arthropod-borne viral fevers and viral haemorrhagic fevers

536

1.22

0.80

1.4

55.01

70.47

mu/l

0.34

475

L01XE Protein kinase inhibitors

268

1.31

0.79

1.8

1.4

29.57

78.66

mu/l

1.45

240

Maternal care for known or suspected abnormality of pelvic organs

189

1141

1.12

0.78

2.1

1.9

36.11

50.79

mu/l

1.53

178

1050

Toxic effects of substances chiefly nonmedicinal as to source

648

1.19

0.77

1.4

1.5

50.57

71.77

mu/l

0.64

582

Wet age-related macular degeneration

109

910

1.16

0.77

1.2

1.3

53.39

57.09

mu/l

0.06

800

Exposure to other specified electric current

107

1.50

0.76

1.2

1.3

222.18

66.78

mu/l

0.35

Primary coxarthrosis, bilateral

215

1946

1.11

0.76

1.5

1.4

68.75

62.29

mu/l

0.21

194

1733

Other specified/unspecified deforming dorsopathies

1.61

0.75

1.8

1.3

15.78

36.83

mu/l

0.87

Congenital malformations of genital organs

528

1.21

0.75

2.4

1.6

107.50

63.19

mu/l

0.56

477

Complications of genitourinary prosthetic devices, implants and grafts

133

1.44

0.74

1.5

1.3

55.37

64.98

mu/l

0.12

121

Viral conjunctivitis

108

1.49

0.74

3.5

1.4

93.96

62.31

mu/l

0.30

101

Focal brain injury

263

1.30

0.73

1.2

1.5

113.55

44.72

mu/l

0.56

230

Other and unspecified mental retardation

1.60

0.73

1.2

1.5

62.62

162.29

mu/l

0.36

Migraine without aura, drug-induced

1.68

0.72

1.5

1.4

194.16

47.32

mu/l

—

Nonischemic cardiomyopathy

552

1.20

0.72

1.2

1.5

61.78

51.08

mu/l

0.24

491

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

110

961

1.15

0.71

1.5

1.3

67.57

64.74

mu/l

0.04

102

865

Acne, including avohilmo

148

1065

1.13

0.71

1.6

2.0

41.99

65.39

mu/l

1.96

133

973

Malignant neoplasm of digestive organs

287

2019

1.09

0.71

1.4

1.3

70.57

60.70

mu/l

0.27

255

1815

Hydrocele

563

1.19

0.70

1.6

1.4

40.05

76.72

mu/l

1.41

505

Lichen sclerosus et atrophicus

776

1.16

0.70

1.9

1.4

44.49

51.54

mu/l

0.25

697

Embedded and impacted teeth

153

1388

0.89

0.70

1.9

104.22

62.90

mu/l

0.58

142

1272

Parkinson's disease, strict definition

795

1.16

0.70

1.3

1.4

35.34

67.56

mu/l

1.73

711

Congenital deformities of hip, including avohilmo

1.51

0.69

1.8

1.5

36.22

144.00

mu/l

0.58

Benign neoplasm: Anus and anal canal

135

1.41

0.69

1.8

1.3

53.49

55.95

mu/l

0.03

125

Use of rotigotine

1.54

0.69

1.3

22.92

89.08

mu/l

—

Carcinoma in situ of skin of scalp and neck

110

1.46

0.68

1.2

45.20

58.21

mu/l

0.19

Intentional self-harm by sharp object

110

1.46

0.68

1.0

1.5

54.18

75.36

mu/l

0.31

Alcohol abuse, main dg

110

965

1.14

0.68

1.6

1.5

89.90

72.13

mu/l

0.13

871

Unspecified urinary incontinence

501

1.20

0.68

1.5

1.3

42.62

44.79

mu/l

0.06

440

Lung diseases due to external agents

713

1.17

0.68

2.0

1.4

52.96

72.37

mu/l

0.66

634

Other disorders of cornea

584

1.18

0.68

1.6

1.5

51.58

65.20

mu/l

0.32

525

malignant neoplasm of female genital organs

115

990

1.14

0.68

1.2

1.4

56.70

57.26

mu/l

0.01

104

889

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

104

910

1.15

0.67

1.4

1.5

134.08

67.96

mu/l

0.99

823

Mixed conductive and sensorineural hearing loss

705

1.17

0.67

1.5

1.4

36.82

71.93

mu/l

1.67

633

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

606

1.18

0.66

1.2

1.3

34.84

72.27

mu/l

2.19

542

Retinal detachment with retinal break

781

1.15

0.66

1.9

1.4

51.65

62.46

mu/l

0.39

697

Premature rupture of membranes

124

994

0.89

0.65

2.3

1.9

54.71

53.37

mu/l

0.04

115

912

Other orthopaedic follow-up care

304

1.25

0.65

1.4

1.5

81.93

64.49

mu/l

0.16

271

Schizoaffective disorder

422

1.21

0.64

1.3

1.6

176.83

55.38

mu/l

0.65

385

Congenital malformations of uterus and cervix

1.50

0.63

1.1

1.6

28.68

62.17

mu/l

0.77

Abnormal findings in secretions and smears from cervix uteri vagina vulva

407

2808

1.07

0.63

1.9

1.7

57.45

54.02

mu/l

0.17

371

2548

Other protozoal intestinal diseases

1.53

0.63

1.3

18.73

76.72

mu/l

1.02

Alcohol withdrawal state with delirium

378

1.22

0.63

1.1

1.4

36.51

78.97

mu/l

1.56

344

Seborrhoeic keratosis

192

1751

1.10

0.62

1.6

1.4

63.79

60.49

mu/l

0.07

175

1560

Osteonecrosis due to drugs

1.56

0.62

1.5

1.4

48.25

72.92

mu/l

0.24

Guttate psoriasis

1.56

0.62

1.7

1.3

202.02

80.20

mu/l

0.35

Presbyopia

470

1.19

0.62

1.8

1.5

74.08

74.39

mu/l

0.00

437

Secondary uncertain malignant neoplasm

768

1.15

0.61

1.4

1.3

67.55

69.39

mu/l

0.02

689

Melanoma in situ

218

1.29

0.60

1.4

34.85

51.41

mu/l

0.43

195

Seropositive rheumatoid arthritis, strict definition

110

977

1.13

0.59

1.2

1.4

50.01

68.77

mu/l

0.66

100

873

Hepatocellular carcinoma, including Hilmo

131

1.38

0.59

1.1

1.3

272.27

82.27

mu/l

0.52

119

Colorectal cancer

166

1447

1.10

0.59

1.4

1.3

58.92

63.46

mu/l

0.13

146

1305

Disturbances of smell and taste

228

1.28

0.58

1.7

1.4

55.51

77.74

mu/l

0.29

205

Other superficial mycoses, including avohilmo

622

1.16

0.58

1.6

62.58

66.82

mu/l

0.10

559

Stenosis and insufficiency of lacrimal passages

520

1.18

0.58

1.8

1.4

35.22

53.43

mu/l

0.67

466

Undescended testis, unilateral

1.73

0.58

1.0

1.7

34.53

52.90

mu/l

—

Personal history of malignant neoplasm

548

1.17

0.58

1.5

69.61

69.74

mu/l

0.00

497

severe traumatic brain injury, does not include concussion

147

1331

1.11

0.57

1.4

77.67

59.14

mu/l

0.37

132

1184

Malignant neoplasm of liver and intrahepatic bile ducts, including Hilmo

220

1.28

0.57

1.3

1.4

181.39

74.80

mu/l

0.43

198

Burns and corrosions

839

1.13

0.57

1.5

50.75

69.27

mu/l

0.83

760

Injury of eye and orbit

102

905

1.13

0.57

1.8

1.6

82.40

68.88

mu/l

0.20

826

Other protozoal intestinal diseases, including avohilmo

1.44

0.56

1.2

1.3

16.70

68.52

mu/l

1.18

Neuroendocrine tumor and carcinoma of small intestine

1.52

0.56

1.1

1.3

13.92

88.21

mu/l

1.25

Malignant neoplasm of other and ill-defined sites, including Hilmo

1.52

0.56

1.4

1.3

69.07

79.16

mu/l

0.07

Other infective otitis externa

329

1.22

0.56

1.5

1.4

61.04

63.82

mu/l

0.03

297

Malignant neoplasm of bone and articular cartilage of other and unspecified sites, including Hilmo

1.55

0.56

1.6

1.3

44.09

93.93

mu/l

—

Carcinoma in situ of rectum

1.55

0.56

1.2

59.92

78.42

mu/l

—

Status post-ami

157

1082

1.10

0.55

1.2

1.5

77.09

51.05

mu/l

0.84

138

963

Use of levodopa decarboxylase inhibitor

785

1.14

0.55

1.3

1.4

24.72

68.58

mu/l

3.55

697

Other degenerative diseases of the basal ganglia

1.47

0.54

1.1

1.2

21.31

74.96

mu/l

—

Congenital obstruction of the pelviureteric junction

1.55

0.53

1.8

1.2

12.58

53.54

mu/l

—

Pleural plaque with presence of asbestos

322

1.21

0.53

1.1

1.4

80.87

88.98

mu/l

0.09

283

1.43

0.53

2.8

1.8

42.22

76.36

mu/l

0.55

L02BB Anti-androgens

414

1.19

0.53

3.4

1.3

81.54

81.74

mu/l

0.00

364

Alzheimer’s disease (Atypical or mixed)

474

0.83

0.53

1.2

1.3

58.89

53.00

mu/l

0.07

406

Puerperal sepsis

854

1.13

0.52

1.2

1.4

55.82

61.94

mu/l

0.16

774

Colon adenocarcinoma, helper endpoint

722

1.14

0.52

1.3

1.4

74.45

70.02

mu/l

0.06

637

Orthopaedic devices associated with adverse incidents

0.61

0.52

1.0

1.3

10.68

74.38

mu/l

—

Communicating hydrocephalus

0.62

0.52

1.0

1.4

40.82

64.31

mu/l

—

Injury of muscle and tendon at wrist and hand level

865

1.12

0.51

1.5

65.94

68.56

mu/l

0.06

785

Pedal cyclist injured in noncollision transport accidents

705

1.14

0.51

1.8

1.5

63.42

67.95

mu/l

0.07

635

Myocardial infarction, unclassifiable

122

984

1.11

0.51

1.3

1.4

63.95

75.75

mu/l

0.28

104

869

Dislocation, sprain and strain of joints and ligaments of elbow

342

1.20

0.51

1.6

1.5

27.99

94.97

mu/l

1.42

306

Carcinoma in situ of breast, intraductal

564

0.85

0.51

1.3

1.4

64.38

55.73

mu/l

0.10

508

Malignant neoplasm of retroperitoneum and peritoneum, including Hilmo

1.42

0.51

1.2

1.3

214.92

73.03

mu/l

0.52

Primary open-angle glaucoma, strict

180

1655

1.09

0.50

1.3

1.4

44.57

62.93

mu/l

1.26

159

1466

Primary open-angle glaucoma

218

1948

1.08

0.50

1.3

1.4

41.02

61.29

mu/l

1.91

195

1724

Other disorders of choroid

1.50

0.50

1.5

1.2

131.75

40.11

mu/l

—

LSIL lesion of the cervix uteri, vagina or vulva

100

896

1.12

0.49

2.2

1.7

80.82

55.10

mu/l

0.49

817

Adenocarcinoma and papilloma adenocarcinoma of rectum

557

1.15

0.49

1.3

51.57

77.04

mu/l

0.92

499

Foreign body entering into or through eye or natural orifice

427

1.17

0.49

1.6

1.4

27.13

84.91

mu/l

2.61

386

Barrett oesophagus

271

1.22

0.48

1.3

38.73

84.71

mu/l

0.86

243

Undescended testicle

1.46

0.47

1.1

1.6

37.81

105.25

mu/l

—

Polyhydramnios

245

1.23

0.47

3.2

1.8

29.66

48.78

mu/l

1.43

227

Other lesions of median nerve

120

1.34

0.46

1.9

1.4

437.17

57.71

mu/l

0.46

104

Caries in Clefts patients

1.41

0.45

1.0

1.4

14.79

80.55

mu/l

—

Contraceptive management

310

2292

0.94

0.44

1.4

1.6

54.25

64.17

mu/l

0.57

273

2102

Tooth eruption problems

753

1.12

0.44

2.0

1.8

148.16

67.11

mu/l

0.66

691

Lichen planus, including avohilmo

144

1326

1.09

0.44

1.7

1.4

40.16

63.23

mu/l

1.71

132

1192

Optic neuritis

220

1.23

0.43

1.8

1.5

52.45

74.57

mu/l

0.33

201

Infections with a predominantly sexual mode of transmission, including avohilmo

300

2593

1.06

0.43

1.7

1.8

62.26

61.08

mu/l

0.04

276

2370

Malignant neoplasm of rectum, including Hilmo

696

1.12

0.43

1.3

1.4

49.55

70.49

mu/l

0.88

630

Chronic suppurative otitis media, including avohilmo

377

1.17

0.43

1.4

1.5

29.27

86.63

mu/l

1.27

333

Alzheimer’s disease (Late onset), excluding more controls

491

0.89

0.41

1.1

1.5

44.00

55.19

mu/l

0.32

434

Neuralgic amyotrophy

0.00

0.41

0.0

1.1

—

17.53

—

Chronic myeloproliferative disease

1.39

0.41

1.3

23.81

86.46

mu/l

—

Carcinoma in situ of skin of other and unspecified parts of face

444

1.15

0.41

1.3

38.76

72.42

mu/l

1.18

387

Malignant neoplasm of colon

889

1.10

0.41

1.3

65.71

64.89

mu/l

0.01

798

Infections of genitourinary tract in pregnancy

539

1.13

0.40

1.6

49.89

55.23

mu/l

0.13

481

Mixed connective tissue disease

1.37

0.40

1.2

1.3

54.22

68.43

mu/l

0.18

Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies

241

1.21

0.40

1.6

1.5

118.73

37.91

mu/l

0.90

223

Transient synovitis

1.43

0.39

1.0

1.3

43.78

37.79

mu/l

—

Other abnormal products of conception

234

1445

1.06

0.39

1.6

1.9

69.84

53.26

mu/l

0.43

216

1335

Other and unspecified noninflammatory disorders of ovary, fallopian tube and broad ligament

133

1.28

0.38

3.1

1.6

109.17

52.20

mu/l

0.35

126

Pregnancy, childbirth and the puerperium

192

1071

0.93

0.38

1.4

1.7

34.32

45.75

mu/l

0.93

176

962

Failed induction of labour

307

1.17

0.38

2.2

2.0

37.10

45.00

mu/l

0.27

273

All dysplastic lesions of the cervix uteri, vagina or vulva

213

1954

1.06

0.38

2.1

1.8

65.26

52.15

mu/l

0.42

198

1777

Malignant neoplasm of bladder

279

1.18

0.38

1.3

54.74

79.67

mu/l

0.54

247

Motor disorders

1.41

0.38

1.8

1.7

52.00

220.95

mu/l

—

Exclusion endpoint for clefts

1.35

0.37

1.3

1.4

23.39

178.88

mu/l

0.84

Coronary artery bypass grafting

148

1019

1.08

0.37

1.2

1.5

151.33

54.18

mu/l

2.14

129

903

Other noninflammatory disorders of cervix uteri

262

1.19

0.37

1.5

1.4

25.78

58.12

mu/l

1.74

240

Pemphigoid

125

1.28

0.37

1.1

1.3

84.55

62.04

mu/l

0.21

113

Squamous cell neoplasms and carcinomas of the skin

477

1.13

0.37

1.1

1.3

35.35

70.40

mu/l

1.52

428

Specific developmental disorder of motor function

1.39

0.37

1.8

52.00

227.82

mu/l

—

Oral lichen planus, including avohilmo , including avohilmo

431

1.14

0.36

1.9

1.4

55.94

56.71

mu/l

0.01

388

Assault by other specified means

1.47

0.36

1.5

1.3

38.53

26.01

mu/l

—

Benign neoplasm: Vulva

108

1.30

0.35

2.1

1.4

25.69

85.16

mu/l

0.72

False labour

215

1259

1.06

0.34

2.0

1.9

40.73

53.16

mu/l

1.03

200

1158

Respiratory and cardiovascular disorders specific to the perinatal period

1.29

0.34

2.1

1.9

156.45

162.93

mu/l

0.02

Routine general health check-up of defined subpopulation

100

1.30

0.33

1.2

1.3

18.59

37.03

mu/l

2.28

Contact with machinery

624

1.11

0.33

1.3

1.4

55.17

70.26

mu/l

0.50

570

Other and unspecified acute skin changes due to ultraviolet radiation

109

1.29

0.33

1.4

1.3

26.88

64.99

mu/l

0.82

Malignant neoplasm of breast, HER-positive

234

1836

0.95

0.33

1.4

1.5

40.44

53.12

mu/l

0.98

208

1663

LSIL lesion of the cervix uteri

682

1.10

0.33

2.3

1.7

72.29

54.53

mu/l

0.36

630

Non-Hodgkin lymphoma, all, including Hilmo

779

1.09

0.32

1.2

1.3

44.93

69.80

mu/l

1.15

700

Lichen ruber planus, wide definition including periferal and oral lichen planus

170

1601

1.06

0.32

1.7

1.4

45.56

64.10

mu/l

1.33

154

1434

Malignant neoplasm of breast, ER-positive, including Hilmo

235

1838

0.95

0.32

1.4

1.5

40.25

53.43

mu/l

1.04

209

1665

Inguinal hernia

442

2829

1.04

0.32

1.5

1.6

68.19

70.79

mu/l

0.06

395

2559

ILD, hospital admissions 1, main diag only

770

1.09

0.32

1.3

1.4

43.68

67.39

mu/l

0.90

678

Infliximab

101

1.29

0.32

1.0

1.4

77.76

83.27

mu/l

0.06

Non-small cell lung cancer, adenocarcinoma

323

1.15

0.31

1.4

1.3

110.18

86.45

mu/l

0.21

290

Postpartum care and examination

555

0.91

0.31

1.7

2.1

54.16

53.89

mu/l

0.00

515

Caries of enamel

817

5480

0.97

0.30

1.6

54.43

66.74

mu/l

1.16

734

4958

Vitamin B12 deficiency anemia due to intrinsic factor deficiency

1.31

0.30

2.7

1.2

151.59

67.86

mu/l

0.31

Cytomegalovirus infection, IBD co-morbidity

102

1.28

0.30

1.7

1.3

44.69

68.22

mu/l

0.32

Chronic viral hepatitis

260

1.16

0.28

1.6

105.15

60.31

mu/l

0.31

237

Other and unspecified nail disorders

121

1.24

0.28

1.7

1.3

38.80

55.94

mu/l

0.25

111

Injury of nerves at forearm level

1.29

0.28

1.3

162.22

79.44

mu/l

—

Benign neoplasm: Connective and other soft tissue, unspecified

1.27

0.28

1.0

1.2

10.51

85.06

mu/l

—

Shoulder region

1.25

0.27

1.3

178.75

89.82

mu/l

—

Other benign neoplasms of connective and other soft tissue

547

1.10

0.27

1.2

1.4

47.02

67.77

mu/l

0.61

491

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

586

1.09

0.26

1.3

51.57

76.91

mu/l

0.94

528

Injury of muscle and tendon at lower leg level

102

953

1.07

0.26

1.6

1.5

50.30

61.08

mu/l

0.40

864

Malignant neoplasm of head and neck, including Hilmo

548

1.10

0.26

1.2

1.4

133.99

74.06

mu/l

0.32

496

Malignant neoplasm of heart, mediastinum and pleura, including Hilmo

0.67

0.26

1.8

1.2

26.82

91.97

mu/l

—

Hydrocephalus

386

1.12

0.26

1.3

1.4

48.23

86.26

mu/l

0.84

342

Congenital deformities of hip

1.28

0.26

1.9

1.4

32.37

152.93

mu/l

0.61

Deep endometriosis

568

1.09

0.26

1.7

1.5

63.52

52.61

mu/l

0.19

509

Cleft lip, lip and palate or palate

1.24

0.25

1.2

1.3

15.96

200.61

mu/l

—

Schizophrenia

105

984

1.07

0.25

1.2

1.6

48.52

68.73

mu/l

0.61

906

Other specified congenital malformation syndromes affecting multiple systems

1.22

0.25

1.2

1.3

25.99

184.05

mu/l

—

Other predominantly sexually transmitted diseases, not elsewhere classified, including avohilmo

136

1286

1.06

0.25

1.8

61.26

58.52

mu/l

0.08

128

1173

Erectile dysfunction

382

0.89

0.24

1.7

1.5

102.50

87.53

mu/l

0.12

341

Cerebral palsy

1.19

0.24

1.0

1.3

27.07

46.18

mu/l

—

Malignant neoplasm of rectum

560

1.09

0.24

1.3

53.55

76.78

mu/l

0.79

502

Benign neoplasm: Connective and other soft tissue of head, face and neck

1.27

0.24

1.2

1.3

38.95

67.45

mu/l

0.39

Maternal care for other known or suspected fetal problems

161

959

1.05

0.24

1.9

2.0

48.50

50.29

mu/l

0.05

146

888

Human immunodeficiency virus [HIV] disease resulting in other conditions

0.71

0.24

2.5

1.3

53.70

59.12

mu/l

—

Human immunodeficiency virus [HIV] disease resulting in other conditions, including avohilmo

0.71

0.24

2.5

1.3

53.70

59.12

mu/l

—

Ankylosing spondylitis

465

1.10

0.24

1.4

1.5

33.69

62.86

mu/l

1.18

419

Malignant neoplasm of breast, ER-negative, including Hilmo

156

1388

1.05

0.23

1.4

60.86

53.04

mu/l

0.21

142

1250

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

125

0.80

0.23

1.6

1.3

15.38

81.23

mu/l

—

112

Multiple myeloma

125

0.80

0.23

1.6

1.3

15.38

81.23

mu/l

—

112

Malignant neoplasm of breast

312

2080

0.97

0.22

1.5

46.70

54.09

mu/l

0.42

278

1890

Other/unspecified cytomegaloviral diseases

1.25

0.22

1.7

1.3

52.05

71.60

mu/l

0.21

Human immunodeficiency virus [HIV] disease, including avohilmo

0.77

0.22

2.3

1.3

47.69

64.77

mu/l

—

Malignant neoplasm of breast, HER2-negative, including Hilmo

319

2111

0.97

0.22

1.5

45.06

53.77

mu/l

0.54

286

1918

Toxic effect of contact with venomous animals

219

1.14

0.22

1.3

47.58

52.56

mu/l

0.05

196

Coxarthrosis, primary, with hip surgery

347

3119

1.03

0.22

1.4

48.49

58.79

mu/l

0.83

317

2769

Malignant neoplasm of corpus uteri

535

1.09

0.22

1.2

1.3

43.21

55.78

mu/l

0.38

477

Malignant neoplasm of breast, including Hilmo

319

2110

0.97

0.22

1.5

45.06

53.78

mu/l

0.54

286

1917

Other drug-induced osteomalacia in adults

0.00

0.22

0.0

1.1

—

23.33

—

Exposure to electric transmission lines

0.00

0.21

0.0

1.2

—

246.47

—

Other and specified injuries of hip and thigh

107

1.22

0.21

1.3

41.71

65.79

mu/l

0.26

Congenital mitral valve regurgitation

0.00

0.21

0.0

1.1

—

27.58

—

Sphingolipidosis, other/unspecified

0.00

0.21

0.0

1.1

—

16.90

—

Craniosynostosis EXCLUDE syndromes

0.00

0.21

0.0

1.6

—

42.24

—

Non-small cell lung cancer, adenocarcinoma, helper endpoint

334

1.11

0.21

1.4

1.3

110.18

91.78

mu/l

0.15

299

Malignant neoplasm of accessory sinuses

0.00

0.21

0.0

1.3

—

20.37

—

Transient global amnesia

575

1.08

0.21

1.6

1.4

36.28

65.70

mu/l

1.11

510

Malignant neoplasm of head and neck

440

1.09

0.21

1.2

1.4

153.46

75.42

mu/l

0.33

403

Endometriosis ASRM stages 3,4

161

1542

1.04

0.20

1.6

56.42

53.37

mu/l

0.10

149

1391

Other specified disorders of external ear

183

1.15

0.20

1.3

27.99

59.01

mu/l

0.87

169

Other disorders of amniotic fluid and membranes

819

1.06

0.20

1.9

37.97

54.85

mu/l

1.25

758

Non-small cell lung cancer, including Hilmo

815

1.06

0.19

1.5

1.3

114.86

68.66

mu/l

0.61

731

Persons encountering health services in circumstances related to reproduction

463

3178

0.98

0.19

1.5

1.6

66.26

69.80

mu/l

0.10

422

2891

HSIL lesion of the cervix uteri, vagina or vulva

132

1260

1.05

0.19

2.0

1.8

37.02

53.99

mu/l

1.79

125

1151

Non-small cell lung cancer

555

0.93

0.19

1.4

1.3

119.98

78.12

mu/l

0.49

500

Pyogenic granuloma

1.24

0.19

1.3

43.72

73.69

mu/l

—

Divergent concomitant strabismus

395

1.09

0.18

1.7

1.5

33.09

86.66

mu/l

1.26

361

Malignant neoplasm of breast, HER2-negative

313

2076

0.97

0.18

1.5

46.58

54.17

mu/l

0.43

279

1886

Follow-up care involving plastic surgery

223

1.12

0.18

1.4

36.74

77.92

mu/l

0.85

199

Malignant neoplasm of testis

1.17

0.18

1.3

1.6

40.57

111.23

mu/l

—

Other/unspecified rheumatoid arthritis

708

1.06

0.17

1.4

54.72

65.74

mu/l

0.32

624

Burns and corrosions of external body surface, specified by site

640

1.06

0.17

1.3

1.5

53.07

72.05

mu/l

0.61

572

Obstructed labour due to maternal pelvic abnormality

1038

0.95

0.16

1.5

109.33

47.84

mu/l

0.65

937

Contact with other sharp object(s)

369

1.09

0.16

1.6

52.16

74.85

mu/l

0.56

333

Spirochaetal infections, other/unspecified

534

1.07

0.16

1.6

1.4

74.28

56.82

mu/l

0.22

478

Secondary malignant neoplasm of respiratory and digestive organs

0.78

0.15

2.0

1.3

76.45

80.10

mu/l

—

Personal history of certain other diseases

1.16

0.15

1.9

1.4

45.90

49.82

mu/l

—

Non-follicular lymphoma

526

1.07

0.15

1.3

1.4

39.71

77.47

mu/l

1.25

472

Maternal care for known or suspected malpresentation of fetus

114

847

0.96

0.15

2.1

2.0

48.82

52.52

mu/l

0.13

108

781

Malignant neoplasm of respiratory system and intrathoracic organs, including Hilmo

152

1207

1.04

0.14

1.4

1.3

86.17

64.06

mu/l

0.43

128

1082

Human immunodeficiency virus [HIV] disease

0.80

0.14

2.3

1.3

47.69

63.37

mu/l

—

Benign neoplasm of breast

758

0.95

0.14

1.8

1.5

47.11

54.27

mu/l

0.20

683

Toxic effect of carbon monoxide

1.19

0.14

1.2

1.3

68.28

75.80

mu/l

—

Alzheimer disease, excluding more controls

607

1.04

0.14

1.2

1.5

37.05

56.16

mu/l

0.94

538

Other infestations, including avohilmo

0.83

0.14

1.3

31.32

64.57

mu/l

—

All dysplastic lesions of the cervix uteri

174

1666

1.03

0.12

2.2

1.8

61.25

53.69

mu/l

0.22

163

1524

Other ill-defined and unspecified causes of mortality

444

1.06

0.11

1.3

1.4

40.93

87.16

mu/l

1.40

392

Other sexually transmitted chlamydial diseases, including avohilmo

517

0.95

0.11

1.8

1.7

48.52

63.80

mu/l

0.69

473

Malignant neoplasm of bronchus and lung

108

931

0.97

0.10

1.4

1.3

102.81

64.45

mu/l

0.59

835

Unspecified dementia

416

0.95

0.10

1.2

1.3

81.01

55.36

mu/l

0.28

361

Cleft palate

1.09

0.09

1.4

1.3

17.06

228.59

mu/l

—

Foreign body on external eye

920

1.03

0.09

2.1

1.5

69.41

79.16

mu/l

0.16

836

HSIL lesion of the cervix uteri

116

1128

1.03

0.09

2.1

1.8

37.14

54.72

mu/l

1.65

110

1034

Ductal carcinoma of pancreas

1.04

0.09

1.6

1.3

88.52

85.59

mu/l

—

Pregnancy examination and test

626

0.97

0.09

1.9

2.0

48.75

50.65

mu/l

0.05

580

Arteriovenous malformation of cerebral vessels

1.07

0.08

1.2

120.13

88.40

mu/l

—

Mesothelioma, including Hilmo

1.07

0.08

1.0

1.2

19.30

89.47

mu/l

—

Malignant neoplasm of breast, HER-negative

140

1313

1.02

0.08

1.4

56.30

52.80

mu/l

0.09

126

1179

Pedestrian injured in collision with car, pick-up truck or van

107

1.12

0.08

1.4

1.3

19.38

60.51

mu/l

0.95

100

Congenital malformations of ovaries, fallopian tubes and broad ligaments

302

1.06

0.08

2.3

1.6

185.03

64.22

mu/l

0.79

278

Retinal breaks without detachment

112

1092

1.03

0.08

1.9

1.4

61.92

59.44

mu/l

0.05

103

988

Brain glioblastoma, helper endpoint

1.03

0.08

1.3

1.2

32.73

78.05

mu/l

—

Tuberculosis

254

1.06

0.07

1.5

1.3

20.94

63.19

mu/l

2.25

223

Accidental poisoning by and exposure to alcohol

0.84

0.07

3.4

1.4

49.76

65.78

mu/l

—

Superficial injury of neck

0.82

0.07

1.0

1.3

31.96

75.99

mu/l

—

Other assisted single delivery

1.07

0.07

1.2

2.0

22.19

47.56

mu/l

—

Overjet

127

1.10

0.07

3.2

1.7

113.84

63.56

mu/l

0.30

118

Torsion of testis

1.05

0.07

1.9

1.6

50.56

56.93

mu/l

—

Portal vein thrombosis

1.02

0.07

1.1

1.3

71.79

42.43

mu/l

—

Malignant neoplasm of respiratory system and intrathoracic organs

127

1075

0.98

0.07

1.4

1.3

93.24

65.63

mu/l

0.47

109

960

Tularaemia, including avohilmo

0.86

0.06

2.6

1.3

37.04

69.25

mu/l

—

Toxic effect of ethanol

183

0.93

0.06

2.2

1.4

20.37

59.44

mu/l

1.81

166

Motorcycle rider injured in other and unspecified transport accidents

306

1.05

0.05

1.8

1.6

62.46

66.63

mu/l

0.06

278

Ill-defined and unknown causes of mortality

494

1.03

0.05

1.3

1.4

37.67

81.50

mu/l

1.51

439

Other predominantly sexually transmitted diseases, not elsewhere classified

109

1071

1.02

0.05

2.0

1.8

57.32

61.26

mu/l

0.10

102

976

Undefined dementia

417

0.97

0.03

1.2

1.3

81.01

56.57

mu/l

0.26

358

Schizoid personality disorder

1.09

0.03

1.4

1.3

33.28

77.58

mu/l

—

Malignant neoplasm of bronchus and lung, including Hilmo

131

1081

1.01

0.02

1.5

1.3

94.56

65.36

mu/l

0.50

109

967

Retained placenta and membranes, without haemorrhage

790

0.99

0.02

1.7

1.6

84.52

46.20

mu/l

0.64

712

Hepatocellular carcinoma

1.08

0.02

1.1

1.2

363.96

103.31

mu/l

—

Organic, including symptomatic, mental disorders

370

2611

1.00

0.01

1.4

71.31

59.09

mu/l

0.48

321

2327

Pterygium

133

1.05

0.01

1.9

1.2

39.65

62.74

mu/l

0.42

118

Dementia in other diseases classified elsewhere

223

1.03

0.01

1.2

1.4

86.45

56.27

mu/l

0.35

197

Persistent delusional disorders

407

0.98

0.01

1.4

28.38

51.39

mu/l

1.16

365

ILD, hospital admissions 3, with pneumonia sepsis

436

0.99

0.00

1.4

32.73

69.43

mu/l

1.47

391

Single delivery by caesarean section

133

755

1.00

0.00

1.9

2.0

41.37

62.41

mu/l

1.50

124

689

Impacted teeth

117

1004

1.00

0.00

1.8

1.9

65.69

67.33

mu/l

0.03

110

922

Impacted cerumen

673

1.00

0.00

1.6

1.4

112.85

69.43

mu/l

0.49

592

Diffuse brain injury

121

0.99

0.00

2.7

1.5

47.07

37.43

mu/l

0.17

104

ILD, hospital admission 2, with pulmonary infections

502

1.00

0.00

1.3

1.4

35.27

56.05

mu/l

1.01

447

Alzheimer’s disease (Atypical or mixed), excluding more controls

267

1.01

0.00

1.2

1.6

63.71

42.27

mu/l

0.27

240

Respiratory tuberculosis

224

0.98

0.00

1.3

21.34

63.06

mu/l

1.84

196

Respiratory tuberculosis, confirmed and not-confirmed

224

0.98

0.00

1.3

21.34

63.06

mu/l

1.84

196

Benign neoplasm: other/unspecified salivary gland

122

0.98

0.00

1.4

1.2

53.75

101.03

mu/l

0.46

110

Dilated cardiomyopathy

664

0.99

0.00

1.3

1.4

142.64

69.52

mu/l

0.45

595

Erosion and ectropion of cervix uteri

152

0.99

0.00

2.1

1.4

45.46

41.08

mu/l

0.08

138

Malignant neoplasm of liver and intrahepatic bile ducts

141

0.99

0.00

1.1

1.3

268.79

82.97

mu/l

0.37

128

Benign neoplasm: Other and unspecified parts of mouth

171

0.99

0.00

1.5

1.4

63.02

91.54

mu/l

0.29

155

Ankylosing spondylitis, ICD10

499

1.00

0.00

1.4

1.5

34.22

75.78

mu/l

1.68

455

Suppurative otitis media, unspecified

107

1.03

0.00

1.4

38.40

72.84

mu/l

0.62

Injury of muscle and tendon at ankle and foot level

135

0.96

0.00

1.0

1.3

147.40

60.91

mu/l

0.41

122

Disorders of globe

115

0.96

0.00

2.0

1.3

47.62

55.90

mu/l

0.08

105

Macrocephaly

0.00

0.0

2.2

—

1716.26

—

Intentional self-harm by jumping or lying before moving object

0.00

0.0

1.2

—

20.29

—

Toxic effect of metals

0.00

0.0

1.2

—

13.66

—

Carcinoma in situ of anus and anal canal

0.00

0.0

1.0

—

20.08

—

Fracture of upper limb, level unspecified

0.00

0.0

1.0

—

23.86

—

Tuberculosis of nervous system

0.00

0.0

1.1

—

22.62

—

Chronic bullous disease of childhood

0.00

0.0

1.3

—

25.10

—

Diaper [napkin] dermatitis

0.00

0.0

1.0

—

22.18

—

Defect, injury or illness of skull

0.00

0.0

1.0

—

16.51

—

Tuberculosis of nervous system, including avohilmo

0.00

0.0

1.1

—

22.62

—

Diphtheria, including avohilmo

0.00

0.0

1.2

—

16.84

—

Dislocation of lens

0.85

0.00

1.6

1.2

9.60

88.94

mu/l

—

Unspecified contact dermatitis due to drugs in contact with skin

0.00

0.0

1.0

—

22.70

—

Malignant neoplasm of testis, including Hilmo

0.99

-0.00

1.3

1.5

40.57

96.08

mu/l

—

HSIL lesion of the vagina

0.89

-0.00

1.0

1.3

72.57

52.24

mu/l

—

Traumatic amputation of wrist and hand

210

1.00

-0.00

1.3

1.4

88.11

83.16

mu/l

0.04

187

Congenital musculoskeletal deformities of head, face, spine and chest, including avohilmo

0.85

-0.00

1.4

35.88

93.97

mu/l

—

Other disturbances of cerebral status of newborn

0.00

-0.00

0.0

1.8

—

39.50

—

Other conditions originating in the perinatal period

0.00

-0.00

0.0

1.6

—

41.30

—

Use of benzatropine

0.00

-0.00

0.0

1.0

—

18.96

—

Use of pergolide

0.00

-0.00

0.0

1.2

—

17.24

—

Congenital absence of the uterus

0.00

-0.00

0.0

1.4

—

35.03

—

Other congenital malformations of eye

0.00

-0.00

0.0

1.8

—

1411.12

—

Other meningitis

0.91

-0.00

1.8

1.3

93.43

73.58

mu/l

—

Other protozoal diseases, not elsewhere classified/unspecified, including avohilmo

0.00

-0.00

0.0

1.0

—

25.75

—

Diphtheria

0.00

-0.00

0.0

1.2

—

16.84

—

Erysipeloid

0.00

-0.00

0.0

1.0

—

23.00

—

Other respiratory conditions originating in the perinatal period

0.00

-0.00

0.0

1.2

—

1664.24

—

Phlebitis and thrombophlebitis of unspecified site, drug-induced

0.00

-0.00

0.0

1.3

—

16.30

—

Congenital glaucoma

0.00

-0.00

0.0

2.0

—

36.54

—

Ebstein's anomaly

0.00

-0.00

0.0

1.0

—

28.47

—

Nocardiosis, including avohilmo

0.00

-0.00

0.0

1.3

—

23.59

—

Diphyllobothriasis and sparganosis, including avohilmo

0.00

-0.00

0.0

1.0

—

20.95

—

Noonan syndrome

0.00

-0.00

0.0

1.8

—

69.68

—

Single ventricle heart

0.00

-0.00

0.0

1.4

—

33.96

—

Hypersensitivity pneumonitis due to organic dust

1.00

-0.00

2.3

1.2

56.67

75.12

mu/l

—

Mature T/NK-cell lymphomas, hilmo

0.89

-0.00

1.0

1.2

119.00

78.36

mu/l

—

Kidney diseases associated to Fabry's disease

0.00

-0.00

0.0

1.1

—

18.22

—

Fibrosis and sclerosis of liver

0.00

-0.00

0.0

1.0

—

405.40

—

Benign neoplasm of mesothelial tissue

0.00

-0.00

0.0

1.0

—

18.31

—

Hereditary factor XI deficiency

0.00

-0.00

0.0

1.0

—

22.02

—

Disorders of glycoprotein metabolism

0.00

-0.00

0.0

1.0

—

27.24

—

Disorders of muscle in diseases classified elsewhere

0.00

-0.00

0.0

1.2

—

16.68

—

Brain glioblastoma

1.01

-0.00

1.3

32.73

83.95

mu/l

—

Sequelae of hyperalimentation

0.00

-0.00

0.0

1.2

—

14.67

—

Thyrotoxicosis from ectopic thyroid tissue

0.00

-0.00

0.0

1.2

—

14.22

—

Nail disorders in diseases classified elsewhere

0.00

-0.00

0.0

1.0

—

10.76

—

Induced delusional disorder

0.00

-0.00

0.0

1.0

—

22.52

—

Scleritis and episcleritis in diseases classified elsewhere

0.00

-0.00

0.0

1.0

—

12.72

—

Disorders of olfactory nerve

0.00

-0.00

0.0

1.0

—

12.67

—

Other accidental hanging and strangulation

0.00

-0.00

0.0

1.0

—

20.70

—

Progressive external ophthalmoplegia

0.00

-0.00

0.0

1.0

—

19.76

—

Accident to watercraft causing other injury

0.00

-0.00

0.0

1.1

—

26.43

—

Guillain-Barre syndrome

0.98

-0.00

1.3

1.2

84.66

66.12

mu/l

—

Toxic effect of soaps and detergents

0.00

-0.00

0.0

1.0

—

16.58

—

Traumatic amputation of hip and thigh

0.00

-0.00

0.0

1.1

—

271.10

—

Mucinosis of skin

0.00

-0.00

0.0

1.1

—

22.86

—

Pustulosis subcornealis

0.00

-0.00

0.0

1.0

—

13.84

—

Café au lait spots

0.00

-0.00

0.0

1.2

—

36.25

—

Other abnormal auditory perceptions

0.89

-0.00

1.2

1.3

10.28

96.32

mu/l

—

Malignant neoplasm of other and unspecified male genital organs

0.00

-0.00

0.0

1.0

—

481.14

—

Chondrolysis

0.00

-0.00

0.0

1.2

—

25.82

—

Other disorders of skin and subcutaneous tissue related to radiation

0.00

-0.00

0.0

1.1

—

24.40

—

Organic amnesic syndrome, not induced by alcohol and other psychoactive substances

0.00

-0.00

0.0

1.2

—

14.08

—

Flexion deformity

0.00

-0.00

0.0

1.1

—

13.05

—

Chronic postrheumatic arthropathy [Jaccoud]

0.00

-0.00

0.0

1.0

—

25.70

—

Injury of blood vessels at ankle and foot level

0.00

-0.00

0.0

1.3

—

21.93

—

Psoriatic arthropathies, strict definition

0.00

-0.00

0.0

1.0

—

19.43

—

Beta thalassaemia

0.00

-0.00

0.0

1.2

—

15.70

—

Congenital absence of the vagina

0.00

-0.00

0.0

1.3

—

39.70

—

Common variable immunodeficiency with predominant abnormalities of T-cell numbers and function

0.00

-0.00

0.0

1.0

—

24.98

—

Nocardiosis

0.00

-0.00

0.0

1.3

—

23.59

—

Turner's syndrome

0.00

-0.00

0.0

1.4

—

37.47

—

Pectus carinatum

0.00

-0.00

0.0

1.0

—

27.28

—

Polydactyly

0.00

-0.00

0.0

1.0

—

25.00

—

Ascariasis

0.00

-0.00

0.0

1.3

—

20.84

—

Lipodystrophy, not elsewhere classified

0.00

-0.00

0.0

1.0

—

22.33

—

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Renin [Units/volume] in Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS